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Preface 
 
This thesis in clinical nutrition for the degree of Candidata Scientiarum is written in the form 
of an article, i.e., it includes a manuscript for an article, which represents the work performed 
for this thesis. The results are thoroughly presented and discussed in the article. A more in 
depth introduction than the one in the article is included in the thesis, and a detailed section on 
materials and methodology, as well as a presentation of the most important results and a more 
thorough conclusion than contained in the article.  
 
Lisa Berg Ajmi 
 
 
 Summary 
 
Background 
This experiment was performed at the Norwegian Institute of Public Health as a study 
preliminary to a larger project in cooperation with Rikshospitalet University Hospital. 
 
 The reason for the increasing colorectal cancer (CRC) incidence trend over time in Norway 
compared with its neighbouring countries is obscure. Norway is, however, diverging in an 
important factor; we have been consuming hydrogenated fish oil and cod liver oil to a greater 
extent than our neighbours during the last century. 
 
 The first aim of this study was to examine whether hydrogenated fish oil (HFO) in the diet 
would increase induction and/or growth of CRC. Since it is unethical to treat humans with 
potentially harmful amounts of fat, the effects of HFO in the diet was tested on A/J mice 
treated with azoxymethane (AOM). Because of the complex composition of hydrogenated 
oils, the intension was to correlate potential biological effects to degree of hydrogenation 
rather than to specific fatty acids in the oil. This was done by using three degrees of HFO; 
partially hydrogenated fish oil (PHFO), highly hydrogenated fish oil (HHFO), and totally 
hydrogenated fish oil (THFO). As controls, fish oil (FO), butter oil (BO), soybean oil (SO), 
and soybean oil similarly hydrogenated as the fish oil (HSO); partially hydrogenated soybean 
oil (PHSO), highly hydrogenated soybean oil (HHSO), and totally hydrogenated soybean oil 
(THSO), were used. In this way, the study included oils exemplifying some of those used in 
the Norwegian household during different time periods. 
 
 The second aim was therefore to examine patterns of effect in the material which might be 
elicited through the four analyses. This was done by thorough description and discussion of 
the results; also including non statistically significant, in the manuscript for an article. In the 
thesis, mostly statistically significant results.were treated in the Results Chapter. In addition, a 
view to the specific oils was given.  
 
The problem was approached by setting up three hypotheses, which were tested by the use of 
general working hypotheses in four series of analyses. To aid the problem solving, the data 
material was first checked for possible protecting properties of unhydrogenated FO. 
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Methods 
Relations between induction and/or growth of CRC and diets with 19 w/w % (and 1 w/w % 
corn oil) of three different degrees of HFO; PHFO, HHFO or THFO, mixed with AIN-76M, 
were studied. As controls, native FO, BO exclusive water and salt, refined SO, and three 
degrees of HSO; PHSO, HHSO, and THSO, similarly hydrogenated as the HFO, were used. 
Tumors were induced by AOM-injections at age 1 and 2 weeks, and the animals were fed the 
diets from day 4 until killed at age 15 weeks. The surface of unsectioned methylene blue 
stained colon preparations of 104 female and 95 male animals was examined by 
transillumination in an inverse light microscope, and differences in induction (tumor 
incidence and number) and growth (tumor size) of CRC and in tumor load (considers both 
induction and growth) between the diets were studied.  
 
Results  
The words “tend” and “tendency” are used when  0.20 ≥ p > 0.05, “seem” and “seemingly” 
when p > 0.20, and the rest is statistically significant, i.e., p ≤ 0.05.  
 
The protecting properties of FO. In the preanalysis, unhydrogenated FO tended to reduce 
induction of CRC and tumor load, and seemed to increase growth of CRC in females relative 
to males. Compared with SO, FO protected females considerably against induction and 
seemed to protect them moderately against growth, but males were seemingly not protected. 
Compared with BO, FO seemed to protect both genders considerably against induction, but 
not against growth.  
 
When fish oil was hydrogenated, no evidence was found of HFO increasing induction and/or 
growth of CRC regarding to unhydrogenated FO, irrespective of gender. Compared with FO; 
in females, all the HFO seemed to have lost some protecting properties regarding induction, 
increasing it considerably, but to have gained protecting properties regarding growth, 
reducing it considerably, and only PHFO seemed to increase tumor load compared with FO. 
 
In males, THFO tended to have lost protective properties regarding induction, increasing it 
considerably, seemed to have gained protecting properties regarding growth, reducing it, and 
seemed to increase tumor load considerably, while HHFO seemed to have gained protecting 
properties regarding both induction and growth of CRC, reducing all the tumor parameters, 
compared with FO. 
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Judged by hydrogenation degree, the PH degree of fish or soybean oil seemed to be the most 
harmful in increasing induction of CRC, but of the two PH, only PHSO led to seemingly 
extremely large tumor load irrespective of gender, possibly indicating harmful substances in 
PHSO and protecting substances in PHFO. PHSO seemed to almost double tumor load in 
females relative to males, possibly indicating differential modulation by female and male sex 
hormones.  
 
For males, the TH degree of fish or soybean oil seemed to be equally harmful as PHSO in 
induction, but only PHSO and THFO led to equally substantially large tumor load in males, 
possibly indicating harmful substances in THFO compared with THSO. THFO seemed 
substantially more harmful for males than for females regarding induction of CRC and tumor 
load, but substantially more harmful for females than for males regarding growth, which 
might indicate differential effects in the induction and growth phases of CRC by substances in 
this oil, also differentially modulated by female and male sex hormones. These indications 
also seemed to pertain to THSO, albeit to a lesser degree, and THFO seemingly increased 
tumor load substantially compared with THSO, but only in males.  
 
The HH degree of both fish and soybean oil seemed to give body weight among the lowest 
and to protect the animals of both genders regarding induction and tumor load (together with 
THFO in females), while HHSO seemed to give the most extreme tumor size.  
 
Conclusion.  
Certain effect patterns in this material seemed to indicate that the effects of the experimental 
oils on colorectal carcinogenesis in the AOM treated A/J mice, in addition to being influenced 
by gender and body weight, might be different in the induction and growth phase of CRC, and 
dependent on type of oil in the diet and hydrogenation degree, the latter might differ between 
HFO and HSO. These indications were not based on statistically significant results only, so 
they must be taken for what they are worth. Some evidence was however found. 
 
No statistically significant evidence was found of increasing CRC by HFO relative to 
unhydrogenated FO, with loss of protecting properties, nor of increasing effects with 
increasing hydrogenation degree; which would have indicated that the effects of HFO were 
due to a change in fish oil by the hydrogenation process per se. 
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That the HH degree of HSO reduced induction of CRC relative to the TH degree, indicated 
that the effects of HSO were dependent on specific hydrogenation degrees, i.e., were related 
to specific substances in these oils. Even if the null hypotheses for HFO could not be rejected,
the possibility that also the effects of HFO might be dependent on specific hydrogenation 
degrees could not be ruled out. 
 
No statistically significant evidence was either found of increased effects of HFO relative to 
corresponding hydrogenation degrees of HSO. On the contrary, when the effects were 
examined with a view to the specific oils, however, it seemed as HSO were more harmful 
than HFO; all the tumor parameters seem to be increase by PHSO relative to PHFO, and 
statistical evidence was found for tumor number and load  in males. 
 
In the view to the specific oils, it actually seemed as any of the experimental oils, including 
those that were exemplifying oils consumed in Norway over different time periods, might 
contain substances that are risk factors in colorectal carcinogenesis; in any way in these 
animals. Even if it had been possible to draw this conclusion for the A/J mice, findings in 
experimental animals will not necessarily apply to man. The mouse is, however, the model 
organism which is closest to humans. 
 
If the oils in this experiment really may exemplify oils used in Norway, and if the results of 
this study might apply to humans; the results would have indicated that of the examined oils, 
HHFO might not be the most likely fat to play a role in the increasing CRC trend in Norway 
compared with its neighbouring countries. More likely candidates would be PHFO or FO (as 
cod liver oil), which besides HHFO were the only of the experimental oils with increased 
consumption relative to the other Nordic countries, and which were used to a great degree 
long enough and early enough to have affected the rising trend in Norway, which started at 
least as late as in the 1950s, when the registering of the CRC incidence started. 
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LA Linoleic acid 
LCFA Long chain fatty acids 
LCFFA Long chain free fatty acids 
LCPUFA Long chain polyunsaturated fatty acids 
LDL Low-density lipoproteins 
LM Light microscope 
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LOH Loss of heterozygosity, i.e. loss of one allele in a tumor cell 
 from a chromosomal region for which the individual’s 
 normal cells are heterozygous 
LOX Lipoxygenase 
LP Lipoproteins 
Lp(a) Lipoprotein (a) 
LPL Lipoprotein lipase 
LT Leukotrienes 
MCFA Medium chain fatty acids 
md Estimated median difference 
MG Monoacylglycerols, monoglycerides 
2-MG Glycerol with a fatty acid esterified at carbon 2 
MIN Microsatellite instability  
MMR Mismatch repair 
MP Melting point 
MTHFR Methylene tetrahydrofolate reductase 
MUFA Monounsaturated fatty acids 
n Number of animals (or tumors) in the treatment group 
N Total number of animals (or tumors) in the comparison 
NF-κB Nuclear factor κB 
NAT N-acetyltransferase 
NO• Nitric oxide 
NSAID Nonsteroidal anti-inflammatory drugs 
ODC Ornithine decarboxylase 
PG Prostaglandins 
PH Partial hydrogenation 
PHFO Partially hydrogenated fish oil 
PHSO Partially hydrogenated soybean oil 
PL Phospholipids 
PLA2 Phospholipase A2
PPAR Peroxisomal proliferator-activated receptors, transcription 
 factors that can bind to regulatory elements of DNA along 
 with another protein and a fatty acid 
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P/S ratio Ratio of PUFA:SFA 
PUFA Polyunsaturated fatty acids 
Ras Proto-oncogene 
RM1 (E) Rat & Mouse No. 1 Maintenance Diet 
RM3 Rat & Mouse No. 3 Breeding Diet 
RR Relative risk 
SCFA Short chain fatty acids 
SFA Saturated fatty acids 
SO Soybean oil, refined 
t Double bond in trans configuration: the hydrogen atoms are 
 placed on opposite sides of the bond 
TFA Trans fatty acids 
TG Triglycerids, also referred to as triacylglycerols 
TGF Transforming growth factors 
TH Total hydrogenation 
THFO Totally hydrogenated fish oil 
THSO Totally hydrogenated soybean oil 
TX Thromboxanes 
UFA Unsaturated fatty acids 
VLCFA Very long chain fatty acids 
VLCSFA Very long chain saturated fatty acids 
VLCUFA Very long chain unsaturated fatty acids 
VLDL Very low density lipoproteins 
Wnt Pronounced “wint”. Wnt was introduced 20 years ago and 
 fused the  names of two orthologous genes: Wingless (Wg), 
 a Drosophila gene, and Int-1, a mouse proto-oncogene 
w/w % % by weight 
 
 WORD EXPLANATIONS 
 
Aberrant crypt foci Defined as crypts that have altered luminal openings, 
 exhibit thickened epithelia, and are larger than  adjacent 
 normal crypts 
Adenocarcinoma Malignant neoplasm, cancer 
Adenoma Gland like structure, benign neoplasm of epithelial tissue, 
 dysplastic polyp, non-invasive tumor 
Angiogenesis The growth of new blood vessels 
Apoptosis Programmed cell death 
Carcinoma Invasive tumor, cancer 
Carcinoma in situ A lesion characterized by cytologic changes of the type 
 associated with invasive carcinoma, but with the pathologic 
 process limited to the lining epithelium; a localized and 
 curable face of carcinoma; must not exceed the muscularis 
 mucosae 
Chylomicron The primary secretory unit of the enterocyte, containing re-
 organized absorbed fatty acids, 2-monoglycerids, phospho-
 lipids, lysophospholipids, cholesterol, phytosterols and 
 smaller amounts of glycerol 
Circadian Relating to biologic variations or rhythms with a cycle of 
 about 24 hours 
CYP-450 monooxygenase Microsomal cytochrome P450 monooxygenase system 
 is a hemeprotein oxidase system found in the liver 
De novo fatty acid synthesis Lipogenesis 
Eicosanoids Oxidized products of fatty acids with 20 carbon atoms 
Epigenetic mechanisms A variety of mechanisms that influence the behaviour but 
 not the structure of DNA 
Genotype The genetic constitution of an individual or, more 
 specifically, the alleles at specific genetic loci 
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Geometrical isomerism Here: An unsaturated fatty acid in two or more forms that 
 are identical with respect to percentage composition but 
 differs as to the restriction of free rotation about a carbon-
 carbon bond in the molecules, cf. cis-, trans-, and also in 
 physical and chemical properties 
Iodine value, decreasing Indicates a general loss of unsaturation 
Leptin Protein secreted by fat cells, acting via its receptor in 
 hypothalamus, and regulating energy expenditure and 
 metabolism 
MIN pathway Microsatellite instability pathway  
MMR proteins Mismatch repair proteins, take care of replication errors 
Morphologic Relating to configuration (form, shape, structure) 
Mount Preparat 
Mucosa In the GI tractus: A mucous tissue consisting of epithelium, 
 lamina propria and a layer of smooth muscle 
Oncogene An activated proto-oncogene, which allow unchecked 
 proliferation of the cells (the accelerator is stuck). “Gain of 
 function” 
Positional isomerism Here: An unsaturated fatty acid in two or more forms that 
 are identical with respect to percentage composition but 
 differs as to the position of one or more double bonds within 
 the molecules, and also in physical and chemical properties 
Prevalence The number of persons who at a specific point in time have 
 a specific diagnosis 
Prostanoids Prostaglandins and thromboxanes 
Proto-oncogene A gene which produces growth-controlling proteins, only 
 one genetic event is required to turn it into an oncogene 
Tumor Swelling, benign or malign neoplasm 
Tumor suppressor gene Gene producing proteins that prevent the cell from 
 reproducing at inappropriate times, or when the DNA is 
 extensively damaged; requires two genetic events, one in 
 each allele, for its inactivation; “Loss of function” 
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Wnts A large family of secreted glycoproteins with at least 19 
 known human members, expressed in species ranging from 
 Drosophila to man, the most upstream ligands of the Wnt 
 signalling pathway 
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 1 INTRODUCTION 
 
1.1 COLORECTAL CANCER 
 
1.1.1 COLORECTAL CANCER IN THE NORDIC COUNTRIES 
Colorectal cancer (CRC) is the most common cause of cancer related death in the Western 
world (1). For the Nordic countries, CRC in 1993-1997 comprised 12.8% and 12.9% of all 
male and female cancer cases, respectively (2). The risk of CRC increases with increasing 
age; in this period, more than 90% of the cases were diagnosed among people aged 55 years 
or more (3). The trends in the incidence rates for males and females have been similar in each 
of the Nordic countries but greatly different between the countries (Figure 1). Since the 
1970s, the Norwegian rates have overtaken both the Swedish and the Danish rates, and are 
now the highest in the Nordic countries (2).  
 
In Norway, colorectal cancer is the most common form of cancer men and women seen 
together, in males secondary to prostate cancer and in females secondary to breast cancer (4). 
In 2001 there were 1,059 cases of colon cancer and 570 cases of rectal cancer in men, 
compared to 1,178 and 471 cases in women. Prevalence of diagnosed colon cancer 
31.12.2001 was estimated to 13,576 and of rectal cancer 7,169. Because of a decline in the 
risk for younger cohorts, the Norwegian incidence rates are predicted to peak 2003-2007, and 
decrease towards 2018-2022 for both sexes (5). 
 
1.1.2 CARCINOGENESIS 
Carcinogenesis results from interplay between environmental factors and susceptibility genes 
that sets off a complex series of neoplastic events. Hanahan and Weinberg suggested that 
most if not all cancers have acquired the same set of functional capabilities during their 
development, albeit through various mechanistic strategies (Figure 2) (6). 
 
Important genes in carcinogenesis 
The gut epithelium is a highly proliferative organ, with high rates of cell loss that need to be 
continually replaced. Homeostasis is achieved by a fine balance between cellular 
proliferation, differentiation and cell death (7). Genes that are involved in this delicate balance
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Figure 1 Observed and predicted age-adjusted incidence rates in the five Nordic countries: colorectal cancer. Møller B. (2). 
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Figure 2 Essential alterations inn cell physiology which collectively dictate malignant growth. Hanahan D. (6). 
 
and also involved in genetic alteration, may be classified into proto-oncogenes, tumor 
suppressor genes and DNA repair genes (8). Proto-oncogenes and tumor suppressor genes are 
genes controlling the cell cycle (9), while DNA repair genes are involved in controlling the 
rate of mutation of other genes (10). One genetic event is enough to activate proto-oncogenes 
to oncogenes, which result in “gain of function”, causing cells to continue to grow in the 
absence of growth signals, an example is K-RAS. Tumor suppressor genes require two genetic 
events, one in each allele, for their inactivation, which results in “loss of function” (10;11), 
examples are APC, and p53. DNA repair genes survey newly replicated DNA for errors and 
repair mismatched bases in the molecule (12), an example is SMAD4.  
 
The adenoma-carcinoma sequence 
Fearon and Vogelstein proposed a multistep adenoma-to-carcinoma model for colorectal 
tumorigenesis (13), based on the assumption that a cell must accumulate four or five defects 
in order to undergo full malignant transformation (Figure 3) (14).  
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Figure 3 Genetic changes associated with colorectal tumorigenesis. A variety of other genetic alterations have each been 
described in a small fraction of advanced colorectal cancers. These may be responsible for the heterogeneity of biologic and 
clinical properties observed among different cases. Kinzler K. W. (15). 
 
Genetic events interact with epigenetic mechanisms, i.e. heritable traits mediated by DNA 
changes other than nucleotide sequence; the pathways of chromosomal instability (CIN) and 
microsatellite instability (MIN) (Figure 4), ensure fast accumulation of mutations allowing 
loss of tumor suppressor genes, activation of proto-oncogenes, and dysregulated expression of 
various molecules (16).  
 
 
Figure 4 Two independent pathogenic pathways for colorectal cancer. They are supposed to diverge after initial inactivation 
of both alleles of the gatekeeper APC. Tejpar S. (17). 
 
Aberrant crypt foci 
Normally, most new intestinal crypts arise in a short postnatal period by crypt fission, and 
only gradually with age (18-23). Elevated rates of crypt fission is the major defect in 
preneoplastic intestine and the mode by which microadenomas enlarge (24), common both in 
human hyperplastic polyps and sporadic colorectal adenomas (25). Aberrant crypt foci (ACF), 
detected by R. Bird in 1987 on the surface of intestinal mouse mucosa as elevated lesions 
(26), was later found by Paulsen et al to include flat lesions with dysplastic crypts similar to 
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those found in adenomas (27). As putative adenoma precursors, ACF are used as biomarkers 
to evaluate agents influencing colon carcinogenesis (28).  
 
1.1.3 HEREDITARY COLORECTAL CANCER 
Hereditary CRC is defined by an inherited predisposition (29). Epidemiological studies have 
suggested that approximately 15% of CRC occur in dominantly inherited patterns (30;31). 
Examples are familial adenomatous polyposis (FAP) and hereditary non-polyposis colorectal 
cancer (HNPCC). 
 
Adenomatous polyposis was first observed in the mid 18th century, the inherited nature of 
adenomatous polyposis coli (APC) was recognized by 1900, and APC was identified and 
proved to cause FAP in 1991 (32;33). The rate limiting step in tumor initiation is a somatic 
mutation or loss of the wildtype APC allele inherited from the unaffected parent (34;35), 
involving the CIN pathway (17). FAP patients typically develop hundreds to thousands of 
benign colorectal tumors during their second and third decades of life, of which some are 
virtually guaranteed to progress to carcinomas. FAP affects about 1 in 7000 individuals (15). 
 
HNPCC is characterized by an early onset of CRC at a median age of 42, usually in the 
proximal colon (36). The diagnosis is based mainly on family history. The patient has 
multiple primary tumors (12). The defect in HNPCC largely targets the genome guardian 
function of DNA mismatch repair involving the MIN pathway (17). HNPCC is thought to 
account for 5-10% of all CRCs (15).  
 
These syndromes have provided unique insights into the process of colorectal carcinogenesis, 
also at work in sporadic forms of human tumors (15).  
 
1.1.4 SPORADIC COLORECTAL CANCER 
CRC not associated with hereditary cancer syndromes are defined as sporadic, but the 
distinction between inherited and spontaneous CRC is vague. Sporadic cancers depend on 
interaction between host genetic background of polymorphisms in genes controlling many 
aspects of tumor development and environmental carcinogens (1;37-41). A colorectal 
epithelial cell generally requires 20-40 years to transform into a metastatic tumor cell (42). 
Average lifetime risk of developing sporadic CRC after age 50 is approximately 5%, while 
the likelihood is doubled in persons with one affected first degree relative (14). Tumors can 
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arise anywhere in the large bowel, although the majority of sporadic cancers are distal to the 
splenic flexure (1). For human carcinogenesis, particularly in relation to the interactions with 
diet, the process of carcinogenesis can be envisaged as a series of events including the three 
stages of initiation, promotion and progression, originally identified in animals (11).  
 
APC can arise spontaneously (43), and adenomatous polyps are found sporadically in 
approximately 33% of the general population by the age of 50 and in approximately 50% by 
the age of 70 (14). 10-20% of these polyps progress to cancer (13;44). The National Polyp 
Study shows a definite relationship between colorectal adenomas and carcinomas (14).  
 
The APC gene is regarded as the gene for CRC (15), mutated in approximately 85% of cases 
(45;46). APC mutations are sufficient to initiate growth of small benign tumors, but not to 
make them progress to more advanced forms (47). APC interacts with numerous molecules 
(48), and one of its functions is control of the WNT signal transduction pathway (48-51) 
(Figure 5). Somatic APC mutations lead to upregulation of β-catenin levels and activity (52). 
Activation of the β-catenin signalling pathway is not only an initiating event, but also plays a 
 
 
Figure 5 The WNT signalling pathway. a. In the absence of a WNT signal, the level of free intracellular β-catenin, which is 
in equilibrium with β-catenin at adherens junctions, is minimized by sending it for degradation in the destruction complex. 
Consequently, β-catenin cannot reach the nucleus. b. In the presence of WNT, its receptor is activated. This leads to a 
signalling cascade which inhibits the regulating destruction of β-catenin and keeps is free to diffuse into the nucleus, where it 
acts as a co-activator for TCF-responsive genes. Fodde R. (49). 
 
pivotal role in the promotion stage of colorectal carcinogenesis (53). In the few CRC without 
mutations in APC or β-catenin, other genes in the same pathway are likely to blame (42). 
 6 
Effects of hydrogenated fish oil in experimental colorectal carcinogenesis in A/J mice      Introduction 
                
Mutations in members of the transform-
ing growth factor-β (TGF-β) signalling 
pathway are thought to have a rate limit-
ing role in CRC (Figure 6). In the colo-
rectum, TGF-β inhibits cell growth (54). 
Binding of TGE-β to its receptor leads to 
translocation of SMAD to the nucleus, 
where it co-activates or represses tran-
scription of specific target genes (49). 
Mutations can inhibit TGF-β signalling 
and overcome its growth inhibition (54). 
In general, tumors acquire TGF-β resis-
tance at later stages of malignancy. Loss 
 
 
Figure 6 The transforming growth factor-β (TGF-β) signalling 
pathway. Fodde R. (49). 
of the SMAD4 wild-type allele was detected in 95% of invasive and metastatic cancers (55). 
 
Cancer metastasis is a highly complex process that involves angiogenesis and invasion, 
dissemination, survival in the circulation, and subsequent attachment and growth of cancer 
cells in the metastasis organ (56). Metastases are the cause of 90 % of cancer deaths (6). 
 
1.2 ANIMAL EXPERIMENTS AND RELATION TO HUMANS 
Within cancer research experimental animals are used to elicit preventing or predisposing 
factors and to develop methods for diagnostic and treatment of this disease (57). In 
experimental systems it is possible to ensure the stages of initiation, promotion and 
progression as consequences of exposure to specific, sequential, ordered and non-overlapping 
agents. For humans or other freeliving animal, none of these conditions is likely to occur (11). 
 
Every animal model has its strengths and weaknesses; however, some of these models have 
proven useful in evaluating hereditary factors, whereas other models were found to be useful 
in understanding relations between nutritional factors and colon cancer (58). 
 
Colorectal tumors seldom arise in animal populations, but since rodents easily develop 
adenomas and adenocarcinomas when exposed to synthetical or naturally occurring chemical 
carcinogens, effects of various factors on colorectal carcinogenesis can be studied (59). 
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1.2.1 FROM RODENTS TO HUMANS 
Similarities between humans and rodents are expected because many of the control systems 
preventing the unregulated cell division that leads to cancer must predate the split of rodents 
and primates (60). Analyses have shown that most of the proto-oncogenes and tumor 
suppressor genes found to be altered in humans also were altered in rodents. Even the 
molecular pathways involved in carcinogenesis appear to be similar in some organs (61). The 
genomes of mice and humans are equal in size, and 90 % identity is found in sequence (62). 
 
1.2.2 ANIMAL EXPERIMENTS AND ETHICS 
The close relationship between animals and humans and a feeling of solidarity should lead to 
respect for the animals for what they are. They do not only have an instrumental value, they 
have intrinsic value. The fact that this limits our use of animals, is clearly expressed in laws of 
animal protection (62). Indeed the “Three Rs”, that is reduction, refinement and replacement 
(Table 1) should constantly be borne in mind by all users of experimental animals (63).  
 
Table 1 Guidance to caretaking of the interests of experimental animals. The three Rs scheduled in “The principles of 
humane experimental technique” by Russel and Burch in 1959, reprinted 1992.  
 
 
Reduction Reduction means a decrease in the number of animals used previously with no loss of useful 
 information. This may be achieved by reducing the number of variables through good 
 experimental design, by using genetically homogeneous animals or by ensuring that the 
 conditions of the experiment are rigorously controlled. 
 
Refinement Refinement means a change in some aspect of the experiment that results in a reduction or 
 replacement of animals or in a reduction of any pain, stress or distress that animals may 
 experience. The establishment of early endpoints for intervention in a study that has the 
 potential to cause pain or distress is an example of refinement. 
 
Replacement Replacement often means the use of an inanimate system as an alternative (e.g., a computer 
 model or program, a mannequin). It can also mean the replacement of sentient animals (usually 
 vertebrates) with less sentient animals (usually invertebrates such as worms, bacteria, etc). It 
 also includes the use of cell and tissue cultures. The cells must come from somewhere and 
 often this means animals. 
 
Animal experiments are in Norway regulated by the Animal Welfare Act given by the 
Norwegian Ministry for Agriculture and an additional new Regulation in a special provision 
of the Act. This law states that animal experimentation may not be carried out without special 
permission from the Norwegian Animal Research Authority or persons with authority 
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delegated by this committee (64). Permission can be given when the aim is to collect 
knowledge, examine a hypothesis, produce or control a product or register the effect of a 
certain procedure (62). At the Norwegian Institute of Public Health, the criteria for this 
permission are fulfilled; approved laboratory animal units, animal species, competent persons 
in charge, and research protocols (65).  
 
1.3 LIPID RELATED RISK FACTORS FOR COLORECTAL CANCER 
Epidemiologic studies strongly suggest that the diet can influence CRC incidence. However, 
human diets are so complex that it has been difficult to determine which dietary components 
are responsible for this modulation (66).  
 
Two examples of carcinogens produced endogenously through physiological processes such 
as inflammation, oxidative stress, repetitive tissue injury, and hormonal or nutritional 
imbalances (11;67), are given here. The first is the radical species nitric oxide (NO•) which 
reacts readily with lipids to form products with biochemical actions (68) and is associated 
with human CRC (69). The second is modified bile acids. A greater excretion of these were 
found in patients with colon cancer compared to healthy subjects (70), and the secondary bile 
acid deoxycholate, a promoter of colon cancer, is present at high levels in the colonic lumen 
of individuals on a high fat diet (71).  
 
There is at present a justifiable debate as to the optimum intake level of dietary fat (72). When 
87 colorectal adenoma cases were compared with healthy controls, an increased risk of 
adenomas was found related to a high intake of total fat (73). In a population based case 
control study among five ethnic groups at different risks of CRC in Hawaii, intakes of total, 
saturated (S) and polyunsaturated (P) fat were not related to the risk of CRC, but an inverse 
association was found for the P/S ratio for both genders (74).  
 
The World Health Organization (WHO) have put forward a classification terminology for the 
evidence of causal relationship between dietary factors and cancer (75) (Appendix I). The 
following underlined judgements of causal relationships were taken from the report of 1997 
by the World Cancer Research Fund/American Institute for Cancer Research (11). Among 
dietary factors for which there is convincing evidence for an increase in risk of CRC are 
overweight and obesity. Among dietary factors which possibly increase the risk of CRC are 
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animal fats (75). The mentioned report is, however, somewhat disputed, which is in line with 
the difficulties on the area in singling out causal factors due to complicated interactions of 
dietary, genetic and other bodily factors (76). 
 
Epidemiologic data suggest that particularly the intake of lipids early in life influences later 
cancer incidence (77;78). 
 
1.3.1 CHEMOPREVENTION 
Chemoprevention is defined as the employment of natural compounds or drugs to prevent the 
development of tumors (79). More than 50 pharmacologic agents, singly or in combination, 
have been evaluated as chemoprotective agents in preclinical models of colorectal 
carcinogenesis, including antioxidants such as vitamin E and carotenes (80;81).  
 
Nonsteroidal anti inflammatory drugs (NSAID) are the best known chemopreventive drugs 
(Figure 7) (14). The non selective NSAID inhibit the constitutive as well as the inducible 
cyclooxygenases (COX), resulting in decreased prostaglandin production and a build up 
of intracellular arachidonic acid 
(AA), promoting apoptosis, and 
also promote apoptosis via other 
pathways. NSAID may inhibit 
angiogenesis, and deprive tumors 
of necessary nutrients for growth 
(82). In an NSAID study, higher 
levels of apoptosis in endoscopy 
patients were associated with 
relatively low BMI and relatively 
low fat intakes as a proportion of 
energy (83). NSAID also affect 
leukotrienes via the 5-lipoxygenase 
 
Figure 7 Mechanisms of NSAID-mediated apoptosis. Chan T. A. (82).
(5-LOX) pathway. Selective NSAID inhibit only inducible COX-2 (84).  
 
A diet rich in fruits and vegetables, which according to AICR probably reduces the risk of 
CRC, nuts and grains, with a reduction in fat intake seems to protect against cancer (85). 
The diet should include fish, since fish consumption was reported inversely associated with 
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the risk of CRC in several case-control and cohort studies (86-90), and especially fat fish, 
since Eskimos on Greenland had lower incidence of several diseases than those who lived on 
a traditional Western diet (91). Doll and Peto estimated 90% of colon cancers as avoidable by 
dietary change, largely on the basis of international comparisons. This estimate should be 
reduced to 50% or less because of the clear evidence that physical activity almost surely 
explains some of the international variation (92). 
 
1.4 FAT 
 
1.4.1 LIPIDS 
Lipids are heterogeneous hydrophobic organic 
molecules that can be extracted from tissues 
by nonpolar solvents (Figure 8) (93). 
 
Dietary lipids 
More than 90% of our dietary lipids consist of 
triacylglycerols (TG). The remainder is made 
up of cholesterol, cholesteryl esters (CE), 
phospholipids (PL), and free fatty acids (FFA) 
(93). Fats contain much less oxygen, i.e. they 
are more reduced than carbohydrates or prote-  
 
Figure 8 Classes of lipids. Lippincott (93).
ins, and therefore yield more energy when oxidized. The complete oxidation of 1 g TG to CO2 
and H2O in the body produces approximately 9 kcal, while the oxidation of 1 g carbohydrate 
or protein produces 4 kcal. A TG molecule contains 3 fatty acids esterified to one glycerol 
moiety (94). 
 
Fat degeneration 
When water is present, hydrolytic rancidity of the fat may be the result. FFA are released 
from the glycerol molecule, and the fat pH is decreasing (95). FFA are even more prone to 
oxidation than TG (96). When oxygen is present, oxidative rancidity may be the result, and 
the double bonds of unsaturated fatty acids are easily broken. Rancidity is accelerated by high 
temperature, enzymes and other catalysts such as iron and copper ions and metalloproteins, 
pH, light, and oxidation products such as peroxides and hydroperoxides (97). The oxidation of 
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fat produces free radicals and volatile substances with intensive tastes (96). Fat degeneration 
may be reduced by antioxidants or by hydrogenation of the fat (95;97).  
 
Bodily functions of lipids 
Important bodily functions of lipids are thermic and electric isolation, energy source, transport 
and storing of cholesterol and fat soluble vitamins (98). Lipids also provide the hydrophobic 
barrier that permits partitioning of the aqueous contents of cells and subcellular structures. 
Some fat soluble vitamins have regulatory or coenzyme functions, and the prostaglandins and 
steroid hormones play major roles in the control of the body’s homeostasis (93). Lipids also 
function as a preface for bile acids and signalling molecules, and as ligands in the regulation 
of gene expression (91;99).  
 
1.4.2 FATTY ACIDS 
Fatty acids are basically hydrocarbon chains with a carboxylic acid head group at one end that 
can combine with another molecule. 
Each carbon (C) in the chain has four 
binding sites. In a saturated fatty acid 
(SFA), all binding sites not linked to 
carbon are “saturated” with hydrogen. In 
an unsaturated fatty acid (UFA), one or 
more pairs of hydrogens have been 
removed and double bonds formed 
between adjacent carbons (100). The 
structure of some important fatty acids is 
shown in Figure 9.  
 
The physical and chemical properties of 
fatty acids are dependent on the length 
of the carbon chain, the saturation 
Figure 9 Formulae and structures of some important fatty 
acids. Bartsch H.  (101). 
degree, and the placing of double bonds in the chain (positional isomerism) and hydrogen 
atoms around the double bond (geometrical isomerism) in UFA. Both chain length and 
saturation contribute to the melting temperature of a fat. In general, fats with shorter fatty acid 
chains or with more double bonds are liquid at room temperature. Saturated fats, especially 
those with long chain fatty acids, as in beef tallow (18C), are solid at room temperature (102).  
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Milk fat has a relatively high percentage of short (C2-6) chain fatty acids (SCFA) and 
medium (C6-12) chain fatty acids (MCFA), and fat from land animals of long (C12-18) chain 
fatty acids (LCFA), largely saturated. Marine derived fat contain very long (C≥20) chain fatty 
acids (VLCFA), but highly unsaturated (100).  
 
Fatty acids are classified according to the number of carbons in the chain, the number of 
double bonds, and the position of the first double bond (100). Systematic and notional names 
of some fatty acids are given in Table 2 by two different conventions for characterization. 
 
Digestion, absorption, and transport 
In the intestinal lumen, the TG are emulsified by bile salts (94), and pancreatic lipase cleaves 
the sn-1 and sn-3 position of TG yielding 2-monoacylglycerols (2-MG) and FFA (103).  
 
Fatty acids are differently absorbed and undergo different metabolic fates depending on their 
chain length and degree of saturation. Fatty acids containing less than 14 carbons and fatty 
acids containing several double bonds can, to a variable degree, be absorbed in the stomach 
by diffusion through the PL bilayer and undergo direct internal transport to the liver via the 
portal circulation (103).  
 
Generally long chain fatty acids (LCFA) are almost completely absorbed by enterocytes in the 
jejunum and ileum (104;105). Along with some other substances, LCFA interact with bile 
salts to form tiny microdroplets called micelles, which help apolar lipids to go through the 
unstirred water layer and reach the microvillous membrane where they are absorbed into the 
intestinal epithelial cells (94).  
 
In the intestinal epithelial cells, the fatty acids and 2-MG are resynthesized into TG and PL, 
which are packaged into chylomicrons (CM) travelling through the lymphatic system and the 
left subclavian vein to the liver (94;104).  
 
The positional distribution of fatty acids in dietary TG determines whether fatty acids are 
absorbed as 2-MG or FFA, and hence, influences the composition of CM. Generally, the 
absorption of fatty acids in the sn-2 position is favoured, whereas no specificity has been 
found for the fatty acids in the sn-1 or sn-3 positions (106). Eicosapentaenoic acid (EPA) and 
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Table 2 Some naturally occurring fatty acids. 
TRIVIAL NAME SYSTEMATIC NAME* NOTIONAL NAME** TYPICAL FAT SOURCE 
 
Saturated 
Butyric Butanoic C4:0 Butterfat 
Caproic Hexanoic C6:0 Butterfat 
Caprylic Octanoic C8:0 Coconut oil 
Capric Decanoic C10:0 Coconut oil 
Lauric Dodecanoic C12:0 Coconut and palm kernel oils 
Myristic Tetradecanoic C14:0 Butterfat, coconut oil 
Palmitic Hexadecanoic C16:0 Palm oil, animal fat 
Stearic Octadecanoic C18:0 Cocoa butter, animal fat 
Arachidic Eicosanoic C20:0 Peanut oil 
Behenic Docosanoic C22:0 Peanut oil 
Lignoceric  Tetracosanoic C24:0 Beech-wood tare 
Cerotic Hexacosanoic C26:0 Wax 
Montanic Octacosanoic C28:0 Montan wax (extracted from lignite) 
 
Unsaturated ∆ 
Caproleic 9-Decenoic C10:1 ω-1 Butterfat 
Lauroleic 9-Dodecenoic C12:1 ω-3 Butterfat 
Myristoleic 9-Tetradecenoic C14:1 ω-5 Butterfat 
Crotonic Trans-2-tetraenoic C14:1 Castor-oil plant 
Palmitoleic 9-Hexadecenoic C16:1 ω-7 Some fish oils, beef fat 
Oleic 9-Octadecenoic C18:1 ω-9 Olive oil, canola oil 
Elaidic Trans-9-octadecenoic C18:1 Butterfat 
Cis-vaccenic 11-Octadecenoic C18:1 ω-7 Beef fat 
Trans-vaccenic Trans-11-octadecenoic C18:1 Butterfat 
Taxoleic 5,9-Octadecadienoic C18:2 ω-9 Conifer seed oil 
Linoleic 9,12-Octadecadienoic C18:2 ω-6 Safflower, corn and soybean oils 
Pinolenic 5,9,12-Octadecatrienoic C18:3 ω-6 Conifer seed oil 
γ-Linolenic (GLA) 6,9,12-Octadecatrienoic C18:3 ω-6 Evening primrose oil 
α-Linolenic 9,12,15-Octadecatrienoic C18:3 ω-3 Soybean oil, canola oil, walnuts 
Gadoleic 9-Eicosenoic C20:1 ω-11 Some fish oils 
Gondoic 11-Eicosenoic C20:1 ω-9 Redfish oil 
Dihomolinoleic 11,14-Eicosadienoic C20:2 ω-6 Conifer seed oil 
Sciadonic 5,11,14-Eicosatrienoic C20:3 ω-6 Conifer seed oil 
Dihomo-α-linolenic 11,14,17-Eicosatrienoic C20:3 ω-3 Conifer seed oil 
Arachidonic 5,8,11,14-Eicosatetraenoic C20:4 ω-6 Lard, meats 
Juniperonic 5,11,14,17-Eicosatetraenoic C20:4 ω-3 Conifer seed oil 
Timnodonic (EPA) 5,8,11,14,17-Eicosapentaenoic C20:5 ω-3 Some fish oils, shellfish 
Erucic 13-Docosenoic C22:1 ω-9 Crusiferae seed oil: mustard, rape 
Cetoleic 13-Docosenoic C22:1 ω-11 Redfish oil 
Clupanodonic (DPA) 7,10,13,16,19-docosapentaenoic C22:5 ω-3 Herring, fish oil 
Cervonic (DHA) 4,7,10,13,16,19-Docosahexaenoic C22:6 ω-3 Some fish oils, shellfish 
Nervonic 15-Tetracosaenoic C24:1 ω-9  
*Systematic names according to the IUPAC nomenclature: the Greek capital letter delta (∆) refers to the carbon preceding 
the double bond, counted from the carboxyl end. **Lower case Greek letters; alpha (α) refers to the first carbon adjacent to 
the carboxyl group, beta (β) to the second carbon, and omega (ω) to the last carbon in the chain. Double bonds labelled with 
ω, are counted from the terminal methyl carbon. Adapted from the Institute of Shortening and Edible Oils. Food, fats and 
oils. 6th ed. Washington, DC, 1988 (100) and Metabolism at a Glance (107). 
 
and docosahexaenoic acid (DHA) are supposed mainly to be esterified to and absorbed from 
the sn-2 position in the TG of fish oil (108). 
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In the circulation, hydrolysis of TG within the core of the CM results in movement of fatty 
acids into tissues and the subsequent production of TG-depleted chylomicrons remnants 
(CMR) which pick up cholesterol esters from high density lipoproteins (HDL) and are rapidly 
taken up by the liver (103). 
 
The endogenous shuttle for lipids and their metabolites, consisting of very low density 
lipoproteins (VLDL), intermediate density lipoproteins (IDL), and low density lipoproteins 
(LDL), coordinate movement of lipids from the liver to peripheral tissues, while high density 
lipoproteins (HDL) returns lipids from peripheral tissues to the liver. In addition, FFA are 
transferred bound to albumin from storage reservoirs to metabolizing organs (103).  
 
1.4.3 ESSENTIAL FATTY ACIDS 
Fatty acids which the body needs but cannot synthesize are called essential fatty acids (EFA). 
Two long chain polyunsaturated fatty acids (LCPUFA) are essential in humans; the ω-6 
linoleic acid (LA) and the ω-3 α-linolenic acid (ALA) (Table 2). Arachidonic acid (AA) 
becomes essential if its precursor LA is missing in the diet (93). In the case of 
polyunsaturated fatty acids (PUFA) that cannot be synthesized in the body, the levels in 
tissues rise and fall with the levels in the diet (109;110). In EFA deficiency, oleic acid and 
palmitoleic acid undergo the same reactions to form polyunsaturated fatty acids of other 
structures (111).  
 
1.4.4 BIOSYNTHESIS OF HIGHLY UNSATURATED VLC FATTY ACIDS 
Once consumed in the diet, LA can be converted via γ-linolenic (GLA) and dihomo-γ- 
linolenic acids (DGLA) to arachidonic acid (AA) by the pathway outlined in Figure 10. Using 
the same pathway, dietary ALA can be converted into EPA, docosapentaenoic acid (DPA) 
and DHA. Thus, the ω-6 and ω-3 fatty acids compete for these enzymes (112).  
 
PUFA can be used for PL biosynthesis via a number of pathways in the endoplasmatic 
reticulum (ER). The types and amounts of PUFA found in membrane bilayer PL are 
controlled by the fatty acid composition of dietary fats, the intracellular metabolism of fatty 
acids, and specificities for esterifying fatty acids into PL (113). Animal biosynthesis of highly 
polyunsaturated fatty acids from LA and ALA is mainly modulated by the ∆-6 and ∆-5 
desaturases through hormonal and dietary stimulated mechanisms and influenced by circadian 
changes. Insulin activates the enzymes, while all the other hormones tested depress them, or 
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at least are inactive (114). 
The extent to which bio-
conversion occurs is in-
fluenced by the propor-
tion and quality of dietary 
carbohydrates, fatty acids, 
and proteins (115). 
 
Peroxisomal β-oxidation  
is the last step in the bio-
synthesis of DHA (113). 
But conversion of ALA to 
EPA is limited in men, 
and further transformation 
to DHA is very low (116). 
Evidence is growing for 
deficiencies of ω-3 fatty 
acids in humans under 
stress conditions and for 
the essentiality of ω-3 
PUFA (117).  
 
Some fatty acids genera-
ted in this pathway and 
found in the plasma mem-
brane PL of different cell 
types serve as substrates 
for formation of eicosa-
noids (103;118;119). 
   Dietary fatty acids Dietary fatty acids  
  ω-6 series Enzymes   ω-3 series
  C18:2   C18:3 
   Linoleic acid (LA)   α-Linolenic acid (ALA) 
   (∆ 9, 12) (∆ 9, 12, 15) 
 ↓    ∆-6 desaturase ↓ 
   C18:3   C18:4 
   γ-Linolenic acid (GLA) Stearidonic acid 
    (∆ 6, 9, 12)  (∆ 6, 9, 12, 15) 
 ↓   Elongase ↓ 
   C20:3   C20:4 
  Dihomo-γ-linolenic acid (DGLA)  Eicosatetraenoic acid 
    (∆ 8, 11, 14)  (∆ 8, 11, 14, 17) 
 ↓    ∆-5 desaturase ↓ 
   C20:4   C20:5 
   Arachidonic acid (AA)  Timnodonic acid (EPA) 
   (∆ 5, 8, 11, 14)   (∆ 5, 8, 11, 14, 17) 
 ↓   Elongase ↓ 
   C22:4   C22:5 
   Adrenic acid  Clupanodonic acid (DPA) 
 (∆ 7, 10, 13, 16)   (∆ 7, 10, 13, 16, 19) 
 ↓   Elongase ↓ 
   C24:4   C24:5 
   Tetracosatetraenoic acid   Tetracosapentaenoic acid 
 (∆ 9, 12, 15, 18)    (∆ 9, 12, 15, 18, 21) 
 ↓    ∆-6 desaturase ↓ 
   C24:5   C24:6 
  Tetracosapentaenoic acid  Tetracosahexaenoic acid 
   (∆ 6, 9, 12, 15, 18)    (∆ 6, 9, 12, 15, 18, 21) 
 ↓  β-oxidation ↓ 
   C22:5   C22:6 
 Osbond acid Cervonic acid (DHA) 
 (∆ 4,7,10,13,16)  (∆ 4,7,10,13,16,19) 
 
Figure 10 Parallel pathways for conversion of the essential ω-6 and ω-3 fatty acids.  
 
1.4.5 BIOSYNTHESIS OF EICOSANOIDS 
Their enzymatic conversion into eicosanoids is one of the more important functions of PUFA, 
since eicosanoids modulate inflammatory and immune responses and play a critical role in 
platelet aggregation, cellular growth and differentiation (120).  
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Eicosanoids are biologically potent short lived, hormone like lipids with chain lengths of 20 
carbon atoms (eicosa = 20), consisting of prostaglandins (PG) and thromboxanes (TX) 
(prostanoids) produced by COXs, and leukotrienes (LT) produced by LOXs. Precursor fatty 
acids are DGLA (leading to series 1 PG), AA (leading to series 2 PG and 4 LT), and EPA 
(leading to series 3 PG and 5 LT) (120).  
 
The production of eicosanoids begins with the hydrolytic release of PUFA from membrane 
PL by various phospholipases (PLA) and appears to occur indiscriminately with ω-3 and ω-6 
PUFA (112;120;121). The relative proportions of PUFA in cell membranes, as well as cell 
type, are the primary factors in regulating which eicosanoids will be generated (122).  
 
1.5 HYDROGENATED FAT 
As a substitute for butter, a new product called “oleomargarine” based on tallow, milk, and 
salt was invented in France in 1868 (123). Eilert Sundt and August Pellerin started the first 
Scandinavian margarine factory in Christiania in 1876 (97). As raw material for margarine 
production, marine oils were hydrogenated partially in Norway from 1912 by Denofa (124). 
 
Liquid plant and marine oils are hydrogenated to achieve the desired consistence for use in 
foods, to increase stability by avoiding degeneration of fatty acids (95), and to give the 
products features such as spreadability, texture/“mouth feel” (the fat is supposed to melt at 
mouth temperature, but not in the fridge), and a longer shelf life (125).  
 
Before the oil is hydrogenated, the raw oil is refined by neutralizing/washing and removal of 
FFA. The hydrogenation is performed by adding H2 under high pressure and temperature to 
saturate double bonds in UFA, in the presence of a catalyst (95;126).  
  
1.5.1 TRANS FATTY ACIDS 
During the hydrogenation process, double bonds in UFA are changed from the cis 
configuration (the hydrogen atoms placed on the same side of the double bond) most 
frequently found in nature, to trans (the hydrogen atoms placed on opposite sides of the 
double bond), see Figure 12, and their position in the carbon chain may shift (110). Trans 
fatty acids (TFA) contain at least one trans double bond with changed geometry compared 
with the cis double bonds (127).  
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                                                      Melting point   
 
Figure 11 Trans fatty acids in hydrogenation. Denofa (102). 
During the hydrogenation process, 
the content of TFA increases until 
the melting point (MP) is 30-40 ○C 
(Figure 11), where after it decreases 
to 0 at MP 50-70 ○C when the oil is 
totally hydrogenated. In the hydro-
genation practice of 1998, the 
hydrogenated fats produced had con-
centrations of TFA in the range of 
10-60% (128;129). 
 
Besides being formed during industrial hydrogenation, TFA are naturally formed by the 
anaerobe bacterial flora in the intestine of most animals, especially ruminants (130), and also 
humans (131). The algae chloroplast membranes contain some fatty acids with a trans double 
bond (132). TFA can therefore also be detected in minor amounts in marine animals (133). 
 
Considerable differences in the quantity of individual TFA in industrially produced trans fat 
and trans fat from ruminants has been found (127). The major fatty acids formed by partial 
industrial hydrogenation are oleic (9c-18:1), elaidic (9t-18:1), and stearic (18:0) acids (Figure 
12), elaidic acid being predominant (110;134). The trans isomers in ruminant milk and meat 
are mainly monoenes with trans vaccenic acid (11t-18:1) being the most dominant (135).  
 
Food sources of trans fatty acids 
Industrially formed TFA fats may be present in substantial amounts in foods, especially in 
baking fat (136;137). In 1993, the percentage of TFA of total fat content was 37% in baked 
goods such as doughnuts and Danish pastry, 38% in imitation cheese, 11-49% in margarines, 
27% in confectionary fats, and up to 36% in deep-fried foods such as fried chicken and 
French-fried potatoes (138). In 2000-2001, partially hydrogenated fat was found varying from 
1 to 33.5 gram per 100 gram product in an analysis of snacks, cakes and sweets. A high 
content of TFA was also found in biscuits, dry food like soups and sauce basis, and in fast 
food, especially in pommes frites and popcorn (127).  
 
Naturally formed TFA are present in milk and flesh of ruminants by 4-11%, tallow contains 
3-5%, pork fat less than 0.5%, and fish, shellfish and sea mammals contain minor amounts 
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(130;133;139). Plants also contain minor amounts of TFA (132), and up to 1% TFA is formed 
in the processing (other than hydrogenation) of almost all edible plant oils. Refined oils have 
higher TFA contents than unrefined, according to the duration and temperature of refining. 
The edible fat sources on a world basis include 20% animal and 80% vegetable oils/fats (128). 
 
Differences between saturated, trans and cis unsaturated fatty acids 
Saturated and trans unsaturated fatty acids are straight, while cis unsaturated fatty acids make 
  
 
 
Figure 12 The chemical structure of the cis monounsaturated oleic acid, the trans monounsaturated elaidic acid and the 
saturated stearic acid. Stender S. (127). 
 
a turn at the double bond (96). TFA resemble SFA in that they have some of the physical 
packing properties of SFA, but they are shaped differently in space (125). Geometrical and 
structural differences between the cis monounsaturated oleic acid (MP 11-13 ○C), the trans   
 
Figure 13 The molecular structure of a trans fatty acid (top) and 
the corresponding saturated fatty acid. Stender S. (127). 
 
monounsaturated elaidic acid (MP 44-
45 ○C) and the saturated stearic acid 
(MP 70-72 ○C), all 18 carbons long, are 
shown in Figure 12. While the double 
bond angle of a TFA is smaller in con-
trast to the corresponding cis isomeric 
configuration, it is larger than that of 
the corresponding saturated configura-
tion (Figure 13). The question is whe-   
ther such differences may provide TFA with different biological effects from SFA (127;133). 
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1.5.2 UNUSUAL FATTY ACIDS IN HYDROGENATED FATS 
TFA may be common in the human body. However, fatty acids in hydrogenated fats may 
contain trans bonds in positions that are unusual in the body, which may affect the 
incorporation of the isomers in tissue lipids and their metabolic conversion (140).  
 
The metabolic aspects of isomeric fatty acids studied relate primarily to trans positional 
isomers of mono- and dienoic acids with the cis positional isomers having been largely 
neglected, despite the fact that they can represent 20% or more of the total cis fatty acids 
consumed and have distinct metabolic effects (133). 
 
Hydrogenated fats may also contain unusual very long chain saturated fatty acids (VLCSFA) 
(111).  
 
1.5.3 ABSORPTION AND METABOLISM OF HYDROGENATED FATTY ACIDS 
Cis-trans configuration affects the polarity of a compound, cis being the more polar. The 
higher lipophilic character of TFA can result in increased aggregation with non-absorptive 
SFA (141), especially with very long chain saturated fatty acids VLCSFA, and lead to 
reduced absorption compared with cis isomers (142).  
 
TFA are incorporated preferentially in the sn-1 position in PL, substituting for SFA (135). 
 
A role was proposed for peroxisomal β-oxidation in relation to the metabolism of fatty acids 
that are poorly β-oxidized by mitochondrias. Trans isomers of MUFA were β-oxidized at 
rates faster than, or similar to, those obtained with corresponding cis-isomers in peroxisomal 
fractions in rat liver induced by diets rich in VLCMUFA (143).  
 
Increased serum TG was found in rats fed a diet with a high amount of VLCSFA, including 
increased contents of arachidic (20:0) and behenic (22:0) acids, while serum PL only 
contained increased arachidic acid (142), possibly due to selective incorporation in PL (144).  
 
Unusual VLCSFA and very long chain trans fatty acids (VLCTFA) with unknown biological 
effects may be produced by desaturation and elongation in the human body of TFA from 
hydrogenated oils. Rats were fed a diet containing 18:1 and 18:2 isomeric substrates which 
were desaturated and elongated by liver microsomes. Large proportions of unusual isomers of 
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18:2, 20:2, 20:3, and 20:4 were found, with measurable amounts at each step of the cascade, 
and incorporated into PL (111).  
 
1.5.4 DECLARATION OF HYDROGENATED FAT 
Today, there are no general demands for declaration of nutrients, specification of fat or trans 
fat, or for maximum content of TFA, in Norway (145). Therefore it is difficult to assess 
whether a product contains TFA.  
 
Although the TFA are chemically unsaturated they are considered so different from the cis 
unsaturated fatty acids that they cannot be legally designated unsaturated for purposes of 
labelling (125). If trans fat is declared in Norway it will be considered a part of saturated fat 
according to the Norwegian Food Safety Authority. Whether the declaration of trans fat will 
be regulated in Norway, might also be influenced by a presumptive cost/benefit analysis. How 
this declaration will be regulated, if possible, is at this point of time an open question (145).  
 
In 1997, the Norwegian National Council of Nutrition recommended reduced use of partially 
hydrogenated oils by the margarine industry. New fat mixtures with lower content of partially 
hydrogenated oils were desired for baking. New products with lower total content of TFA and 
SFA of the type C12-C16 should be secured by choice of raw materials (126).  
 
As the first country in the world, Denmark introduced strict national limits for the TFA 
content in food with an upper limit of industrially produced TFA of 2% after January 1, 2004 
(127). In 2003, directives for declaration of nutrients were adopted by Codex Alimentarius, 
and TFA were included in the format for food labelling. At the moment, a group led by 
Malaysia and Denmark is working on a definition of trans fat and laying the basis for 
discussions concerning rules (145-147). In the European Union (EU), rules are put in place on 
the labelling of foodstuffs (148). Through the EOES agreement, Norway is bound to adapt 
EU’s rules concerning production and sale of food (149). The TFA content in the Norwegian 
diet is today insignificant. If the Danish legislated upper limit of 2% TFA in food fats is 
adopted by the EU, the result might be an increase in TFA in food produced in Norway, while 
the quantity of imported trans fat would be decreased (150).  
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1.5.3 ALTERNATIVES TO HYDROGENATION  
It is possible for the oil/fat industry to produce edible fats with the wanted functionality 
through various modification processes. One method is full hydrogenation of liquid vegetable 
oil (contains mostly C18:0) with addition of liquid oils and interesterification of the fatty 
acids in TG. Additional methods are to use naturally solid vegetable fats such as palm oil 
(contains mostly C16:0 and 18:1, MP 37○C) or coco oil (contains mostly C12:0, 14:0 and 
10:1, MP 25○C), or to use the solid fraction of palm oil by crystallization of specific fatty 
acids, (palm stearin contains more 16:0 and less 18:1 than palm oil, MP 25 ○C) or of coco oil, 
with or without interesterification.  
 
Other alternatives are to produce new solid fats by plant improvement (102;151), or to use 
oils with different kinds of emulgators and other additives (for the baking industry) (152). 
 
1.6 EFFECTS OF FATTY ACIDS 
 
1.6.1 EFFECTS OF FATTY ACIDS ON COLORECTAL CANCER 
The most consistent effect of specific fatty acids on colonic tumor growth is the inhibitory 
influence of fish oils enriched in EPA and DHA, probably mediated via the eicosanoid 
pathway (153). The 3-series prostanoids and the 5-series leukotrienes produced with EPA as 
substrate have positive health effects compared with the 2- and 4-series. Human colon tumor 
growth initiated by subcutaneous inoculation of HT29 cells in athymic mice was promoted by 
high fat diets of other oils, but not of fish oil (154). 
 
Results emphasize the importance of the dietary ω-6/ω-3 PUFA ratio in determining the 
effects of supplementation with fish oil on parameters of colon cancer (155). The multiplicity 
of colon adenocarcinoma was significantly inhibited in rat groups fed 5.9% corn oil + 17.6% 
menhaden fish oil (ω-6/ω-3 = 0.34) compared to those fed 23.5% corn oil (156). This 
indicated that the relative proportions of ω-6 and ω-3 fatty acids in the diet might be 
determinants of the high fat effect (155).  
 
There does not appear to be any specific fatty acid that promotes the development of colon 
cancer when studied in experimental models (153). No literature was found on effects of 
specific unusual fatty acids on CRC.  
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1.6.2 EFFECTS OF TRANS FATTY ACIDS 
Based on experimental data as well as on clinical studies several reports during the early 
1980s concluded that TFA probably were comparable with other MUFA and that they were 
useful alternatives for dietary SFA without apparent side effects (157;158).  
 
Effects early in life 
Trans positional isomeric 18:1 and 18:2 fatty acids from partially hydrogenated soybean oil 
(PHSO) have, however, been shown to inhibit the regulation of reproduction, foetal growth 
and development in rats (111;119). Studies on humans have shown that TFA are transferred 
from the mother to the foetus, and decrease birth weight (159-162). TFA also lower the 
volume of crème in lactating females of all species, including humans (125).  
 
Effects on the risk of cardiovascular disease 
TFA have been associated with risk factors for cardiovascular disease (CVD) such as high 
levels of plasma LDL cholesterol, TG, cholesteryl ester transfer protein (CETP), lipoprotein 
(a), decreased HDL cholesterol, and effects on platelet function and PGI2 production, in 
humans (163-166). TFA seem to be slightly less hypercholesterolemic than palmitic acid 
(167). The content of TFA in human adipose tissue, possibly with margarine as the main 
source, was found associated with increased risk of myocardial infarction (168). TFA from 
partially hydrogenated vegetable oils have been shown to have adverse effects on obesity, 
insulin resistance, diabetes, and immunity, also considered risk factors for CVD (125;169).  
 
Effects on cancer 
When health effects of TFA, including one study of partially hydrogenated vegetable and fish 
oils, were extensively reviewed in the 1980s, no adverse effects were found on the occurrence 
of cancer(158;170;171). Reviewed in 1993, most animals studies indicated that TFA are less 
carcinogenic compared with cis isomers, probably by their inhibition of AA metabolism and 
the following reduction of PGE2 related proliferation in tumors, and metastases (172). Two 
1995 European reviews concluded that TFA do not seem to have any carcinogenic effects 
(173;174), while one study suggested a possible association between TFA and cancer (175). 
A review in 1996, representing the literature available on trans fat (at the expense of cis fat) 
and cancer in animal models, the most recent paper published in 1989, confirmed that there 
had been no evidence to indicate that, under properly controlled conditions, the intake of TFA 
is a risk factor for cancer (176). 
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The Danish Nutrition Council concluded in their 2003 report that there is no evidence for a 
carcinogenic effect of the dietary TFA, but that the studies undertaken after 1994 constitute a 
basis of continued alertness on the possibility of such effects (127).  
 
Effects on colorectal cancer 
In 1997, a strong positive significant correlation was found between TFA status of fat 
aspirates and the incidence of breast and CRC in the EURAMIC study (177). An association 
between breast and CRC was found both in the same individual and also in close relatives 
(178). However, the EURAMIC study was criticised for not taking into account several 
important confounding factors (179).  
 
In a case-control study in 1999, a tendency to increased colorectal adenoma prevalence 
associated with consumption of partially hydrogenated vegetable oils was found in the two 
food groups “oils and condiments” (margarine, bottled oil containing TFA, oil and vinegar 
dressing, and mayonnaise or other creamy salad dressing) and “sweetened baked goods”, but 
not with total dietary TFA (180;181). Nevertheless, the use of hospital based controls and a 
sigmoidoscopy screened population confers disadvantages; there was a potential for 
incomplete case ascertainment (167), and the possible inclusion of cases in the control group 
could introduce biases toward the null in estimating the main effect of TFA intake (179). 
 
In a case control study in 2001, statistically significant positive associations were found 
between TFA intake and colon cancer risk in women and in men and women ≥ 67 years, but 
not in men. Those who did not use NSAID were at a 50% greater risk of developing colon 
cancer when they consumed high levels of TFA. Women who were estrogen negative had a 
twofold increase in risk of colon cancer from high levels of TFA, while estrogen positive 
women did not experience an increased risk regardless of level of TFA consumed (182).  
 
Many of the risk factors for CVD, on which TFA have adverse effects, such as high levels of 
cholesterol, triglycerids, obesity, insulin resistance, diabetes, and immunity, have also been 
related to CRC or colorectal adenomas (183-189).  
 
After a trans MUFA diet for 8 weeks, the TFA present in the diet were actively incorporated 
by tumors in rats (2201) (190). 
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Potential mechanisms for interference by trans fatty acids 
Potential mechanisms for effects of TFA have been proposed, including disruption of the cell 
membrane by incorporation of TFA into membrane PL (180). Possible biological effects 
might include alteration of basic membrane properties including modification of acyl chain 
order and “fluidity”, phase behaviour, elastic compressibility, permeability, fusion, flip flop 
and protein activity. Interaction with other membrane lipids, particularly with cholesterol, 
may play a prominent role in the modulation of the local structure and function of cell 
membranes (191).  
 
The relationship between CRC susceptibility and the distribution of polymorphic variants of 
different forms of metabolic enzymes such as CYP450 1A1 and 1A2, glutathione S-
transferases (GST), N-acetyltransferase (NAT)2, aldehyde dehydrogenase (ALDH)2 and 
methylene-tetrahydrofolate reductase (MTHFR), has been in focus because of their important 
role in the activation of many procarcinogens or chemicals (76).  
 
TFA induce adverse alterations in the activities of the important mixed function oxidase 
(MFO) CYP-448/450 enzyme system that metabolizes carcinogens and drugs, and produce 
alterations in adipose cell size and number, lipid class and fatty acid composition (125).  
 
It was shown by many researchers that TFA in membranes inhibited the function of ∆-6 
desaturase resulting in decreased conversion of e.g. LA to GLA or AA, and of ω-3 fatty acids 
to their elongated tissue ω-3 fatty acids, with a resulting escalation of adverse effects of EFA 
deficiency, in rats fed hydrogenated oil (1991) (111). This may include disruption of 
eicosanoid synthesis with resulting inhibition of immune and inflammatory responses and cell 
differentiation Pedersen, 1998 724 /id;Zolfaghari, 2003 472 /id}.  
 
Problems in obtaining suitable control fat 
The relatively scarce knowledge about the relationship between TFA and cancer risk, albeit 
voluminous information is available concerning effects of the amount and type of fat on 
experimental carcinogenesis, is partially due to difficulties in obtaining a suitable control fat 
so that the impact of TFA can be properly evaluated. This has led to confounding 
interpretation of results, particularly in the early studies. Thus, deficiencies in the design of 
dietary fats used for animal feeding in carcinogenesis experiments have likely been a cause of 
discrepancy in the database (176). 
 25 
Effects of hydrogenated fish oil in experimental colorectal carcinogenesis in A/J mice      Introduction 
                
1.7 INTAKE OF FAT 
A hypothetical scheme of intake of fats and antioxidant vitamins through the evolution 
(Figure 14) indicates that the percent of energy in the human diet from total and saturated fat 
have been increasing, and the intake of vitamin C and E decreasing, since early 1800s. The 
energy percent from ω-6 fatty acids has been increasing since mid 1900s. The energy percent 
from ω-3 fatty acids has been decreasing, while that from trans fatty acids has been increasing 
with the industrial hydrogenation of oils, since early 1900s.  
  
 
 
Figure 14 Hypothetical scheme of (% calories) intake of fats and vitamins; total and saturated fat, ω-6, ω-3, and trans fatty 
acids, vitamin E and C (mg/d), data extrapolated from cross-sectional analyses of contemporary hunter-gatherer populations 
and from longitudinal observations and their putative changes during the preceding 100 years. Simopoulos A. P.  (161). 
 
Such changes in fat intake over a short time period are upsetting the characteristic balance 
during evolution when our genes were programmed to respond to diet and other aspects of the 
environment (161).  
 
As societies industrialize, consumption of fat may increase from less than 20% of total energy 
intake to 40% (11). The still dramatically varying lipid content of diets may perhaps explain 
geographic differences in CRC incidence (66).  
 
1.7.1 RECOMMENDATIONS FOR INTAKE OF FAT 
The Norwegian recommendations state that the total fat intake should not exceed 30% and the 
intake of hard fat (SFA + TFA) should not exceed 10% of total energy intake. The desirable 
intake of MUFA is 10-15% of energy, of PUFA 5-10% (not >10%), including 1% ω-3 fatty 
acids (minimum 0.5%) and at least 3% EFA (192). 
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Suggested intake of polyunsaturated fatty acids 
Suggested minimum and optimum intakes of ω-3 and ω-6 PUFA are shown in Table 3. The 
numbers are based on data from patients with EFA deficiency and on estimation of required 
and optimal intake in healthy, normal individuals with an energy intake of 2200 kcal/d (102).  
 
The Food and Drug Administration (FDA), U.S.A has ruled that intakes of up to 3 g/d of 
marine ω-3 acids are Generally Recognized As Safe (GRAS) for inclusion in the diet (193). 
 
Table 3 Suggested intake of polyunsaturated fatty acids. 
 Omega-3 Omega-6 Omega-3 Omega-6 
 (% of energy)   (mg/d) 
Minimum   0.2-0.3   1-3 400-600 2400-7200 
Optimum   1-2   3-7.5*  2400-4800 7200-18000 
*Pregnant and breast feeding women. Rustan A. C. (102). 
 
1.7.2 DIETARY FAT CONTENT 
After having increased from the start of this century at the expense of starch, except during of 
World War II 1940-1945, the fat content the Norwegian diet decreased from 40 to 34% of 
total energy intake from 1975 to 2003 (194). The content of hard fat (SFA + TFA) in the diet 
is estimated to have decreased from about 21 to 15% of total energy intake from the 1970s to 
the early 2000s (195). The P/S ratio has increased from 0.34 in 1975 to 0.50 in 2000 (196). 
 
1.7.3 INTAKE OF FATTY ACIDS OF CURRENT INTEREST 
In 1998, the mean intake of marine ω-3 
fatty acids in a random sample of the 
Norwegian population between 16 and 79 
years was 0.89 g/d (0.4 % of total energy) 
(197). The estimated intake of TFA in 
2004 decreased from 15 g/d (5.5% of 
energy) in 1958 to 1.5 g/d (0.5% of 
energy), and TFA from industrial products 
decreased from two thirds to one third the 
last 15 years (150;195), see also Figure 15. 
 
 
 
 
Figure 15 Trans fatty acids (% of energy) in the diet of the 
Norwegian household. Johansson L  (195). 
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1.8 OILS OF CURRENT INTEREST 
 
1.8.1 FISH OIL 
Fish oil is extracted from the total fish body and contains mainly TG with variable amounts of 
PL, hydrocarbons, fatty alcohols, glycerol ethers and wax esters. Fish oil is characterized by a 
wide range of C14-22 fatty acids and a high degree of unsaturation ranging up to six double 
bonds per molecule is characteristic of fish oil. The fatty acid patterns vary widely with fish 
species and with the composition of the plankton and the time of year (198). PUFA, including 
EPA and DHA may constitute 70-80% of total fat in fat fish (95).  
 
Fish oil contains relatively high cholesterol concentrations dependent of the fish type and 
smaller amounts of other sterols (199).  
 
Fish oil may also contain prooxidant trace metals such as iron and copper, and sulphur, 
phosphorus, chlorine, bromine, iodine, and heavy metals (198).  
 
Norway has had access to large amounts of fish at a low price (142), and had in 1968 23%, in 
1970 19%, in 1975 17%, in 1980 17%, and in 1983 19% of the world production of fish oils. 
In the early 1990s, the Norwegian production was the fifth highest in the world (200).  
 
In 1990, 76% of the fish oil was being used in margarines and bakery fats, mainly in Europe. 
At that time 16% was used for aqua feed and 8% for various industrial purposes. In 2000, the 
proportion for aqua feed had increased to nearly 60%, the industrial and pharmaceutical usage 
had not changed much, but the use of fish oil in hardened edible fats had decreased to 31%. In 
year 2010, practically all of the fish oil production is expected to be used in aqua feed (201). 
Recent trends in the use of fish oil in Europe and Scandinavia show a significant drop (202). 
 
1.8.2 COD LIVER OIL 
Ordinary fish oil does not usually contain vitamin A and D, but cod liver oil does (203). The 
use of cod liver oil against rickets and rheumatism among several diseases, started in the 
1700s, and has long traditions in Norway. In 1854, Peter Möller developed a new extraction 
process for cod liver oil in Christiania. After World War II, vitamin supplements took over     
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Figure 16 Total consumption of cod liver oil in 
Norway (tons). Concentrated fish oil based on 
sales value 2002 and estimated to 113 tons, is 
not included. Peter Möller AS. (204).  
the market, but Bang and Dyerbergs studies among 
Eskimos lead to increased use of cod liver oil from the 
1960s (Figure 16) (204). In Norway, a supplement of 
5 ml cod liver oil per day is recommended from 4 
weeks of age due to its vitamin D content (203). Cod 
liver oil contains approximately 28% PUFA, 46% 
MUFA and 16% SFA (205), and the recommended 
daily dose contains 1.2 g ω-3 fatty acids, thereof 0.4 g 
EPA and 0.6 g DHA, 250 µg vitamin A, 10 µg vita-
min D, and 10 mg vitamin E (Möllers Cod Liver Oil).
Cod liver oil and concentrated fish oil contributed 150-175 mg/d to the intake of very long 
chain ω-3 fatty acids in Norway in 2002 (196). 
 
1.8.3 BUTTER OIL 
Butter oil is produced from cream in a concentration process that almost completely removes 
water and fat free dry milk substances, and contains 99.9% milk fat including 94.4 % fatty 
acids and 5.5 % glycerol (206), the rest being MG, DG, FFA, PL, and sterols including 10-20 
mg/dl cholesterol (139). The typical distribution of fatty acids in butter is 4% PUFA and 32% 
MUFA, including up to 8% TFA, and 64% SFA, the ω-6/ω-3 ratio being 3:0% (126).  
 
There are important differences between bovine and human milk fat; the bovine milk 
containing more SFA including substantial quantities of 4:0-10:0 and less 18:2, and it also 
contains approximately 2% t-18:1. The TG structure id unique with much of the 4:0-10:0 fatty 
acids at the sn-3 position, where they are available to selective milk or added lipases(139).  
 
Butter have lost a sizable portion of its market share due to controversies associated with its 
cholesterol content and high percentage of LCSFA (207). The butter consumption has 
decreased from 9 to 3 g/d the last 15 years, while butter alone contributed 1% of total energy 
and 4% of SFA in the Norwegian diet (194).  
 
1.8.4 SOYBEAN OIL 
Soy grows faster and soybeans are cheaper than other raw materials for oils. Soybean oil is 
the largest edible oil in the world production (208), and was produced in Norway from 1955 
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(209). This oil contains mostly LA, but also ω-3 fatty acids, MUFA, SFA and lecithin. The ω-
6/ω-3 ratio of soybean oil is 54:8% (126).  
 
The greatest perspective in feed production for the Norwegian fish farming seems to lie in the 
utilization of vegetable fat sources including soybean fat, which is already used in 
considerable quantities (210).  
 
Preliminary drying of the seeds, steam washing of oils, refining and blending with refined 
oils, lead to increased TFA in such oils, and the TFA content, although small, show 18:1, 
18:2, 18:3, and 20:1 fatty acids (211;212). 
 
Besides being the most important raw materials in margarines, soybean oil and hydrogenated 
soybean oils are also central raw materials for producers of mayonnaises, salads and salad oils 
(213). The doubled use of such products in Norway over the last twenty years has made them 
a considerable source of UFA, especially the ω-6 fatty acid LA (194). 
 
1.8.5 HYDROGENATED OILS 
The basic Food and Drug Administration (FDA, USA) definition of a hydrogenated fat is one 
that is solid at room temperature. Such fats typically contain 15-25% TFA. Partially 
hydrogenated oils are defined by the FDA as liquid at room temperature and are lower in 
TFA. Some vegetable fats and oils have been moderately or slightly hydrogenated (133). 
Light hydrogenation produces almost no TFA (214). However, in the reality, different 
hydrogenation degrees are not referred to according to such definitions. Available information 
showed the following use of terms:  
· fats with MP 30-45 ○C (hydrogenated oils), MP 30-33 ○C with 55-60% TFA (hydrogenated 
fish oil) and 30-42% TFA (hydrogenated soybean oil), were referred to as partially 
hydrogenated or lightly hydrogenated 
· fat with MP 29 ± 2.0 ○C and 30.2 ± 4.3% TFA (hydrogenated fish oil) was referred to as 
partially hydrogenated 
· fats with MP 38-42 ○C and 38- a little less than 50-55% TFA (hydrogenated fish oil) or 46-
51% TFA (hydrogenated soybean oil), fat with MP 49 ± 3.0 ○C and 3.6 ± 0.5% TFA 
(hydrogenated fish oil), and fat with 3.6% TFA, were referred to as highly hydrogenated 
· fats with MP 50-60 ○C with approximately 0-21% monoene and diene TFA (hydrogenated 
fish oil) or < 1% TFA (hydrogenated soybean oil) were referred to as totally hydrogenated. 
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Hydrogenated soybean oil 
Light hydrogenation of soybean oil reduces most of the ALA to LA. A low-ALA soybean oil 
contains 4% ALA, has twice the stability of regular soy oil (214). The changes in the fatty 
acid content of soybean oil during hydrogenation is shown in Figure 17.  
 
Five species with tri-cis and tri-trans configurations and three species with cis-trans mixed 
configurations were found in lightly hydrogenated soybean oil (LHSO) with an iodine value 
(IV, a measure of unsaturation) of 111, but at an IV of 96, tri-cis was no longer present (215). 
 
In partially hydrogenated soybean oil (PHSO), elaidic acid 9t-18:1 is the predominating TFA, 
and the 9c,13t,-18:2 isomer is the major trans PUFA (95;212;216).  
 
Totally hydrogenated soybean oil (THSO) has essentially been hydrogenated to completion,  
i.e., > 99% of the fatty acids are saturated (217). THSO may contain 11% palmitic, 88% 
stearic and 1% longer fatty acids (214).  
 
Hydrogenated soybean oils are used in the baking- and food industry as ingredients in a 
countless number of foods, such as frying oils, cookies, biscuits, chocolate, liver paste, wiener 
sausage, sauces, bouillon, rice mixtures, non dairy cream, and nut butters (125;136;218-220).  
 
 
 
Figure 17 Hydrogenation transfers linoleic and α-linolenic acids into stearic acid via oleic acid and various trans fatty acids. 
Iodine value is a measure of unsaturation. Denofa (126). 
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Hydrogenated fish oil 
Hydrogenation of fish oil forms positional and geometrical isomers of VLCPUFA as well as 
VLCSFA which do not exist in hydrogenated vegetable oils (221). Hydrogenated fish oil also 
contains sterols and stanols, i.e. hydrogenated sterols (209).  
 
Usually, the unsaturation of fish oils from capelin, cod liver, and mackerel must be reduced 
considerably to achieve adequate stability. This reduction is primarily of the 20:5 and 22:6 ω-
3 fatty acids. These three fish oils contain substantial proportions of 20:1 (gadoleic and 
gondoic) and 22:1 (erucic and cetoleic) fatty acids, which are, in most instances, simply 
converted to trans forms during hydrogenation. In consequence, the TFA concentration in  
hydrogenated oils from these fish types tends to be relatively high, 40-50%, i.e., at the same 
level as highly hydrogenated soybean oil intended for stick margarines (129), and it may be as 
high as 60% for partially hydrogenated fish oil (PHFO) with MP 30-45 ○C (128).  
 
Menhaden and sardine oils initially have relatively little 20:1 and 22:1. Products of such fish 
oils were granted GRAS status in the U.S.A. in 1998 (129).  
 
In PHFO, a mixture of different trans isomers with chain length 16-24 carbon atoms has been 
found (142), and also numerous long chain cis and trans isomers that had to be included in the
group of unidentified fatty acids (211). 
PHFO is used in margarines, shortenings, 
salad oils, frying fats, low calorie spreads, 
bread, pastries, cakes, cookies, biscuits and 
synthetic creams (222).  
 
Figure 18 shows the reduced consumption 
of hydrogenated fish oil in Norway lately. 
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Figure 18 Reduced consumption of hydrogenated fish oil 
in Norway. Denofa (223). 
Totally hydrogenated fish oil (THFO) is so far not used in foods for humans, but the 
possibility of using this oil in interesterified form has been shown interest (212). Some THFO 
is used in animal feed (224). THFO contains a minimal amount of TFA, but high amounts of 
LCSFA C14-19 and VLCSFA C20-24 (142), which lead to considerably higher melting 
points for THFO compared with PHFO or HHFO (212).  
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The functionality of hydrogenated fish oil is largely based on the high TFA content and the
large range of MP covered by the fatty 
acids (128), giving margarines an excellent 
plastic consistency (198). In comparison 
with a fat consisting of only one kind of 
fatty acid, which would melt at a certain 
temperature, a fat such as PHFO, 
consisting of a mixture of different fatty 
acids, is melting little by little (Figure 19) 
(102). Optimal functionality is attained at 
MP 30-40 ○C. In this area is also the maxi- 
mum TFA content (60-50%) found (128). 
 
 
 
 
 
 
 
 
 
 
 
Solidity of
 
 
 
 
 
Figure 19 Per cent solidity of margarit and oleic acid at 
different temperatures. Margarit is the raw material for 
margarine after hydrogenation of fish oil. Denofa (102).
 
Partially hydrogenated oils in margarine 
Partially hydrogenated whale and fish oils contributed 70% of the raw material for the 
margarine production in Norway between 1912 and 1962. Between 1950 and 1970, whale oil 
was gradually interchanged with herring and soybean oils as raw materials (196;209).  
 
The hard margarines Melange and Per were the main source of hydrogenated marine fatty 
acids and TFA in Norway (194). Figure 20 shows the distribution of margarine containing 
partially hydrogenated fat: total, marine, or vegetable through the 20th century. During the 
1950s, the composition of the Norwegian margarine was least healthy, seen from a nutritional  
Partially hydrogenated fat, weight % of 
total margarine production in Norway 
 
 
Figure 20 Total, marine, and vegetable partially hydrogenated 
fat (% of total margarine weight). Johansson L. (195). 
view. In addition to containing a high 
amount of partially hydrogenated marine 
fat, the margarine had a high cholesterol 
content and a low proportion of PUFA 
(195). In 1992, approximately 35% of the 
fat used for margarine production was of 
marine origin (225). After the negative 
effects of PHFO on risk factors for CRC 
were discovered in the 1990s, the 
production of PHFO and PHSO was 
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gradually reduced, and these oils are no longer used in margarine produced in Norway for 
direct sale to households (196;225). Instead, a mixture of THSO, liquid vegetable oil and/or 
palm or coco fat or fractions thereof was used, with the fatty acids interesterified (209).  
 
The consumption of margarine was traditionally higher in Norway than in South Europe(226). 
The DAFNE II data of approximately 1990 based on Household Budget Surveys firmly 
document the remarkable disparity of food habits among European countries (Table 4). The 
disparity presents both qualitative and quantitative aspects. Vegetable fat generally means 
industrially processed vegetable oils (margarine) (227).  
 
Table 4 Distribution of availability of various added lipids in six European countries, DAFNE II 1990 (227).  
 
 
The distribution pattern shows that partially hydrogenated vegetable oil constituted 75% of 
total added lipids in Norway, a very high percentage compared to the other countries (3-48%). 
Partially hydrogenated vegetable oil seemed to be the highest single fat source, representing 
approximately 28% of total fat intake in Norway, which around 1990 was 98 g/d (194).  
 
The margarine intake in Norway increased strongly during the years after World War II, but 
has during the last 50 years been decreasing from 24 to 11 kg/person/year in 2000 (Figure 
21), which is partly the reason for the decreased intake of total fat, marine fat and TFA (194).  
 
From the early 1990s, the competition on the Norwegian market by international oil and fat 
producers has increased steadily (223). The proportion of margarine consumed in Norway in 
2002 covered by Norwegian producers, was only approximately 8% on energy basis (194).  
 
By considering the cholesterolemic effects of all common individual fatty acids with serum 
cholesterol predictive equations as a tool, the reformulation into “trans free” margarines with 
< 1% TFA, has resulted in healthier products. A cholesterol reducing margarine (Vita), tested
 34 
Effects of hydrogenated fish oil in experimental colorectal carcinogenesis in A/J mice      Introduction 
                
 
0
5
10
15
20
25
1955 1975 1980 1985 1990 1997 2000
Margarine
Soft margarine
Kg Margarine consumption per capita 1955-2000
 
 
 
 
 
 
 
 
 
 
 
   Figure 21 Reduced intake of margarine in Norway. Denofa (223). 
 
tested against butter and a low fat SFA diet, was produced in Norway in 2003 (167).  
 
Fatty acid isomers found in margarines 
High values of t18:1 in margarines of the 1970s were always accompanied by positional 
isomers of c18:1, and of 9t,12t-, 9c,12t-, and 9t,12c-18:2, and two mixed geometric LA 
derived isomers could be identified (228). Mono-t-di-c isomers were found in 1991 (215).  
 
Hydrogenated fish oil in bread 
Shortening and bakery margarines have properties different from those of table margarines. 
The value of hydrogenated fish oil lies in its creaming power, particularly in cake making 
(198). Hydrogenated fish oil contributed 6% to the fat used for production of margarine in 
Norway in 2000, and 3% in 2001 (194). In 2002, the main market for hydrogenated fish oil in 
Norway was still the margarine industry. Of the 165000 tons hydrogenated fish oil sold by 
Denofa in Norway 1989-2002, 50% was of MP 30-32 ○C, 25% of MP 38-40 ○C, 25% blends 
of those two, and very little of MP 50-52 ○C (223). Table 5 shows the contents of trans fat.  
 
Table 5 Trans fat content of partially hydrogenated fish oils used in Norway 1989-2002. Denofa (223). 
Melting point, ○C   % Trans (GLC) monoenes and dienes % Total trans fatty acids (IR) 
 30-32 54-55 55-60 
 38-40 50-52 50-55 
 50-52 20-21 ? 
GLC, Gas-Liquid Chromatography; IR, Infrared spectrophotometry. 
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Margarines containing hydrogenated fish oils are imported or produced by Russia and East 
Europe (209). Norway is now importing dough containing this oil from East Europe (229). 
Due to high flour prices, one third of the bread consumed in Norway in 2003 was of imported 
origin, mainly half finished bread and rolls (230). The import of finished and half finished 
food products is steadily increasing. The contents of hydrogenated fish oil is unknown (209).  
 
1.8.6 NORWAY COMPARED WITH NEIGHBOURING COUNTRIES 
The consumption of TFA has been especially 
high in northern Europe (169). The consump-
tion of PHFO in some European countries in 
1984 and 1985, including Norway, Denmark, 
and Sweden, is shown in Table 6 (231). 
Estimation from national Food Balance Sheet, 
Food Frequency Questionnaire, 3 day Dietary 
Record, and Duplicate Diets showed a dietary 
 
Table 6 Consumption of partially hydrogenated fish oil 
1984 and 1985 (kg/y/person), FAO. Norum K. R. (231). 
content of TFA during 1986-1993  of 1.9 g/d per person in Finland, 3.3 g in Sweden, 5 g in 
Denmark, 6 g in Iceland, and 8-10 g in Norway (221). Thus, Norway appears to have had the 
highest TFA intake among the Nordic countries (212;225;231;232).  
 
The main source of TFA in Scandinavia was partially hydrogenated vegetable oils and fats 
(232), except in Norway, where it was partially hydrogenated marine oils for most of the last 
century (221). As late as the mid 1990s, when TFA mainly was derived from dairy and meat 
in Scandinavia, margarines and shortenings produced from hydrogenated marine and 
vegetable oils were still significant sources of TFA in Norway (80%). Of the partially 
hydrogenated oils used in Norway at that time, approximately two thirds were PHFO, and the 
intake of PHFO in Norway was 11 g/person/day. The daily per capita intake of PHFO and 
partially vegetable oils was approximately 10% and 5% of total fat intake, respectively (233). 
 
The use of fish oil in Norway and colorectal cancer 
The increasing CRC incidence rates in both sexes in Norway ever since the registration 
started in the early 1950s is most remarkable, and the incidence has more than doubled over 
the years (2;5). The reason for the observed difference in the CRC incidence trend in Norway 
compared with neighbouring countries is obscure (234). This difference might be due to 
interaction between genetic predisposition and changes in lifestyle. Known dietary or other 
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life style associated factors cannot fully explain it (3). Norway has, however, used cod liver 
oil and margarine based on hydrogenated fish oil to a greater extent than most other countries. 
The Norwegian diet is to a large degree based on bread with margarine. Thus, in addition to 
the contribution by margarine, also bakery products have contributed to the TFA intake. 
Despite of Norway having had one of the world’s highest productions and intakes of fish oil 
and hydrogenated fish oil, consequences on health have not been sufficiently studied. The few 
controlled human studies undertaken have been associated with circulation diseases.  
 
1.8.7 EFFECTS OF OILS OF CURRENT INTEREST  
Unfavourable effects on lipid risk indicators for coronary heart disease by a PHFO diet (8.0% 
TFA) were found in young men, at least to the same extent as a butterfat diet (0.9% TFA). In 
addition, unfavourable anti fibrinolytic effects by a PHSO diet (8.5% TFA) relative to the 
PHFO or butter diets were found, and butter acted as a procoagulant relative to PHFO 
(233;235). Replacement of PHFO with vegetable oil in margarine led to significant 
improvements on plasma LP in young women (236). 
 
When rats were fed diets containing FO, PHFO, or HHFO, and the fatty acid composition of 
plasma, erytrocytes, subcutaneous adipose tissue, hepatic microsomal membranes, and plasma 
LP profile was compared between groups, the tissue content of MUFA increased and that of 
PUFA decreased after an increase of the degree of hydrogenation of the dietary fat. Tissues 
from rats fed PHFO showed significant amounts of TFA only and significant increases in total 
and LDL cholesterol. Although no direct evidence, the effects on plasma cholesterol may be 
attributable to the high content of trans isomers. The concentration of plasma TG was 
decreased only by highly hydrogenated fat feeding (237).  
 
It was also shown that FO (0.5% TFA), PHFO (30% TFA), and HHFO (3.6% TFA) had 
different effects on different important enzymes in hepatic rat microsomes (238), and that 
young animals were more sensitive than aged animals to the modification of the fatty acid 
composition and ω-6/ω-3 ratio of hepatic microsomal membranes (239).  
 
Hydrogenation degree of fish oil and induction and growth of colorectal cancer in mice  
A study performed with Min mice here at the Norwegian Institute of Public Health showed no 
statistically significant differences in the effects of fish oil, similarly hydrogenated as in the 
present study, on incidence, number, or size of colorectal tumors.  
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1.9 APPROACHES 
 
1.9.1 PROBLEM APPROACH 
With the problem field “Extensive use of hydrogenated fish oil over time in Norway, a 
country with a high colorectal cancer incidence trend compared with its neighbours”, as 
background, the problem approach was to examine whether there is a relation between intake 
of hydrogenated fish oil and CRC. It would be unethical to perform experiments on humans 
exposing them to amounts of edible oils considered to be potentially harmful. The relation 
was therefore studied in mice. 
 
Aims 
The first aim of this study was to examine whether hydrogenated fish oil in the diet can 
increase induction and/or growth of CRC in azoxymethane (AOM) treated A/J mice.  
 
Because of the complex composition of hydrogenated oils, the intension was to correlate the 
biological effects to the degree of hydrogenation rather than to specific fatty acids in the oils. 
As controls, native fish oil, butter oil without water and salt, refined soybean oil, and soybean 
oil similarly hydrogenated as the fish oil, were used. Thereby, oils which were consumed in 
Norway in the past and/or which may be used in the future are exemplified in this study. This 
leads to the second aim, which was to reveal patterns of effects on induction and/or growth of 
CRC in the material, even if the results were not statistically significant. 
 
The native fish oil was first analysed for protecting properties regarding induction and/or 
growth of CRC in the animals in comparison with soybean oil or butter oil (figures are not 
shown here).  
 
Endpoints and outcome variables 
Effects of the exposure to the experimental oils on induction and/or growth of CRC were 
measured by using colorectal tumors as endpoints. Outcome variables were the following 
tumor parameters; incidence and number to express induction, size to express growth, and 
load which takes into consideration both induction and growth of CRC. 
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Hypotheses 
The following three hypotheses were tested in 4 series of analyses:  
 
A. The first hypothesis 
 Hydrogenated fish oil in the diet will increase induction and/or growth of colorectal 
 cancer in AOM treated A/J mice in comparison with unhydrogenated fish oil, thus losing 
 the protecting properties of native fish oil. 
 
 1. Fish oils 
 2. Hydrogenated fish oils and soybean or butter oil 
 
B. The second hypothesis
 Induction and/or growth of colorectal cancer in AOM treated A/J mice will increase with 
 increasing hydrogenation degree of fish or soybean oil in the diet.  
 
 3. Hydrogenated fish and soybean oils 
 
C. The third hypothesis
 Hydrogenated fish oils in the diet will increase induction and/or growth of colorectal 
 cancer in AOM treated A/J mice in comparison with corresponding hydrogenation 
 degrees of soybean oil. 
  
 4. Hydrogenated fish and soybean oils 
 
Working hypotheses 
The following common null hypotheses and alternative hypotheses were set up:  
 
For associations between dependant and independent variables 
1. H0: “There is no relation between the tumor parameter and type of oil in the diet”  
2. HA: “There is a relation between the tumor parameter and type of oil in the diet”  
 
For differences between treatment groups 
1. H0: “The tumor parameter is equal in the two treatment groups” 
2. HA: “The tumor parameter is different in the two treatment groups” 
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1.9.2 EXPERIMENTAL APPROACH 
The following experimental approach was made: 
 
1. Establishing test system 
Before the experiment could be started, a test system for A/J mice had to be established.  
 
Pilot study  
A pilot experiment was undertaken with A/J mice already held at house to find the best 
possible way of increasing the number of colorectal lesions with AOM without damaging 
the animals unnecessary, and the shortest possible experiment time. 
 
Breeding 
A/J mice were imported from the U.S.A. to breed pups for the main experiment.  
 
Mixing experimental oils with the standard feed 
 To achieve reproducible doses of the oils in the feeds, a food processor was tried out. 
 
Feeding automats 
Hanging automats especially fit for feeding non-pelleted diets were tested. 
 
2. Testing of the experimental oils 
Nine groups of A/J mice were injected twice with AOM and each fed a diet containing 19 
w/w % of one of nine experimental oils (Table 7) and 1 w/w % corn oil mixed with AIN-
76M. The animals were killed at week 15 and colons were dissected and examined for tumors. 
 
Table 7 Types and abbreviations of the experimental oils.  
 Experimental oils Types Abbreviation  
 
 Butter oil Natural, without water and salt BO 
 Fish oils Native, raw FO 
  Partially hydrogenated PHFO 
   Highly hydrogenated HHFO 
  Totally hydrogenated THFO 
 Soybean oils Refined SO 
  Partially hydrogenated PHSO 
  Highly hydrogenated HHSO 
  Totally hydrogenated THSO 
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2 MATERIALS AND METHODS 
 
2.1 PILOT STUDY 
A pilot study was undertaken on A/J mice fed Rat & Mouse No. 3 Breeding Diet (RM3) early 
in life and Rat & Mouse No. 1 Maintenance Diet (RM1 (E)) later. The animals were injected 
twice with azoxymethane (AOM) subcutaneously in the neck region on days 6 and 13; 7.5 
mg/kg (8 animals), 10.0 mg/kg (2 animals), and 12.5 mg/kg (3 animals) and killed after 7 
weeks. In addition, 1 animal injected 12.5 mg/kg AOM was killed after 12 weeks. After 
cervical translocation, the colons were dissected, prepared, and mucosal lesions examined. 
 
2.2 EXPERIMENT 
 
2.2.1 BREEDING 
Fifty female and ten male A/J mice were purchased from Jackson Laboratory (Bar Harbour, 
ME, US) to breed pups for the main experiment. The animals had been born during week 3 
2003, arrived in week 10 approximately 7 weeks of age, and were acclimatized for 4 weeks.
 
 
   Pairing in 10 male cages (1 ♂ + 2 ♀), the first round  
                             
   2003   3a-7/4            9-13/4        15-19/4                                               24/4       
                  ↓                    ↓                  ↓                                                      ↓                                                               
               20 ♀              20 ♀            10 ♀                                            First births                  
 
                                                       
   Several more rounds                                                                                                                               6/7 
__________________________________________________________________________________↓_______
                                                                                                                                                             Last birth 
   Pairing (1 ♂ + 1 ♀) 
    
Figure 22 Breeding display. aStart of the breeding. 
 
The ten male mice were caged individually (Figure 22) and the fifty female mice two and two 
together in suspended polysterol cages with filter top and wood chips bedding. The animals 
received the special breeding diet RM3 ad libitum and had free access to tap water. Room 
conditions were as described in the next paragraph. After pairing, the females were returned 
to their original cages, but after detection of pregnancy, they were placed in individual cages. 
Several rounds of pairing were necessary to get the most of the females fertilized. In this 
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connection, a 4 days pairing routine (a period as long as the oestrus cycle) and two days rest 
for males was changed to 8 days pairing and 5 days rest to increase the chance of fertilization.  
The latter cycle was repeated until the planned numbers of living offspring for the experiment 
had been achieved after approximately 3 months. Only first litters were used. 
 
2.2.2 EXPERIMENTAL ANIMALS 
Randomized, placebo controlled studies aiming at preventing the occurrence of adenomatous 
polyps in voluntary humans are considered the best method within chemopreventive research. 
A weakness with this method is, however, that the endpoint is not cancer, but relapse of 
adenomas (240).  
 
In this experiment, the A phenotype of JAX mice named A/J mice were used. This mouse 
strain was developed by L.C. Strong in 1921 and has been widely used in cancer research 
(241). Inbred mice differ dramatically in their sensitivity to the colon carcinogen AOM (242). 
The A/J mice are wild type animals highly susceptible to inducement of ACF and multiple 
intestinal tumors (243), primarily in the distal colon (244), representative of human adenomas 
or carcinomas in situ (245). For these reasons they can be used as a murine model of human 
sporadic CRC as a sensitive test system for dietary factors.  
 
Care 
The experimental animals were housed in polysterol cages with a layer of wooden chips as 
bedding in a ventilated holding room maintained under controlled conditions (21 ± 2 ˚C and 
50 ± 10% relative humidity) in a 12 h light/dark cycle. A low level of noises was held.  
 
The cages were of two different sizes, suspended cages with filter top designed for up to eight 
mice, and smaller cages for up to four mice placed in ventilated glass cabinets. The small 
cages were especially used around the time of birth for one dam with pups. Cages with pups 
were changed every week and cages with grown animals every two weeks. 
 
The animals had free access to tap water, which was changed twice a week, while the bottles 
were changed ones a week. The feeding mode was ad libitum, and feeding was attended to on 
a daily basis. Not to disturb dam and litter, feeding the first week after birth was attended to 
daily only from day 4, when the experimental feeds were introduced.  
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2.2.3 EXPERIMENTAL FEEDS 
 
Basal feed 
American Institute of Nutrition-76M Semi-Purified Diet (AIN-76M) (Table 8), a pulverized 
feed modified (the 5% corn oil removed) from the standard feed AIN-76A, was bought from 
Special Diets Services (P.O. Box 705, Witham, Essex CM8 3AD, UK).  
 
Table 8 Ingredients and energy providing nutrients of the basic feed AIN-76M. 
 
Ingredients   g/kg 
 
Casein, High Protein   210.50 
DL-Methionine       3.20 
Sucrose   526.30  
Corn Starch   157.89 
Fiber (cellulose)     52.60 
Mineral Mix     36.90 
Vitamin Mix     10.50 
Choline Bitartrat   2.10 
Ethoxyquin (antioxidant)   0.01 
TOTAL   1,000.00 
 
Energy sources                 %                            kcal/g 
 
Protein                            23.8 
Carbohydrate                  76.2 
SUM                             100.0 
 
Metabolizable Energy   3.59 
 
 
 
 
Earlier animal experiments have shown that feeding animals with partially hydrogenated 
vegetable oils leads to symptoms of EFA deficiency (246). To ensure supply of the essential 
linoleic and α-linolenic acids for the animals, corn oil from Mills DA (Box 4644 Sofienberg, 
0506 OSLO, Norway) bought from the grocery shop was added to the feeds amounting to 
1.9% of total energy (Table 11). The corn oil contained 13 mg vitamin E per 100 g oil. 
 
Antioxidants limit degeneration of fat, but might also represent a source of error in the 
experiment. Therefore, no extra antioxidants or micronutrients were added.  
 
Experimental oils 
Fish and soybean oils produced 12th-13th of Dec 2002 and transported frozen at -20 ○C to 
Rikshospitalet University Hospital on the 17th of Des 2002 were donated by Denofa (Øraveien 
2, 1631 Gamle Fredrikstad, Norway). Butter oil produced and fetched in week 2, 2003, was 
donated by Tine Fellesmeieriet BA (Kalbakken, 0902 Oslo, Norway). The oils were ordinary 
raw materials for the food industry taken directly from the production line, except THFO, 
which was produced in the laboratory by Denofa.  
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The experimental oils were not analyzed specifically for TFA contents. In general, the trans 
content in hydrogenated oil will vary within certain limits depending upon the composition of 
the crude oil (unsaturation degree) and furthermore on the hydrogenation conditions (233). 
Exact conditions for the hydrogenation of the experimental oils and for the refining of the SO 
are not known. Hydrogenation conditions for hydrogenated soybean oils in a study by K. 
Almendingen were; temperature: 155○C (MP 40/42○C), 155-180○C (MP 30/32 and 38/40○C), 
catalyst: nickel, pressure: 0.5-1.0 bar above atmospheric pressure (233). FO, PHFO, HHFO, 
and THFO were supposed to contain equal amounts of cholesterols (209), and the same goes 
for SO, PHSO, HHSO, and THSO. Approximated values for the trans and cholesterol 
contents and melting points are shown in Table 9, and the fatty acid profiles of the 
experimental oils, as analyzed by Denofa, Table 10. 
 
Table 9 Approximated melting points and trans and cholesterol contents of the experimental oils, adapted from Denofa, 
Tine, and diverse literature. 
 
 Trans monoenes 
Experimental oil MP, ca. ○C and dienes (GLC), ca. % Total trans (IR), ca. % Cholesterol, mg/100 g (%) 
 
BO 33A, 40B 2.2A 3.7A-4.84T 268, 1933 (~0.3,19)B, 219D
 
FO 25S  0.3M 500 (~0.5)P 
PHFO 31-33E, 30S 54-55 GA, a little > 54-55S+GA 54S, a little > 55-60S+GA 250-800 (0.25-0.80)GA
HHFO 40-42E, 40S 50-21GA, a little < 50-52S+GA 38S, a little < 50-55S+GA 480-925 (0.48-0.93)GA
THFO 55-60S 21-0GA < 1S ? 
 
SO 0 0.24-0.48T 0.40-0.86T 0D 
PHSO 31-33E, 30S ? 42S  ? 
HHSO 40-42E, 40S 49.5A 46S, 51A ? 
THSO 55S  ? < 1S ? 
BO, butter oil; FO, fish oil; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally 
hydrogenated fish oil; SO, soybean oil; PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; 
THSO, totally hydrogenated soybean oil; MP, melting point; GLC, Gas-Liquid Chromatography; IR, Infrared 
spectrophotometry. AFrom K. Almendingen (233).BBy A. S. Biong (206). DFrom The Large Food Table (205), EBy A. 
Evennett (247), GABy G. Andersen, Denofa (248), MFrom N. Morgado (239), PFrom J. Pettersen (199), SBy H. Standal, 
Denofa (128;209), TFrom A. Aro (TRANSFAIR) (211). Real figures of these characteristics for the experimental oils may 
differ from the values of this table. Supposed melting points for some of the oils are highlighted. 
 
The MP of the experimental PHSO was supposed to be 31-33 ○C and of HHSO 40-42 ○C, and 
the MP of PHFO and HHFO probably were in similar areas. There are no common criteria for 
referring to hydrogenated oils with MP within these areas as “partially” and “highly” 
hydrogenated, respectively (see point 1.8.5 Hydrogenated oils). The phrases “partially” and 
“highly” hydrogenated were used here to keep the two hydrogenation degrees apart.  
. 
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The fish oils 
FO, PHFO, HHFO and THFO were all obtained from the same batch of a mixture of several 
crude fish oils, mainly from South America. The fish species are not known. A certificate of 
analysis for a sample of fish oil received earlier from Denofa is presented in Appendix II. 
 
The FO was native and contained approximately 33% PUFA, including 12.1% EPA and 8.4% 
DHA, 30% MUFA, 2% unidentified fatty acids, and 36% SFA. Thus, the FO might be 
characterized as containing not far from equal parts of SFA, PUFA, and MUFA.  
 
The PHFO contained approximately 45% PUFA, 12% MUFA, 6% unidentified fatty acids, 
and 37% SFA, and may be characterized as containing mostly PUFA, a great part of SFA, and 
some MUFA and unidentified fatty acids, including fatty acids changed by the hydrogenation.  
 
The HHFO contained approximately 38% PUFA, 7% MUFA, 5% unidentified fatty acids, 
and 51% SFA, and may be characterized as containing mostly SFA, a great part of PUFA, and 
some MUFA and unidentified fatty acids, including fatty acids changed by the hydrogenation.  
 
The THFO contained approximately 2% PUFA, < 1% MUFA and unidentified fatty acids, 
and 97% SFA, and may be characterized as containing almost only SFA, including fatty acids 
changed by the hydrogenation.  
 
The soybean oils 
The SO, PHSO, HHSO and THSO were obtained from the same boat load of soybeans.  
 
The SO was refined and contained 61% PUFA, 23% MUFA, < 1% unidentified fatty acids, 
and 15% SFA, and may be characterized as containing mostly PUFA, a great part of MUFA, 
including up to 1% TFA (128), and some SFA.  
 
The PHSO contained 1% PUFA, 77% MUFA, < 1% unidentified fatty acids, and 22% SFA 
and may be characterized as containing mostly MUFA, a great part of SFA, and ≤ 1% PUFA 
or unidentified fatty acids, including fatty acids changed by the hydrogenation.  
 
The HHSO contained < 1% PUFA, 69% MUFA, < 1% unidentified fatty acids, and 30% SFA 
and may be characterized as containing mostly MUFA, a great part of SFA, and < 1% PUFA
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Table 10 Fatty acid profiles of the experimental oils.a
 Butter oil  Fish oil Soybean oil 
 Degree of hydrogenation   Degree of hydrogenation 
   Raw Partial High Total  Refined   Partial   High   Total 
Fatty acid BOb  FO PHFO HHFO THFO  SO   PHSO    HHSO   THSO 
4:0   4.9 
6:0   2.4 
8:0   1.3 
10:0   2.7 
11:0   0.3 
12:0   2.9   0.2   0.2 
14:0 10.3   8.3   8.7   8.8   8.0   0.1   0.2   0.1   0.1
15:0   0.8   0.6   0.6   0.6   0.5     
16:0 27.8 21.7 21.4 25.6 35.5 11.2 12.0 11.0 15.0 
17:0   0.5   0.5   0.7   0.5   0.2   0.1   0.1   0.2 
18:0 12.3   4.2   4.8   9.5 22.4   3.3   8.5 17.1 83.0 
19:0   0.3   0.1   0.2   0.5  
20:0   0.2   0.2   0.5   3.4 18.1   0.3   0.4   0.4   0.7 
22:0   0.3   1.8 12.5   0.4   0.4   0.4   0.6 
24:0   0.2   0.1   0.1 
14:1 cis   0.9 
14:1 n5   0.2   0.2   0.2   0.2     
16:1 n7 10.5 11.8   6.8   0.2   0.1 
16:1 cis   1.4 
16:1 trans   0.8  
17:1   1.5   0.2       
18:1 n7   3.2   1.5    
18:1 n9 10.4 21.5 
18:1 cis 25.9 
18:1 trans   2.8 
18:1 total 76.2 68.8  
20:1 n7   0.2 
20:1 n9   2.0   0.2   0.2   0.1  
22:1 n9 eruka   0.2 
22:1 n11   1.1 
24:1   0.3 
16:2 n6   1.3   0.1   0.2 
18:2 n6   1.6   0.2   0.1 55.4   1.1   0.9 
18:2 cis,cis   1.5 
18:2 conjug.   0.7 
20:2   0.2 
16:3 n3   0.6 
18:3 n3   0.8   5.8 
18:3 all cis   0.4    
16:4 n3   0.7   0.1      
18:4 n1   0.2 
18:4 n3   1.7   0.1    
20:4 n3   1.0 
20:4 n6   1.1   0.7     
22:4 n6   0.3   0.6     
20:5 n3 EPA 12.1 
21:5 n3   0.6 
22:5 n3   2.6 
22:6 n3 DHA   8.4 
18:1n9+C 18n7 17.3 11.1 
20 poly 17.2 15.1       
22 poly   9.9 11.5 
Unidentified   2.0   6.2   4.5       0.2   0.2   0.6   0.3   0.3 
TOTAL   100.0   100.0   100.0   100.0   100.1   100.0   100.0   100.0   100.0 
aThe hydrogenated fish oils came from the same batch as the native fish oil, and the hydrogenated soybean oils from the same 
boat load of soybeans as the refined soybean oil. These oils were analyzed by Denofa (% areas). bThe experimental butter oil 
was not analyzed, thus the fatty acid profile for this oil (%) is that of a “mean” Norwegian butter oil, analyzed by Tine 1991. 
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and unidentified fatty acids, including fatty acids changed by the hydrogenation.  
 
The THSO contained 0% PUFA, 0% MUFA, < 1% unidentified fatty acids, and nearly 100% 
SFA, and may be characterized as containing almost only SFA, including fatty acids changed 
by the hydrogenation. 
 
The butter oil 
Product specification of the experimental BO was not available. However, the biological 
variation of butter oil is low. The fatty acid profile of the BO in Table 10 is based on 341 
samples of butter analyzed in 1991 (TINE FoU). The samples were taken in ten dairies in 
different parts of Norway, one sample per dairy per month during one year (249).  A general 
product specification of butter oil is presented in Appendix III.  
 
BO contains approximately 3% PUFA, 32% MUFA, 0% unidentified fatty acids, and 66% 
SFA, and may be characterized as containing mostly SFA, a great part of MUFA, and little 
PUFA, including 3-8% TFA (126;150). 
 
Mixing of experimental feeds 
The experimental oils were mixed by food processor with AIN-76M and corn oil without 
heating, the hardened oils for 20 minutes, and the viscous oils for a shorter time, with stirring 
in between, to achieve adequate homogeneity in the standard feed.  
 
Amounts of prepared experimental feeds were recorded, and average feed expenditure (FE) 
was estimated for each treatment group of animals at the end of the experiment.  
 
Composition of feeds 
The distribution of ingredients per 100 gram feed and per production unit is shown in Table 
11, and the nutrients of the experimental diets are specified in Table 12, along with their 
contribution to total energy. The diets were high fat diets, thus the contents of the other 
nutrients and fibre were proportionally reduced compared with a low fat diet. Experimental 
oil provided 36.6% and total fat 38.5% of total isocaloric dietary energy. The energy percent 
from fat lies in an area not unusual for human intakes.  
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Table 11 Distribution of ingredients in the feeds and production unit by weight, and their contribution to total energy. 
 
Ingredient   g/100 g feed   Kcal/100 g feed Energy, %    Production unit, g 
 
AIN-76M 80  287 61.5   400  
Experimental oil 19  171 36.6      95 
Corn oil   1  9   1.9   5  
TOTAL  100  467   100.0   500 
AIN-76M, American Institute of Nutrition-76M Semi-Purified Diet. 
 
Table 12 Specification of dietary nutrients and their contribution to total energy. 
 
Nutrient % w/w   Kcal/100 g feed   % Energy 
 
Protein 17    68 14.6 
Fat 20  180 38.5 
Carbohydrates 55  219 46.9 
Fiber   4  
Micro nutrients   4 
TOTAL   100   467   100.0 
 
Storage 
The experimental oils were thoroughly stored on nitrogen in containers packed in several 
layers of aluminium folio and placed in paper boxes at Rikshospitalet University Hospital at -
30 C○ until the start of the experiment. After transferring the oils to the Norwegian Institute of 
Public Health, oils and mixed feeds were lettered and stored on nitrogen in airtight buckets in 
the dark at 4 C○, as done by Duthie et al, to avoid degeneration of the fats (171). 
 
2.2.4 FEEDING AUTOMATS 
Due to the different consistencies of the various oils, some feeds were light and fluffy, others 
light and sticky, and others again dense and sticky. Therefore, several automats of the same 
type but differing with respect to the size of the feeding openings were used. The automats 
were checked daily and feeds replenished when needed. In addition, the feeds were stirred 
down in the automats in order to ensure that feeding could take place ad libitum. 
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2.2.5 EXPERIMENTAL TREATMENT OF THE ANIMALS 
Prior to the start of feeding the experimental diets, there was an adjustment period of 3 days 
for dam with pups. The experiment started on the 28th of April 2003. The experimental design 
is shown in Figure 23.  
 
The order of introduction of diets to the animals was drawn randomly before the start of 
births, and the diets were scheduled in the randomized order. The first born litter was 
presented diet number one, the second born litter diet number two, and so on, until the nine 
diets were represented. Since births took place over 10.5 weeks, the diets were delegated from 
the start of the schedule in several turns. 
 
  
   Test display 
   2003  
                       
   First litters:   24/4                                                                                                                                   7/8 
   Last litters:    6/7                                                                                                                                  19/10 
    
   d                           0                 7±1             14±1              20-26                                                       105 (15wk)      
                                ↓                   ↓                   ↓                    ↓                                                                  ↓         
                                                     ↑                   ↑                    ↑                                                                  ↑               
   Birth             AOM            AOM         Separation                                                      Killed 
 
                                            ↑ d 4: Start experimental diets                                                                        ↑             .                               
      
                                                                               
AOM, azoxymethane; d, day; wk, weeks. 
 
Figure 23 Experimental design. 
 
When the diet had been introduced to the last born litter, each of the nine treatments BO, FO, 
PHFO, HHFO, THFO, SO, PHSO, HHSO, and THSO had been presented to a group 
constituting ≥ 20 animals which lived through the experimental time period.  
 
Since the diets were introduced to dams with offspring on day 4 after birth, the pups were 
exposed to the treatment through the mother’s milk already before they started being exposed 
through eating the diets themselves. The exposure lasted until the animals were killed.  
 
In order to increase the number of tumors in the colons, the animals were treated twice, ones a 
week, with 10 mg/kg body weight AOM, purchased from Sigma Chemical Co (St. Louis, 
MO, US), dissolved in saline, by subcutaneous injection in the neck region. AOM undergoes 
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biotransformation in the liver to produce the carcinogenic metabolite methylazoxymethanol 
(MAM). The metabolizing enzyme system is the alcohol inducible P4502E1, also found in 
colon tissue (250).  
 
The animals were weighed once a week, for the first time on day 7 ± 1 and the last time on 
day 105 ± 1, when they were killed by cervical dislocation. Colons were removed and the 
number and diameter of tumors scored by the use of light microscope (LM) from Nikon 
(Melville, NY, U.S.A.) in sections (fields of view) of ca 1 cm, from anus towards coecum. 
Samples of liver and coecum were collected in plastic test tubes, snap-frozen in liquid 
nitrogen, and stored at - 70 ○C.  
 
2.3 PINWORM INFECTION 
The summer 2003, a pinworm infection was detected in mice used in another experiment, but 
housed in the same room as the animals of this experiment. It was decided that ongoing 
experiments were to continue to the end without medication of the animals, while strict 
precautions were taken to hinder spreading of the pinworm.  
 
2.4 SCORING OF LESIONS 
The mice were killed by cervical dislocation and final weight (FW) registered. The colons 
were dissected, rinsed in cold (ca. 4○C) PBS (1.14 mM NaH2PO4 · H2O, 5053 mM Na2HPO4 · 
12 H2O, 0.14 M NaCl, pH 7.4), slit open along their longitudinal median axes, and fixed flat 
between identification numbered PBS wet filter papers (27). The fixated colons were placed 
in 10% neutral buffered formalin solution (3.7% formalin in 28.9 mM NaH2PO4 · H2O, 44.4 
mM Na2HPO4 · H2O) for at least 24 h prior to staining. Staining of the colons was performed 
for 4 s with 0.2% filtered methylene blue from George T. Gurr Ltd. (London, UK) dissolved 
in the same formalin solution. They were then placed in sterile plastic test tubes from Cellstar 
(Greiner, Germany) filled with the same neutral buffered formalin solution.  
 
At least 24 h after staining, the surface of the whole mount colons was transilluminated in an 
inverse LM, and the size of the tumors was scored under x20 magnification. The examination 
of the specimens was carried out blind. The colons were assessed in the direction anus to 
coecum. During scoring, the colons were placed between two Petrie discs, with a few drops of 
neutral buffered formalin solution, to protect the colons from drying up. One of the Petrie 
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discs was divided into sections by marking stripes with a diameter of 1 cm, corresponding to 
one field of vision at a magnification of x20. The size of each tumor was scored as the 
diameter in the length direction of the intestine by an eyepiece graticule.  
 
The diameter and localization of the tumors were recorded on a form shaped as a network, 
and successively identified by the blind number of the animal. The first colonna indicated the 
blind number, while the rest of the colonnas indicated the numbers of the fields of vision. In 
the rows, the diameters were recorded below the field of vision numbers they were found in.  
 
When the recording was finished, the tumors were added up for each animal, and the number 
of tumors noted on the form under the blind number of the animal. Scored diameter values 
were later corrected for magnification (scored d/20), and mm2 areas were calculated by use of 
the formula A = π · [scored d/(20 · 2)]2 = π · scored d2/1600.  
 
2.5 STATISTICS 
The data material was analysed by the use of the statistical program SPSS, from SPSS Inc. 
(Chicago, Illinois, US). Data showing normal distributions and homogenous variances were 
analysed by parametrical tests, but for most of the material non parametrical tests were used. 
Tests used to look for associations between lesion incidence and treatments or differences in 
incidence between treatment groups were Fisher’s Exact or Pearson Chi-Square tests, and the 
effect measure for differences in incidence between treatment groups was relative risk (RR) 
with 95% confidence interval (CI). Tests used to look for associations between lesion number, 
size, or load and treatments were Kruskal-Wallis Test with Exact Sig. or Asymp. Sig. and 
very seldom Oneway Anova, while Mann Whitney Test with Exact Sig. (2-tailed) or Asymp. 
Sig. (2-tailed) and very seldom T-Test were used to look for differences in tumor number, 
size, or load between treatment groups, and median was used as effect measure.  
 
Since the results of this preliminary study were intended as a basis for generating hypotheses 
for further experiments in a larger project, a large number of comparisons were performed in 
the analyses. The results were looked at in series according to hypotheses and questions 
decided in advance, and the p-values were adjusted manually à la Bonferroni in accordance 
with the number of comparisons in each series.  
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Due to lack of information, it was not possible to figure out in advance the number of animals 
needed in the experiment to secure a high power in the study. Hence a cut off point of p ≤ 0.2 
was set, to avoid the risk of not detecting real differences. However, where a full table for 
these reasons was analysed for one of the genders, it was also analysed for the other gender, 
even if the overall p-value for the association between the tumor parameter and type of oil in 
the diet was higher than the cut off point.  
 
The significance level (the probability of finding a difference only by chance, when it is not 
real) was set at p ≤ 0.05. 
 
Recorded confounding factors were animal gender and weight. The planned use of General 
Linear Model to take into consideration the effects of these factors on the results had to be 
departed because the criteria for the use of this test were not present. Thus, it was not possible 
to analyse interactions between dietary oils, gender, and final weight. The data material was 
therefore first checked for differences between genders, and then analysed separately for 
females and males. FW is dealt with in connection with the tumor parameters in text, tables, 
and illustrative curves for females and males separately.  
 
2.6 LIMITATIONS 
In this thesis, colorectal tumors include tumors between the anal opening and the coecum. 
Two fast growing large tumors originating in the skin of the outer anal region were therefore 
excluded, one from a female animal in the HHFO group and one from a male animal in the 
SO group. One of these tumors was collected as a sample. 
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3.1 ESTABLISHING TEST SYSTEM 
 
3.1.1 PILOT STUDY 
Because the animals injected with 12.5 mg/kg AOM were losing fur, maximum tolerable dose 
(MTD) was set at 10 mg/kg for the main experiment. The animals given this dose seemed to 
tolerate two subcutaneous injections in the neck region with days 6 and 13 as safe points of 
time. Lesions were observed in the colon of the animals. To ensure adequate number of 
lesions in the main experiment, it was decided to treat the experimental animals for 12 weeks 
(summer vacations postponed the harvesting of colons until week 15).   
 
3.1.2 BREEDING ACCOUNT 
114 pairings in total resulted in 45 living litters, 4.4 living offspring per living litter, and 199 
animals living throughout the experiment, i.e., 1.75 living offspring per pairing (Table 13). 
 
Table 13 Breeding account. 
  Butter oil Fish oils    Soybean oils 
Animals          BO     FO      PHFO    HHFO      THFO    SO    PHSO        HHSO      THSO   Total 
Born 
Total offspringa       40     27      24    29      32    25    27      22       48    274 
Litters born     5       5        5      5        6      5      5        4     8      48 
Mean per litter     8    5.4     4.8       5.8     5.3    5.4        5.4     5.5     6     5.7 
 
Cannibalizedb
Before AOM     5       0        1      1        3      1       1        0        2      14 
After AOM     5       7        0      5        6      3       5        0       19      50   
 
Died 
After separation     0       0        0     1♀ 1♂          0     1♀       0          0     2+1♂        6    
Ill, killedc    2♂                1♂    1♂        4 
Sacrificedd    1♂                1 
 
Living 
Living offspring       27     20      23    21      23    20     21      21       23    199 
Living litters     5   5    5  5    6  5   5    4 5  45 
Mean per litter      5.4       4         4.6       4.2         3.8      4        4.2  5.3      4.6     4.4 
aAfter counting. It is not known how many pups disappeared before counting. bThe most of these animals disappeared, 
probably by cannibalization. cHair loss, prepuce infection, obstipation. dOccurence of pinworm investigated. FO, native fish 
oil; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil; SO, 
soybean oil; PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally 
hydrogenated soybean oil; AOM, azoxymethane. 
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In the THSO group more than 50% of the offspring was lost after introduction of the diet. Of 
he 50 purchased females, 8 gave no living offspring even after several rounds of pairing. The 
number of animals cannibalized before counting is not known.  
 
3.1.3 MIXING EXPERIMENTAL OILS WITH AIN-76M, FEEDING AUTOMATS 
The mixing of unheated experimental oils by food processor into the basis feed seemed to 
produce adequate homogeneity for all the different oils. Clumps found during feeding were 
traced back to the AIN-76M. The feeding automats turned out suitable for ad libitum feeding. 
 
3.1.4 ACCOUNT OF EXPERIMENTAL FEEDS 
Average expenditure of feed per mouse per day was 4.46 g including wasting by the animals, 
and varied from 3.70 g in the HHFO group to 5.45 g in the FO group (Table 14).  
 
Table 14 Expenditure of experimental ingredients and feeds. 
Expenditurea   Butter oil  Fish oils Soybean oils  
Products    BO  FO    PHFO    HHFO     THFO     SO   PHSO        HHSO     THSO TOTAL 
 
In total, kg
AIN 76M 12.200   17.600    10.664    11.864 12.784   13.000   8.800 7.600  9.064 103.576 
Experimental oil   2.898 4.180  2.533  2.817   3.036    3.088 2.090 1.805  2.153   24.597 
Corn oil   0.153 0.220  0.133  0.148   0.160    0.163 0.110 0.095  0.113 1.295 
FEED 15.250   22.000    13.330    14.830 15.980  16.250   11.000 9.500    11.330 129.470 
 
Mouse days    3249  4038         2644   4012    3852 3275  2453  2544   2884    28951 
 
Per mouse per d, g
AIN-76M 3.76   4.36    4.03    2.96 3.32  3.97   3.59   2.99    3.14  3.57 
Experimental oil 0.89   1.04    0.96    0.70 0.79  0.94   0.85   0.71    0.75  0.85 
Corn oil 0.05   0.05    0.05    0.04 0.04  0.05   0.04   0.04    0.04  0.04 
FE 4.70   5.45    5.04    3.70 4.15  4.96   4.48   3.74    3.93  4.46 
aExpenditure by 303 animals in total, including the 199 experimental animals, 44 animals in an alternative test procedure, 60 
animals which died or were exposed of after separation, and 49 dams. Expenditure by 81 pups which disappeared before they 
were weaned is not included. FO, native fish oil; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; 
THFO, totally hydrogenated fish oil; SO, soybean oil; PHSO, partially hydrogenated soybean oil; HHSO, highly 
hydrogenated soybean oil; THSO, totally hydrogenated soybean oil; AIN-76M, basis feed; FE, feed expenditure. 
 
3.2 WHAT THE COLONS SHOWED 
The colons differed in size by length, width, thickness, strength, and appearance. Some 
looked “clean” with flat regular appearing mucosae, while others looked “messy” with folds 
and many vaguely coloured spots. Some colons had blue stained corny appearing large 
lymphoid nodules with many compartments, while others had small nodules. Some nodules 
seemed erythematous while others showed some kind of network. Some colons had few and 
others many light blue or turquoise stained fine-corny appearing lymphoid like tissues which 
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appeared as small oval or round “holes”. Some “holes” had green or turquoise coloured crypts 
around or against the edge, which looked as if they were decomposing. Other green crypts 
were seen along straight or bending fissures with or without such “holes”.  
 
3.2.1 TUMORS AND ABERRANT CRYPT FOCI 
Tumors were identified by their circular appearance, high protruding, bright blue staining, and 
chaotic looking irregular and dis-
torted crypts (Figure 24). Elevated 
and flat ACF were seen, and some 
of the flat ACF were recorded as 
tumors due to their prominent and 
chaotic appearance, even if they 
were not highly elevated or circu-
lar. Some of the tumors seemed to 
originate in lymphoid nodules.  
 
 
Figure 24 Tumor in the A/J mouse colon. Magnification x20. Photo 
by Jan Erik Paulsen, Norwegian Institute of Public Health. 
 
3.3 TESTING OF THE EXPERIMENTAL OILS 
 
3.3.1 DISTRIBUTIONS OF SAMPLES 
The distribution of animals on the nine diets is presented in Table 15. Uneven distribution of 
animals between the genders led to some quite small samples of animals for examination of 
tumor incidence, number and load. Uneven distribution of tumors between genders led to 
some quite small samples less than 10 tumors for examination of tumor size. The distribution 
of tumors on the nine treatment groups is presented in Table 16. 
 
Table 15 Distribution of A/J mice on the nine diets, by gender and in total. 
   A/J mice 
 
       ♀ 
 
       ♂ 
 
   N total 
 
    BO 
  
       14 
 
       13 
 
       27 
FO 
  
       11 
 
         9 
 
       20 
PHFO 
 
         7 
 
       16 
 
       23 
HHFO 
 
         9 
 
       12 
 
       21 
THFO 
 
       12 
 
       11 
 
       23 
SO 
 
       10 
 
       10 
 
       20 
PHSO 
 
       13 
 
         8 
 
       21 
HHSO 
 
       16 
 
         5 
 
       21 
THSO 
       
       12 
 
       11 
 
       23 
 
N total 
 
     104 
 
       95 
 
     199 
BO, butter oil; FO, native fish oil; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally 
hydrogenated fish oil; SO, refined soybean oil; PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated 
soybean oil; THSO, totally hydrogenated soybean oil. 
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Table 16 Distribution of tumors on the nine dietary treatment groups of A/J mice in the main experiment, also by gender. 
   Tumors 
 
       ♀ 
 
       ♂ 
 
   N total 
 
  BO 
  
      14   
 
      26 
 
      40 
FO 
  
        2 
 
        9 
 
       11 
PHFO 
 
         6 
 
       13 
 
       19 
HHFO 
 
        7 
 
      10 
 
      17 
THFO 
 
       15 
 
       28 
 
       43 
SO 
 
       16 
 
       20 
 
       36 
PHSO 
 
       28 
 
       16 
 
       44 
HHSO 
 
        5 
 
        2 
 
        7 
THSO 
       
        11 
 
        21 
 
        32 
 
N total 
 
      104 
 
      145 
 
      249 
BO, butter oil; FO, native fish oil; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally 
hydrogenated fish oil; SO, refined soybean oil; PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated 
soybean oil; THSO, totally hydrogenated soybean oil. 
 
3.3.2 EFFECTS OF THE EXPERIMENTAL OILS ON ANIMAL BODY WEIGHT 
The weight development of the animals is dealt with in the manuscript for an article found in 
Appendix IV. Final weight (FW) was highly statistically significantly related to gender. Seen 
in total, males had 1.2 times as high FW as females, the median difference being 3.7 g, p < 
0.0005. Males also had highly statistically significantly higher FW than females in any of the 
treatment groups, the median differences ranging from 2.5 to 5.9 g (Table 17). Differences in 
FW are dealt with in the article in connection with the tumor parameters. 
 
Final weight seen in connection with feed expenditure 
Figure 25 shows illustrative curves of median FW and average FE for the total of female and 
male animals in each treatment group. Average FE in the various treatment groups must not 
be mistaken for means used in statistical tests, since FE was not measured for each mouse. 
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Figure 25 Final animal weight (FW) seen in connection with feed expenditure (FE). 
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3.3.3 EFFECTS OF THE EXPERIMENTAL OILS ON TUMOR PARAMETERS 
The effects of the experimental oils are thoroughly described in the manuscript for the article 
(Appendix IV). In the present section, the results regarding the three hypotheses are presented 
based on statistical evidence, with overviews comprising ranked effects and indications of 
statistical evidence for each series. Median differences between treatment groups with p-
values are found in Tables 1-24 (Appendix V) along with data for final weight. 
 
Differences in effects between genders 
An overview of the gender differences is shown in Table 17. Males had increased tumor 
incidence and number, i.e., induction of CRC by THFO and increased tumor load by FO 
relative to females, while females had increased tumor size, i.e., growth of CRC by SO and 
THFO relative to males (Table 1-4 Appendix V). In the treatment groups not mentioned, no 
gender differences were found, or the differences were not statistically significant.   
 
Table 17 Gender differences in colorectal tumor parameters and final weight in AOM treated A/J mice.  
 
Genders Ranked estimated median gender differences in tumor parameters Statistical evidenceb
Tumor and final weight, largest difference firsta for association 
 *     ♦   ♦  ♦  
 THFO > FO > THSO > BO > SO > PHSO > HHSO > HHFO > PHFO  
Incidence   0.576 0.485   0.409  0.346 -0.300  0.260   0.087 0.084  0.054 strong 
 
     *   ♦ ♦  ♦ 
 THFO > THSO > FO > BO > SO = PHSO = HHSO = HHFO = PHFO  
Number    2.0 1.5    1.0 0.5 0.0 strong 
 
   *  *
 SO > FO > THFO > THSO > PHFO > HHSO > HHFO > BO > PHSO  
Size, mm2   -3.21  -2.37   -2.23    -2.01  1.51  -0.84    -0.23    0.13   0.00 strong 
 
 ♦ ♦  *
 THFO > PHSO > BO > SO > FO > THSO > PHFO > HHSO = HHFO  
Load, mm2  4.45  -3.83  3.78  -2.39   0.79  0.49    0.38   0.00 yes 
 
   †    †    †   † †   † †  †    †  
 FO > BO > SO > THFO > HHSO > PHFO > THSO > PHSO > HHFO 
FW, g 5.9  5.0   5.0  4.1     3.9  3.4    3.0 2.8   2.5 strong 
aFigure in black: males have higher tumor parameter value than females. Figure in red: females have higher tumor parameter 
value than males. bStrong or †, P ≤ 0.005; yes or *, P ≤ 0.05; weak (tendency) or ♦, ﻿﻿﻿0.20 ≥ P > 0.05; no, P > 0.20, p-values 
have not been adjusted a la Bonferroni. AOM, azoxymethane; BO, butter oil without water and salt; FO, native fish oil; 
PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil; SO, refined 
soybean oil; PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally 
hydrogenated soybean oil; FW, final weight. 
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Differences in effects between treatment groups 
FO had been analysed for possible protecting properties in comparison with SO or BO in 
advance. The results will be mentioned in series 2. 
 
Series 1: No statistically significant differences were found in the tumor parameters between 
HFO and unhydrogenated FO, irrespective of gender (Tables 18-19, Tables 5-8 Appendix V).  
 
Series 2: Because the tumor parameters seemed more increased in females by SO and in 
males by BO relative to the other gender (Table 17), protective properties of HFO were 
analysed in comparison with SO for females and BO for males (Tables 18-19, Tables 9-12 
Appendix 5).  
 
In the preanalysis, FO clearly reduced tumor incidence, number, and load in females, but 
there was no statistically significant difference for tumor size, compared with SO. When FO 
was hydrogenated; THFO reduced tumor incidence (RR SO-THFO = 2.70), PHFO reduced 
tumor size (md = -3.9 mm2), and PHFO and HHFO reduced tumor load (md = -6.0 and -6.2 
mm2, respectively) in females relative to SO, and tumor incidence, size, and load were related 
to type of oil in the diet.  
 
Table 18 Series 1 and 2: Ranked tumor parameters and final weight in female AOM treated A/J mice and statistical evidence 
for change in effects, or in protection compared with SO, when fish oil was hydrogenated. 
 
Series 1 and 2 Ranking Increase by HFO  Statistical evidence* for 
Females, tumor  found compared with differences  association 
 FO  SO 
 
 SO > PHFO > THFO = HHFO > FO 
Incidence   0.900  0.571 0.333 0.182 no no FO: no, SO: yes  FO: no 
 THFO, weak HHFO  SO: yes 
 SO > PHFO > THFO = HHFO = FO 
Number 1.5   1.0  0.0 no no FO: no, SO: no  FO: no 
  SO: no 
Load, mm2    6.18  0.16 0.00 no  no FO: no, SO: yes  FO: no 
 PHFO, HHFO  SO: yes 
 SO > FO > THFO > HHFO > PHFO 
Size, mm2    4.44    3.70    3.14 1.04   0.50 no no FO: no, SO: yes  FO: weak 
 PHFO  SO: yes 
 SO > FO > PHFO > THFO > HHFO 
FW, g    25.0  20.9   19.0    18.9  17.8 no no FO: yes all  FO: strong 
 SO: strong all  SO: strong 
*Statistical evidence: strong, P ≤ 0.005; yes, P ≤ 0.05; weak (tendency), ﻿﻿﻿0.20 ≥ P > 0.05; no, P > 0.20, p-values have been 
adjusted a la Bonferroni. AOM, azoxymethane; SO, refined soybean oil; FO, native fish oil; HFO, hydrogenated fish oil; 
PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil; FW, final 
weight.  
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In the preanalysis, FO seemed to reduce tumor incidence and load, but to increase tumor size, 
in males, compared with BO, but these results were not statistically significant. When FO was 
hydrogenated; THFO seemed to increase tumor incidence, number, and load and PHFO to 
increase tumor size in males compared with BO, not either statistically significant. HHFO, on 
the contrary, reduced tumor load (md = -4.0 mm2), and tumor incidence, number, and load 
were related to type of oil in the diet.  
 
Table 19 Series 1 and 2: Ranked tumor parameters and final weight in male AOM treated A/J mice and statistical evidence 
for change in effects, or in protection compared with BO, when fish oil was hydrogenated. 
 
Series 1 and 2 Ranking Increase by HFO Statistical evidence* for 
Males, tumor found compared with differences    association 
 FO  BO 
 
 THFO > BO > FO > PHFO > HHFO  
Incidence 0.909   0.846  0.667  0.625  0.417 no FO: no    FO: weak 
  no BO: weak HHFO    BO: yes 
Load, mm2    4.45  3.97    0.79  0.54   0.00 no FO: no    FO: yes 
  no BO: yes HHFO    BO: strong 
 weak PHFO 
 THFO > BO = FO = PHFO > HHFO 
Number   2.0   1.0    0.0 tendency THFO FO: weak THFO    FO: yes 
  no BO: no    BO: yes 
 PHFO > FO > BO > THFO > HHFO  
Size, mm2   2.01 1.33  1.08 0.91   0.81 no FO: no    FO: no 
  no BO: no    BO: no 
 BO > FO > THFO > PHFO > HHFO 
FW, g    27.5  26.7    23.1 22.4   20.3 no FO: strong all    FO: strong 
  no BO: strong all    BO: strong 
*Statistical evidence: strong, P ≤ 0.005; yes, P ≤ 0.05; weak (tendency), ﻿﻿﻿0.20 ≥ P > 0.05; no, P > 0.20, p-values have been 
adjusted a la Bonferroni. AOM, azoxymethane; BO, butter oil without water and salt; FO, native fish oil; HFO, hydrogenated 
fish oil; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil; 
FW, final weight.  
 
Series 3: In females, THFO increased tumor size relative to PHFO (md = 2.6 mm2), and 
PHSO increased tumor number relative to HHSO (md = 2). Tumor size was related to degree 
of HFO in the diet for females and tumor number to degree of HSO for both females and 
males. In males, THFO increased tumor number compared with PHFO (md = 1) or HHFO 
(md = 2) and tumor load compared with HHFO (md = 4.5 mm2), and tumor number and load 
were related to degree of HFO in the diet. Tables 20-21 and Tables 13-20 Appendix V.
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Table 20 Series 3: Ranked tumor parameters and final weight in female AOM treated A/J mice and statistical evidence for 
increasing effects with increasing hydrogenation degree of fish oil (a) or soybean oil (b). 
 
Series 3 Ranking Increase found with increasing   Statistical evidence*for 
Females, tumor hydrogenation degree of HFO or HSO differences   association 
 
a) Hydrogenated fish oils 
 
 PHFO > HHFO = THFO 
Incidence  0.571  0.333 no no   no 
Number   1.0    0.0 no no   no 
Load, mm2   0.16   0.00 no no   no 
 
 THFO > HHFO > PHFO 
Size, mm2  3.14    1.04 0.50 no, but TH>PH yes TH-PH   yes 
 
 PHFO > THFO > HHFO 
FW, g  19.0    18.9     17.8 no, but weak tendency TH>HH weak PH-HH   weak 
 weak TH-HH 
b) Hydrogenated soybean oils 
 
 PHSO > THSO > HHSO 
Incidence 0.615   0.500    0.313 no no   no  
Number   2.0 0.5 0.0 no yes PH-HH   yes 
Load, mm2  8.29    0.32     0.00 no weak PH-HH   weak 
 
 PHSO > HHSO > THSO 
FW, g  20.5    18.1     18.0 no yes PH-HH   strong 
 yes PH-TH 
 HHSO > PHSO = THSO 
Size, mm2  3.97  3.14 no no   no 
*Statistical evidence: strong, P ≤ 0.005; yes, P ≤ 0.05; weak (tendency), ﻿﻿﻿0.20 ≥ P > 0.05; no, P > 0.20, p-values have been 
adjusted a la Bonferroni. AOM, azoxymethane; HFO, hydrogenated fish oils;  HSO, hydrogenated soybean oils; PHFO, 
partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil;  PHSO, partially 
hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally hydrogenated soybean oil; PH, the partial 
hydrogenation degree; HH, the high hydrogenation degree; TH, the total hydrogenation degree; FW, final weight. 
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Table 21 Series 3: Ranked tumor parameters and final weight in male AOM treated A/J mice and statistical evidence for 
increasing effects with increasing hydrogenation degree of fish oil (a) or soybean oil (b). 
 
Series 3 Ranking Increase found with increasing Statistical evidence*for 
Males, tumor hydrogenation degree of HFO or HSO  differences association 
 
a) Hydrogenated fish oils: 
 
 THFO > PHFO > HHFO 
Incidence  0.909    0.625   0.417 no, but tendency TH>HH  weak TH-HH weak 
Number    2.0  1.0 0.0 no, but TH>PH, TH>HH  yes TH-PH, TH-HH yes 
Load, mm2   4.45 0.54    0.00 no, but TH>PH, TH>HH  yes TH-PH, TH-HH strong 
FW, g   23.1     22.4    20.3 no, but tendency TH>HH  weak TH-HH, PH-HH yes 
 
 PHFO > THFO > HHFO 
Size, mm2   2.01  0.91    0.81 no  no no 
 
b) Hydrogenated soybean oils: 
 
 THSO > PHSO > HHSO 
Incidence  0.909    0.875   0.400 no, but weak tendency TH>HH  weak TH-HH weak 
 THSO = PHSO > HHSO 
Number   2.0 0.0 no, but tendency TH>HH  weak TH-HH, yes 
  weak PH-HH 
 PHSO ≈ HHSO > THSO 
Size, mm2   3.14  3.13    1.13 no  no no 
 
 PHSO > HHSO > THSO 
FW, g   23.3 22.0    21.0 no, but PH>TH yes PH-TH yes 
 
 PHSO > THSO > HHSO 
Load, mm2   4.46 0.80    0.00 no, but weak tendency TH>HH weak TH-HH weak 
*Statistical evidence: strong, P ≤ 0.005; yes, P ≤ 0.05; weak (tendency), ﻿﻿﻿0.20 ≥ P > 0.05; no, P > 0.20, p-values have been 
adjusted a la Bonferroni. AOM, azoxymethane; HFO, hydrogenated fish oils; HSO, hydrogenated soybean oils; PHFO, 
partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil; PHSO, partially 
hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally hydrogenated soybean oil; PH, the partial 
hydrogenation degree; HH, the high hydrogenation degree; TH, the total hydrogenation degree; FW, final weight. 
 
Series 4: No statistically significant increases were found  HFO increasing any of the tumor 
parameters relative to corresponding degrees of HSO, irrespective of gender (Tables 22-23 
and Tables 21-24 Appendix V). On the contrary; in females, PHSO clearly increased tumor 
size compared with PHFO (md = 2.6 mm2), but tumor size was not statistically significantly 
related to type of hydrogenated oil in the diet. And in males, PHSO increased tumor load (md 
= 3.9 mm2) compared with PHFO, and tumor load was clearly related to type of hydrogenated 
oil in the diet. 
 
Differences in effects with a view to the specific oils 
Results are here presented from a different point of view. Some results may in this way be 
treated several times. Also results that are not statistically significant may be described here.
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Table 22 Series 4: Ranked tumor parameters and final weight in female AOM treated A/J mice and statistical evidence for 
hydrogenated fish oils increasing effects compared with corresponding hydrogenation degrees of soybean oil. 
 
Series 4 Ranking HFO found more harmful    Statistical evidence* for 
Females, tumor than HSO, by degree differences    association 
 
 PHSO>PHFO  >  THSO>THFO  =  HHFO>HHSO 
Incidence 0.615 0.571    0.500   0.333  0.333 0.313 no no    no 
 
 PHSO>PHFO  >  THSO>THFO  =  HHFO=HHSO 
Number    2.0  1.0 0.5     0.0  0.0 no no    no 
 
 PHSO>PHFO  <  THSO>THFO  =  HHFO=HHSO 
Load, mm2   8.29 0.16     0.32    0.00 0.00 no no    no 
 
 HHSO>HHFO  <  THFO=THSO  =  PHSO>PHFO 
Size, mm2   3.97  1.04   3.14   3.14   0.50 no strong PH    weak 
 
 PHSO>PHFO  >  THFO>THSO  >  HHSO>HHFO 
FW, g  20.5 19.0    18.9   18.0   18.1  17.8 no no   yes  
*Statistical evidence: strong, P ≤ 0.005; yes, P ≤ 0.05; weak (tendency), ﻿﻿﻿0.20 ≥ P > 0.05; no, P > 0.20, p-values have been 
adjusted a la Bonferroni. AOM, azoxymethane; HFO, hydrogenated fish oils; HSO, hydrogenated soybean oils; PHFO, 
partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil; PHSO, partially 
hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally hydrogenated soybean oil; PH, the 
partially hydrogenation degree; HH, the high hydrogenation degree; TH, the total hydrogenation degree; FW, final weight.  
 
Table 23 Series 4: Ranked tumor parameters and final weight in male AOM treated A/J mice and statistical evidence for 
hydrogenated fish oils increasing effects compared with corresponding hydrogenation degrees of soybean oil.  
 
Series 4 Ranking HFO found more harmful   Statistical evidence* for 
Males, tumor than HSO, by degree differences    association 
 
 THFO=THSO  >  PHSO>PHFO  >  HHFO>HHSO 
Incidence   0.909    0.875   0.625 0.417 0.400 no no    yes 
 
 THFO=THSO  =  PHSO>PHFO  >  HHFO=HHSO 
Number 2.0 2.0 1.0  0.0 no weak PH    strong 
 
 THFO>THSO  <  PHSO>PHFO  >  HHFO=HHSO 
Load, mm2    4.45  0.80    4.46    0.54 0.00 no yes PH    strong 
 
 PHSO>PHFO  <  HHSO>HHFO  <  THSO>THFO 
Size, mm2  3.14 2.01     3.13    0.81   1.13   0.91 no no    no 
 
 PHSO>PHFO  <  THFO>THSO  <  HHSO>HHFO 
FW, g  23.3 22.4     23.1   21.0   22.0  20.3 only TH  yes TH    yes     
*Statistical evidence: strong, P ≤ 0.005; yes, P ≤ 0.05; weak (tendency), ﻿﻿﻿0.20 ≥ P > 0.05; no, P > 0.20, p-values have been 
adjusted a la Bonferroni. AOM, azoxymethane; HFO, hydrogenated fish oil; HSO, hydrogenated soybean oils; PHFO, 
partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil; PHSO, partially 
hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally hydrogenated soybean oil; PH, the partial 
hydrogenation degree; HH, the high hydrogenation degree; TH, the total hydrogenation degree; FW, final weight. 
 
Between genders 
PHSO seemed to increase tumor incidence in males {RR = 1.42, with CI = (0.86, 2.35, P = 
0.336) and to increase tumor load in females (md = 3.8 mm2, P = 0.875) relative to each other.  
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SO increased tumor size (md = 3.2 mm2, P = 0.05) and also seemed to increased tumor 
incidence and load (P = 0.303 and 0.251, respectively) in females relative to males.  
 
THFO increased tumor incidence {RR = 2.73, with CI = (1.20, 6.20) and P = 0.009} and 
number (md = 2.0, P = 0.041), and tended to increase tumor load (md = 4.4 mm2, P = 0.081), 
in males relative to females. On the contrary, THFO increased tumor size in females relative 
to males (md = 2.2 mm2, P = 0.026).  
 
THSO tended to increase tumor incidence {RR = 1.82, with CI = (1.00, 3.30), P = 0.069}and 
tumor number (md = 1.5, P = 0.092) and seemed to increase tumor load (md = 0.5 mm2, P = 
0.309) and reduce tumor size in males relative to females (md = -2.8 mm2, P = 0.218).  
 
PHFO seemed to increase tumor incidence {RR = 1.09 (0.52, 2.31), P = 1.00}, size (md = 0.0 
mm2, P = 0.915) and load (md = 1.5, P = 0.253) in males relative to females, but no statistical 
evidence was found. 
 
FO increased tumor load (md = 0.8 mm2, P = 0.035), tended to increase tumor incidence {RR 
= 3.67, with CI = (0.96, 13.95), P = 0.065) and tumor number (md = 1.0 mm2, P = 0.053) in 
males relative to females.  
 
BO tended to increase tumor incidence {RR = 1.69, with CI = (0.95, 3.00), P = 0.103}, 
number (md = 0.5, P = 0.147) and load (md = 3.8 mm2, P = 0.086), and seemed to increase 
tumor size (md = 0.1 mm2, P = 0.817) in males relative to females. 
 
In the HH degree of fish and soybean oil, there was probably no difference between the 
genders in incidence or tumor number (P = 1.00 or near), except that HHFO seemed to 
increase tumor size in females relative to males (md = 0.2 mm2, P = 0.239). 
 
Between specific oils 
In females, PHSO increased tumor number relative to HHSO (md = 2.0 mm2, P = 0.048, and 
P = 0.039 for the relation between tumor number and type of HSO in the diet), reduced tumor 
size (md = -2.6 mm2, P = 0.030, and P = 0.031 for the relation between tumor number and 
type of HSO in the diet), and tended to increase tumor load relative to HHSO (md = 8.3 mm2, 
P = 0.123, and P = 0.094 for the relation between tumor load and type of HSO in the diet).  
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In males, PHSO tended to increase tumor number relative to HHSO (md = 2.0 mm2, P = 
0.111, and P = 0.033 for the relation between tumor number and type of HSO in the diet). 
 
In females; SO increased tumor incidence relative to THFO {RR = 2.70, with CI = 
(1.18,6.17), P = 0.033, and P = 0.029 for the relation between tumor incidence and type of oil 
in the diet}, tumor size relative to PHFO (md = 3.9 mm2, P = 0.048, and P = 0.036 for the 
relation between tumor size and type of oil in the diet), and tumor load relative to both PHFO 
and HHFO (md = 6.0 mm2, P = 0.030, and md = 6.2 mm2, P = 0.045, respectively, and P = 
0.041 for the relation between tumor load and type of oil in the diet).  
 
In the preanalysis of protecting properties of FO, SO increased tumor incidence, number, and 
load in females relative to FO, while no statistically significant differences were found for 
males. SO was not tested for males against any other oil.   
 
In females; THFO reduced tumor incidence relative to SO {RR SO-THFO = 2.7, with CI = 
(1.18, 6.17), and P = 0.033, and = P = 0.029 for the relation between tumor incidence and type 
of oil in the diet} and increased tumor size relative to PHFO (md = 2.6 mm2, P = 0.030, and P 
= 0.031 for the relation between tumor size and degree of HFO in the diet).  
 
In males; THFO tended to increase tumor incidence relative to HHFO {RR = 2.18 with CI = 
(1.09, 4.37), P = 0.081, and P = 0.051 for the relation between tumor incidence and degree of 
HFO in the diet), increased tumor number relative to PHFO and HHFO (md = 1.0, P = 0.030 
and md = 2.0, P = 0.045, respectively, and P = 0.011 for the relation between tumor number 
and degree of HFO in the diet) and also tended to increase it relative to FO (md = 1.0, P = 
0.099, and P = 0.023 for the relation between tumor number and type of fish oil in the diet).  
 
THFO increased tumor load in males relative to HHFO (md = 4.4 mm2, P = 0.006), tended to 
increase it relative to PHFO (md = 3.9 mm2, P = 0.051), and P = 0.005 for the relation 
between tumor load and degree of HFO in the diet, and also seemed to increase it relative to 
FO (md = 3.7 mm2, and p = 0.017 for the relation between tumor load and type of fish oil in 
the diet). 
  
In females, none of the differences regarding THSO were statistically significant.  
 
 64
Effects of hydrogenated fish oil in experimental colorectal carcinogenesis in A/J mice Results 
 
In males, THSO tended to increase tumor incidence {RR = 2.27, with CI = (0.76, 6.76), P = 
0.189}, tumor number (md = 2.0, P = 0.078), and tumor load (md = 0.8 mm2, P = 0.156) 
relative to HHSO, and tumor incidence and load were weakly related to type of HSO in the 
diet (P = 0.094 and 0.085, respectively) while tumor number was related (P = 0.033).  
 
In females, PHFO reduced tumor size (md = -3.9 mm2, P = 0.048) and load (md = -6.0 mm2, 
P = 0.030) relative to SO, and P = 0.041 and 0.036, respectively, for the relation between 
tumor size and type of oil in the diet. 
 
In males, PHFO tended to reduce tumor load relative to BO (md = -3.4 mm2, P = 0.105, and P 
= 0.003 for the relation between tumor load and type of oil in the diet). 
 
FO was not found to differ statistically significant from HFO. In the preanalysis of protecting 
properties, FO reduced tumor incidence, number, and load in females relative to SO, but no 
statistically significant differences was found for males relative to BO. FO tended to reduce 
tumor number in males relative to THFO (md = -1.0, P = 0.099), and P = 0.023 for the 
relation between tumor number and type of fish oil in the diet. FO was not tested against the 
other oils. 
 
In females, the only test regarding BO was in the preanalysis of protecting properties of FO. 
BO seemed to increase tumor incidence {RR FO-BO = 0.36, with CI = (0.09, 1.42), P = 
0.624) and number (md = 0.5, P = 0.204), relative to FO. In this analysis, also SO was 
compared with BO. BO seemed to reduce tumor incidence (RR SO-BO = 1.80, with CI = 
(1.03, 3.16), P = 0.237}, number (md = -1.0, P = 0.294), size (md = -3.5 mm2, P = 0.120), and 
reduced load (md = -6.0 mm2, P = 0.042), relative to SO,  and P = 0.004, 0.002, 0.135, and 
0.002, respectively, for the relations between tumor incidence, number, or size and type of oil 
in the diet. 
 
In males, the differences regarding BO in the preanalysis had higher P-values. BO tended to 
increase tumor incidence {RR = 0.49, with CI = (0.24, 1.00), P = 0.123}, seemed to increase 
tumor number (md = 1.0, P = 0.252), and increased tumor load (md = 4 mm2, P = 0.018), 
relative to HHFO, and P = 0.045, 0.019, and 0.003, respectively, for the relations between 
tumor incidence, number, and load and type of oil in the diet. 
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In females, HHFO tended to reduce tumor incidence {RR SO-HHFO = 2.70, with CI = (1.05, 
6.96), P = 0.060), seemed to reduce tumor number (md = -1.5, P = 0.234), and reduced tumor 
load (md = -6.2 mm2, P = 0.045), relative to SO, and P = 0.029, P = 0.236, and 0.041 for the 
relation between tumor incidence, number, or load and type of oil in the diet) 
 
In males, HHFO tended to reduce tumor incidence {RR = 0.49 with CI = (0.24, 1.00), P = 
0.123}, seemed to reduce tumor number (md = -1.0, P = 0.252), and reduced tumor load (md 
= -4.0 mm2, P = 0.018), relative to BO, and P = 0.045, 0.019 and 0.003, respectively,  for the 
relations between tumor incidence, number, or load and type of oil in the diet).  
 
HHFO also tended to reduce tumor incidence relative to THFO {RR THFO-HHFO = 2.18, 
with CI = (1.09, 4.37), P = 0.081} and number (md = -2.0 mm2, P = 0.045), and reduced 
tumor load (md = -4.4 mm2, P = 0.006), and P = 0.51, 0.011, and 0.005, respectively, for the 
relations between tumor incidence, number, or load and type of HFO in the diet. 
 
In females, HHSO seemed to reduce tumor incidence {RR = 0.51, with CI = (0.22, 1.18), P = 
0.309}, number (md = -2.0 mm2, P = 0.048), and load (md = -8.3, P = 0.123), relative to 
PHSO, and P = 0.254, 0.029, and 0.094, respectively, for the relations between tumor 
incidence, number, or load and type of HSO in the diet.  
 
In males, HHSO tended to reduce tumor incidence {RR = 2.27, with CI = (0.76, 6.76), P = 
0.189}, tumor number (md = -2.0, P = 0.078), and tumor load (md = -0.8 mm2, P = 0.156), 
relative to THSO, and P = 0.094, 0.033, and 0.085, respectively, for the relations between 
tumor incidence, number, or load and type of HSO in the diet.  
 
HHSO also tended to reduce tumor number relative to PHSO (md = -2.0, P = 0,111) and 
seemed to reduce tumor load (md = -4.5 mm2, P = 0.210).  
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DISCUSSION 
 
4.1 ESTABLISHING TEST SYSTEM 
 
4.1.1 BREEDING 
The reproductive performance and behaviour of inbred strains varies depending on the 
individual strain. Breeding with A/J mice seemed to be difficult due to problems with 
infertility and cannibalism. Exposure to sudden noises, vibrations, and excess handling  may 
influence breeding (241). Sudden noises from outside the building and noises and vibrations 
from equipment inside were unavoidable. It is not known whether such disturbances partly 
were the reason for the behaviour of the animals. 
 
Biological variation 
The large variation in effect parameter values within treatment groups might indicate 
biological variation in the A/J mice. This makes it difficult to obtain statistical significance 
for real differences, and necessitates larger samples in order to make investigations 
meaningful (251). Inbred strains of mice are maintained by successive brother x sister 
matings. The fifty female and ten male animals used as parents in the breeding at the 
Norwegian Institute of Public Health cannot have come from the same female and male 
couple. Thus, the breeding performed here was not brother x sister matings. Whether this 
mating procedure could increase the biological variation of the animals is not known.  
 
Experimental period 
When animal models are used in research, the experimental treatment is usually started at the 
same time for all of the animals to avoid time point dependent variations of influencing 
factors. Such an approach was not possible in this instance, since several rounds of breeding 
had to take place. The animals were born during a time period of approximately two and a 
half months. This method is seldom used. However, delegating the diets from the start of the 
schedule in several turns should assure representation of all of the treatments throughout the 
whole experimental period. In this way, a possible error or weakness with the experiment due 
to time point dependent factors should be more evenly distributed on the treatment groups. 
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4.1.2 HOMOGENEITY OF THE FEEDS 
Homogenous dispersion of the oils in the feeds is important in order to achieve reproducible 
treatment doses. It has earlier been shown that, due to the high content of tristearin in totally 
hydrogenated fat and trans fatty acids in partially hydrogenated fat, melting of the fat into the 
feed is unfavourable, since it hardens very quickly. Fat drops are then formed, which may not 
be eaten by the animals (217).  
 
In this study, unheated fats were mixed into the pulver feed AIN-76M. Even if the 
experimental oils differed a lot with regard to consistency, the mixing of as much as 20% by 
weight unheated oils/fats by food processor into the basis feed seemed to produce adequate 
homogeneity for all the feeds. The employed procedure prevented unnecessary degeneration 
of the oils by termic oxidation or hydrolysis. This method has also earlier been used with 
success at the Norwegian Institute of Public Health (252). 
 
4.1.3 FEEDING AUTOMATS 
A new feeding automat for pulverized feed was invented at the Norwegian Institute of Public 
Health in 1994, and further developed in 1995 and 2002 (253-255). One type of these models 
was used in this study. The differing sized feeding openings turned out to be of major 
advantage. Through a certain age period, the animals were playing inside the automats, which 
led to feed wasting. Smeary feeds stuck to their fur, while fluffy feeds just blow away. In such 
periods, automats with small openings were used. Adult animals were given automats with 
small openings for fluffy feeds and large openings for sticky feeds. In this way, feed waisting 
diminished and the access to the feed was enhanced.  
 
Securing continual access to feed for the animals was, however, time consuming. The 
stickiness of some of the feeds led to extra work, and feeding had to be attended to every day. 
Secondly, rodents do not normally prefer pulverized feed. In fact, the animals did themselves 
produce pellet like clumps from some of the feeds, which they dragged around in the cages. 
Clumps like that were never seen during filling of the automats. Besides, they were too large 
to pass through the top lattice into the automats. In addition, pulverized feed is easily wasted. 
Feed in the form of pellets would function much better. There are, however, limitations for 
pelleting diets. Diets with about 17-21% of weight fats/oils produce fairly soft and usually 
fragile pellets, and the pelleting capability diminishes with further increases in fat/oil (256). 
Further attempts to find new pelleting methods for feeds with high fat contents are needed. 
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4.1.4 CONFOUNDING FACTORS IN THE FEEDS 
The feeds included a very high energy percent of fat, 38.5%. Findings indicate that increased 
ingestion of fats markedly enhances tumor promotion in the colon (257-260). But since fat 
contributed the same energy percent to all of the diets, the treatment groups would be equally 
affected. The same goes for the high content of sucrose in AIN-76M (261;262).  
 
4.2 PINWORM INFECTION 
The animals were not medicated against the pinworm (Syphacia obvelata/muris), since such 
treatment might influence the effects of the experimental diets at a higher degree than the 
pinworm infection. An infection like this may be subclinical, but if it develops it can 
influence the immune system of the animals. An influence on colon cancer models has not 
been documented, but is not out of the question (263).  
 
The A/J mice were not the source of the infection. One male A/J mouse was sacrificed to 
check for the worm. After thorough examination, one worm was found. It was visible by the 
eye. When the colons were dissected after 15 weeks, they were not checked especially for 
worm, but no worms were seen. If the infection had been severe, worms would have been 
detected. When the colons were examined in the LM, a bloody bubble was found in 1 of 243 
colons. This might have been a result of the infection. It seemed as a high fat diet did not 
create a desirable environment for the worm.  
 
4.3 TESTING OF THE EXPERIMENTAL OILS 
There has been an increasing CRC trend in Norway over the last decades compared with the 
other Nordic countries. Norway has had a higher consumption of hydrogenated fish oils and 
cod liver oils relative to its neighbours. The first aim of this study was to examine whether 
hydrogenated fish oil in the diet can increase induction and/or growth of CRC in 
azoxymethane (AOM) treated A/J mice, by setting up three hypotheses that were addressed 
by four series of analyses.  
 
The effects of the experimental oils are dealt with thoroughly in the manuscript for an article 
(Appendix IV), where also patterns of interest in the material are discussed based on the same 
series of analyses, which was the second aim. In the present paragraph, only the most 
important results are dealt with. 
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4.3.1 DIFFERENCES IN EFFECTS BETWEEN TREATMENT GROUPS 
Consistent with results in Min mice (224), no statistically significant evidence was found in 
support of the first two hypotheses concerning increased effects of HFO in the diet, neither 
relative to unhydrogenated FO, nor with increasing hydrogenation degree, irrespective of 
gender. For increasing hydrogenation degree, this result also applied to the HSO. There was 
however some support, regarding males; for the first hypothesis by a tendency to increased 
tumor number and loss of protecting properties by THFO relative to FO, and for the latter 
hypothesis by a tendency to 2.2 times increased tumor risk by THFO relative to HHFO, and 
statistically significantly increased tumor number and load by THFO relative to HHFO and 
tumor number and size with a tendency to increased tumor load by THFO relative to PHFO. 
And, regarding females, statistically significantly increased tumor size was found by THFO 
relative to PHFO. Similar support was found for HSO; a tendency to increased tumor number 
and weak tendencies to increased tumor risk and load by THSO relative to HHSO.  
 
Patterns in this material seemed to indicate that the HFO had effects different from FO, and 
that these effects rather than being caused by a change in fish oil by the hydrogenation 
process per se, might be related to specific hydrogenation degrees of the oils. This notion also 
seemed to apply to the effects of HFO in the study with Min mice, which neither showed 
statistically significant differences. This was not supported by statistically significant findings 
for HFO, but there was some support for HSO; increased tumor number and a weak tendency 
to increased tumor load in females and a tendency to increased tumor number also in males 
were found by PHSO relative to HHSO. If the effects had been caused by the hydrogenation 
process per se, all of the hydrogenated oils would have been expected to increase the effects 
both relative to their respective unhydrogenated oils and with increasing hydrogenation 
degree. Thus, one cannot due to the supporting results in the first paragraph of this section 
rule out the possibility that also the effects of HFO were related to specific hydrogenation 
degrees.  
 
Unhydrogenated FO had been analysed in advance for protecting properties in comparison 
with SO and BO. When HFO were compared with FO, no statistically significant differences 
in effects were found, thus showing no evidence of change in protective properties when FO 
was hydrogenated. When HFO, however, in addition were analysed for protecting properties 
in comparison with the same control oils that had been used for FO, protecting properties 
were still found for some of the HFO; in females, for THFO regarding tumor incidence, for 
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PHFO regarding growth, and for PHFO and HHFO regarding tumor load, relative to SO, and 
in males, for HHFO regarding tumor load relative to BO. Also weak tendencies to protective 
properties were found for HHFO regarding tumor incidence in both genders and for PHFO 
regarding tumor load in males, compared with the two respective control oils.  
 
Patterns in the material seemed to indicate that protecting properties might not only be lost, 
but also gained, when FO was hydrogenated. This seemed to pertain to for example the above 
mentioned PHFO regarding growth in females and HHFO regarding tumor load in males. 
There was, however not conclusive evidence.  
 
It has been stated that the relatively scarce knowledge about the relationship between TFA 
and cancer risk partly is due to difficulties in obtaining a suitable control fat for proper 
evaluation of the impact of TFA (176). Patterns of effects in the material seemed to indicate 
that when protecting properties of HFO were studied with SO and BO as controls, the control 
oils might contain substances affecting the figures describing these properties. This could 
have led to confounding interpretation of the results, if it were not for the fact that both FO 
and the HFO were studied in comparison with the same control oils. Since the control oils 
were SO for females and BO for males, the figures for protection cannot be compared directly 
for females and males. But this was done because in the preanalysis of protecting properties 
of FO, it seemed as FO did not protect males like it protected females, and SO seemed to 
increase the tumor parameters less and BO more in males than in females. This way the 
chance of revealing effects was larger, and the number of comparisons somewhat reduced.  
 
No statistically significant evidence was either found in support of the third hypothesis, i.e., of 
increased effects of HFO in the diet relative to corresponding hydrogenation degrees of 
soybean oil, irrespective of gender, even though HHFO seemed to increase tumor incidence 
slightly in both genders relative to HHSO, and THFO to increase tumor load substantially 
relative to THSO (there was some doubt about this result). On the contrary, patterns in the 
material seemed to indicate that all the hydrogenation degrees of soybean oil might increase 
some effects relative to the corresponding hydrogenation degrees of fish oil, seemingly in 14 
of the 24 comparisons. Indeed, relative to PHFO; PHSO clearly increased growth in females 
(although the relation between tumor size and type of hydrogenated oil in the diet was weak) 
and tumor load in males considerably, and also a tendency to increased tumor number was 
found for males. But there was no evidence for the rest of the comparisons.   
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4.3.2 DIFFERENCES IN EFFECTS BETWEEN GENDERS 
Even if the analyses were undertaken based on specific hypotheses, many comparisons were 
made in total in this study. This increases the risk of finding false positive results (251). The 
p-values for the gender differences were not adjusted a la Bonferroni; if they had been, many 
of them would not have been statistically significant. It seems, however, important to mention 
the effects of THFO, SO, and FO, see below. Relations were found between tumor incidence, 
number, size or load and gender (P = 0.001, 0.003, 0.001 and 0.033, respectively). Totally 
seen, males had 1.5 times as high tumor risk as females in this experiment {RR = 1.53, with 
CI = (1.20, 1.95)}. The effects seemed to be depending on gender for at least some of the 
experimental oils. 
 
4.3.3 EFFECTS OF THE EXPERIMENTAL OILS ON BODY WEIGHT 
Irrespective of gender, the oils mostly seemed to influence body weight the same way through 
the whole experimental period. All of the experimental oils each seemed to have a similar 
effect on body weight in both genders, perhaps except PHFO and THFO, and was seemingly 
ranked as follows: SO > BO > FO > PHSO > PHFO (♂THFO) > THFO (♂PHFO) > HHSO > 
THSO > HHFO. The weights were increased more in males than in females for all of the oils. 
The differences in FW between males and females seemed to be ranked as follows: FO > BO 
> SO > THFO > HHSO > PHFO > THSO > PHSO > HHFO, and the differences in feed 
expenditure: FO > SO > PHFO > BO > PHSO > THFO > THSO > HHSO > HHFO.  
 
Statistically significantly increased FW were found for FO relative to HFO in both genders 
gender (highly statistically significant for males), for SO relative to HFO in females and for 
BO relative to HFO in males (highly statistically significant), for PHSO relative to HHSO or 
THSO in females and for PHSO relative to THSO in males, and for THFO relative to THSO 
in males. Tendencies to increased FW were found for PHFO or THFO relative to HHFO in 
both genders. 
 
4.3.4 INFLUENCE OF GENDER AND BODY WEIGHT  
The data material did not fit the criteria for the use of tests which take into consideration 
putative interference with the effects of the experimental oils by gender and body weight 
simultaneously. Therefore, females and males were analysed separately. No conclusions can 
be made on interference by body weight on the tumor parameters. Patterns in the material did, 
however, give some clues.  
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It looked like body weight might affect induction and/or growth of CRC, possibly dependent 
on experimental oil and gender. High body weight is known to affect sex hormones through 
leptin and to increase CRC, and, in humans, it was earlier found that the relationship between 
leptin and the sex hormone testosterone is influenced by progress of puberty and is different 
in obese girls and boys (75;264). It has been proposed that a high fat intake, which the 
animals in this experiment were exposed to, raises the concentrations of circulating sex 
hormones such as estrogen (265). Conversion of estradiol generates free radicals and 
chemically reactive intermediates (101). In recent years, several lines of epidemiologic, 
clinical and experimental evidences have been reported showing that estrogen hormones may 
be involved in malignant colorectal tumors (266). Most estrogen action appears to be exerted 
via estrogen receptors (ERs) on target cells (265). ERs have been reported in CRC tumors. An 
ER subtype found in rat, mouse, and human homologs has been demonstrated in normal and 
neoplastic human colorectal tissues and in vitro in colonic epithelial cells (266).  
 
The different effects of sex hormones on body weight and its fat proportion and vice versa, 
and the putative effects of sex hormones and body weight on colorectal carcinogenesis, 
should lead to the inferences that gender differences in effects on CRC exist, and that the 
effects would increase with increasing body weight. Since the latter mostly was not the fact in 
this study, additional risk factors for CRC not only to gender but also to body weight had to 
be present. At the same time, this shows that gender and body weight, rather than being 
confounding risk factors of their own, were intermediate risk factors for substances in the 
experimental oil in the carcinogenesis. If it had been possible to use a test taking into account 
the interference by gender and body weight, such a model would have explained the 
percentage of the effect variation for gender and body weight, and, in the end for the more 
direct effects of substances in the experimental oils.  
 
4.3.5 WEAKNESS OF THE STUDY 
This study was characterized by large variances, weak tests, and occasionally small samples 
which when less than ten may have weakened the usefulness of specific tests (251). The 
uneven distribution between genders led to samples of animals less than ten in the PHFO and 
HHFO groups for females and in the FO, PHSO, and HHSO groups for males, and of tumors 
less than ten in the FO, PHFO, HHFO, and HHSO groups for females and the FO and HHSO 
groups for males. These weaknesses of the study may have led to many false negative results, 
i.e., many of the results that were not statistically significant, but led to possible indications 
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when the patterns of effects in the material were studied, might possibly have been true. The 
probability of not detecting a real difference is depending on the power of the study, which, 
judged by the many large variances, was low. Thus the magnitude of false negative results 
might be high.  
 
With the chosen significance level, there was a 5% risk of getting false positive results, i.e., of 
presenting a difference as real when it was not. 
 
In this study, the effect measure in comparisons of groups is estimated median difference 
(md). The real figure for the difference may vary grossly from the estimated one. Since the 
statistical tests that were used do not calculate variance for median differences, the 
uncertainty of the estimated effects is not known.  When effect sizes are assessed by figures, 
they may differ a lot from the real ones. This also applies to the assessments by words in the 
next paragraph.  
 
4.3.6 EFFECTS OF SPECIFIC OILS 
Some of the experimental oils seemed to be more harmful to the animals than others regarding 
tumor load, such as PHSO to both genders, SO to females, and THFO to males. THSO 
seemed to be a special case, giving a high induction rate and fairly large growth in males, and 
a fairly high induction rate and quite large growth in females, but unexpectedly not very large 
tumor load in either gender.  
 
Several results seem to indicate that the effects might be dependent on phase of colorectal 
carcinogenesis for most of the oils. 
 
PHSO and SO has been increasingly used in Norway since production of these oils was 
started in here in the 1960s. PHSO is now used to a low degree. THFO is not used in human 
foods. THSO has been used in interesterified form during the last decade, since it was 
substituted for PHSO. In addition, PHFO has been used since 1912, and FO (as cod liver oil) 
and BO from even earlier times. Thus, it seems important to elucidate the effects of these oils. 
 
The PHSO contained a large amount of TFA (42%) of C18:1, a putative risk factor for CRC, 
at least in humans (177). Relative to the other oils tested, PHSO seemed to give both genders 
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about the highest induction and growth of CRC and tumor load, but tumor incidence seemed 
to be increased and tumor load reduced in males relative to females. PHSO clearly increased 
growth in females and tumor load in males considerably relative to PHFO. Although no direct 
evidence, these results seem to support the idea that TFA as risk factors for CRC. 
 
The SO contained a large amount of ω-6 fatty acids (55%) and a high ω-6/ω-3 ratio (9.4:1), 
both putative risk factors for CRC possibly in both humans and rodents (267). It has been 
proposed that exocyclic adducts might be formed in the colonic epithelium via lipid 
peroxidation of ω-6 PUFA, and that this is related to induction of tumors (268). Results from 
animal models indicate that ω-6 PUFA have a tumor enhancing effect, predominantly during 
the post initiation phase (154;269).  
 
In addition, a high intake of the ω-6 PUFA linoleic acid inhibits the detoxification of 
estrogens (267), and synergism between high dietary intake and estrogen catabolism has been 
suggested for females (101). It has been suggested that estrogens and their receptors play an 
important role in the progression stage of colorectal tumors (266). In this study, SO seemed to 
give females about the highest induction and growth of CRC and the second highest tumor 
load, relative to the other oils tested. This seems to fit well with the above mentioned 
propositions and findings.  
 
If lipid peroxidation of ω-6 PUFA increases colorectal carcinogenesis in female animals, it 
seems logic that also males would be affected. The tumor parameter figures also seemed to be 
high in males. The high fat diets may have increased the body weight of the animals, and in 
addition, SO seemed to increase body weight more than the other oils. Increased body weight 
is a risk factor for CRC. Thus, the high body weight may also explain a part of the large effect 
in both genders, both alone and as an intermediate risk factor for substances in SO. Increased 
body weight also affect sex hormones, which might be one of the mechanisms that makes it a 
risk factor for CRC (see Influences of gender and body weight). 
 
The effects of SO still seemed to be considerably lower in males than in females. Estrogen is 
typically a female hormone, but is also produced in males. If a high intake of ω-6 PUFA 
inhibits the detoxification of estrogens in females, it would probably do so in males too, but 
the effects would be less since males have a much lower level of estrogen than females. Also, 
the proportion of leptin and estrogen producing body fat is usually less in males than in 
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females. This might partly explain the lower effects in males  (264;270). Male hormones may 
also influence these questions. 
 
The THFO contained a high amount (97%) of VLCSFA (31%) and LCSFA (64%), which 
even though they are poorly absorbed in male rodents (142), have been suspected to be risk 
factor for CRC. Relative to the other oils tested, THFO seemed to give males about the 
highest induction of CRC and tumor load but fairly low growth, and to give females low 
induction and tumor load, but large growth. Induction and tumor load by THFO seemed to be 
increased and growth reduced in males relative to females. This seems to support the idea of 
substances in THFO being risk factors for CRC, whether it could be the content of VLCSFA 
or LCSFA, or the high total amount of SFA that increases the effects. 
 
The THFO is used in animal feed (224), but so far not in foods for humans. The possibility of 
using THFO in interesterified form in foods for humans has been shown interest. If the 
interesterification is non specific, a part of the SFA will change place in the TG from their 
natural sn-1 or 3 positions to the sn-2 position, where they might be absorbed to a larger 
degree. This might increase the putative pathological consequences of THFO (271).  
 
The THSO contained nearly 100% SFA, of which 83% were C18 and 15% C16. Earlier 
evidence seems consistent with no relationship between palmitic or stearic acids and CRC in 
humans (179). The results of the present study did not seem to be consistent with this. 
Relative to the other oils tested, THSO seemed to give males about the highest induction of 
CRC but not so large growth and tumor load, and to also give females fairly high induction 
and large growth but low tumor load. Induction by THSO seemed to be increased and growth 
reduced in males relative to females. THSO seemed to give males equal induction of CRC 
relative to THFO, somewhat higher growth, and strangely, much lower tumor load. The 
results seem to indicate the possibility that high amounts of C18 and 16 SFA might be risk 
factors for CRC, contrary to earlier findings. 
 
The PHFO contained a large amount of TFA (55-60%) mostly of VLCFA C20-22 PUFA, 
C18:1 and 16:1. Relative to the other oils tested, PHFO seemed to give both genders a fairly 
high induction of CRC and a fairly low growth and tumor load. Growth seemed to be 
increased, and tumor load a little increased, in males relative to females. This seems to 
indicate that PHFO even if it hydrogenated still contains protective substances.  
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FO consists to a large degree of ω-3 fatty acids, especially the EPA and DHA (212). The FO 
in this study contained EPA/DHA (20.5%), other PUFA (12.5%), MUFA (30%),  unidentified 
fatty acids (2%), and a high content of LCSFA (36%). An impressive body of epidemiological 
data suggests an inverse relationship between CRC risk and consumption of diets rich in ω-3 
fatty acids, and earlier evidence show that ω-3 PUFA act at different stages of cancer 
development (9;272). The present results seemed to be in accordance with this, with the 
exception of gender differences. Relative to the other oils tested, FO seemed to give females 
about the lowest induction of CRC and tumor load, but large growth, and seemed to give 
males a high induction, but not very large growth and tumor load. Tumor incidence, number, 
and load seemed to be increased in males relative to females.  
 
Besides the dependence of phase of the carcinogenesis, both the effects on both genders and 
the gender differences in the effects of FO might be related to body weight as well. There is a 
possibility that the high contents of fat and/or sucrose in the diets may have affected the 
animals differently due to differences in the amounts eaten. According to the feed expenditure 
measured for females and males in total, the intake of the FO diet might have been the 
highest, and not far from 50% higher than the possibly lowest, which was that of the HHFO 
diet. The intake would probably also have been higher for males than for females. The higher 
intake of fat and sucrose may have affected the males relative to the females.  
 
A 20% by weight FO diet has earlier been shown to increase both secondary tumor formation 
in colon cancer involving liver metastases in rats, and to develop 1000 fold more metastases 
than in rats fed a low fat diet or a diet enriched with safflower oil (273). 
 
The BO contained 65% SFA mostly of C16, 18 and 14. The MCFA content was 21%. 
Relative to the other oils tested, BO seemed to give males a fairly high induction of CRC and 
large tumor load, and tended to increase them considerably relative to females. But also 
females had fairly high induction. Incidence and tumor load tended to be increased in males 
relative to females. The growth was fairly low in both genders. BO seemed to increase tumor 
load at least 7.4 times relative to PHFO and HHFO in males.  
 
Rises in the intake of the MCFA lauric and myristic acids among subjects at high risk for 
CRC and CRC patients have been reported (179). These fatty acids are able to induce COX-2 
overexpression in human tissues (274), and COX-2 is upregulated from 2 to 50 fold in 85-
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90% of CRC patients (275). If this applies to these animals, the high intake of MCFA might 
explain some of the increased effects. In addition, the results regarding THFO and THSO also 
points to the high amount of C16 and 18. 
 
There is some doubt about the amounts of TFA in the HH degree of the fish and soybean oil 
in this study. But, there was a predominance of changed C18:1 fatty acids in the HHSO (30% 
SFA, mostly C16), and a predominance of changed C20-22 PUFA and SFA (51% SFA, 
mostly C18) in the HHFO. Relative to the other oils tested; irrespective of gender, the HH 
degree of fish and soybean oil seemed to give the animals the lowest induction of CRC and 
tumor load, only second to FO regarding induction in females. HHSO seemed to give the 
largest growth, only next to SO in females, while HHFO did not give very large growth. 
There were possibly no gender differences in effects, except that tumor size seemed to be 
increased in females relative to males.
 
Both the HH degree oils seemed to be the most protecting oils in both induction and growth 
of CRC, only second to FO in induction, and almost without gender differences. There 
probably are several reasons for the seemingly protective capacity of the HHs. HHFO has 
earlier also shown protective potential against heart disease by reducing the plasma TG 
concentration in male rats compared with FO or PHFO (237).  
 
On the background of foregoing results; since HHFO contains large proportions of TFA 
including VLCTFA, SFA including VLCSFA, and unusual VLCPUFA of the cis 
configuration, and less protecting fatty acids than FO or PHFO, most of the seemingly large 
protecting capacity of HHFO must be based on other factors than EPA and DHA.  
 
Low body weight may partly have been the reason for the protection. Both the HHs seemed to 
give about the lowest FW. This might partly have been due to low fat absorption, low feed 
intake (seemingly the lowest feed expenditure in this experiment was measured), and 
increased energy expenditure by hyperactivity at a young age.  
 
No literature was found on absorption of HH oils. But, the absorption of fatty acids in HHFO 
might possibly be lower than that of PHFO (95%) and higher than that of THFO (61%) (142). 
The HH oils had in common with the TH oils almost white faeces, an extremely harsh odour 
coming from their cages, like the smell of trimethylamines, and hyperactivity at a young age. 
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If the light coloured faeces was due to soapification of SFA with calcium and magnesium the 
absorption coefficient for fatty acids in HHFO would have been closest to that of THFO. 
Then the intake of the suspicious fatty acids would have been reduced. This may also have 
contributed to the reduced effects on the carcinogenesis. 
 
The protecting properties of the HH oils do not indicate that they are harmless in colorectal 
carcinogenesis. Seemingly, HHSO led to the second largest growth of CRC, while it was 
reduced by HHFO, although not relative to BO or PHFO in females and to THFO and HHFO 
in males. 
 
4.3.7 THE APPLICATION OF MOUSE DATA TO HUMANS 
Even if mice are small animals with increased metabolism and short life span compared with 
humans, they develop tumors in the same tissues, in most cases with histology remarkably 
similar to that of humans (276). It must, however, be emphasized that animal models cannot 
substitute for humane clinical studies. Compared to small rodents, humans must have evolved 
more complex genetic controls over cell growth in at least some of their tissues because of 
their greater size and longevity (60). Animal model are, however, used for preexaminations to 
make the human studies more specific with a higher degree of validity. And, the mouse is the 
model organism which is closest to humans (62). 
 
This experiment was performed over 15 weeks. It is possible that longer time effects might be 
different from those found here. 
 
4.3.8 OVERALL CONCLUSION 
Certain effect patterns in this material seemed to indicate that the effects of the experimental 
oils on colorectal carcinogenesis in the AOM treated A/J mice, in addition to being influenced 
by gender and body weight, might be different in the induction and growth phase of CRC, and 
dependent on type of oil in the diet and hydrogenation degree, the latter might differ between 
HFO and HSO. These indications were not based on statistically significant results only, so 
they must be taken for what they are worth. Some evidence was however found. 
 
No statistically significant evidence was found of increasing CRC by HFO relative to 
unhydrogenated FO, with loss of protecting properties, nor of increasing effects with 
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increasing hydrogenation degree; which would have indicated that the effects of HFO were 
due to a change in fish oil by the hydrogenation process per se.  
 
That the HH degree of HSO reduced induction of CRC relative to the TH degree, indicated 
that the effects of HSO were dependent on specific hydrogenation degrees, i.e., were related 
to specific substances in these oils. Even if the null hypotheses for HFO could not be rejected, 
the possibility that also the effects of HFO might be dependent on specific hydrogenation 
degrees could not be ruled out. 
 
No statistically significant evidence was either found of increased effects of HFO relative to 
corresponding hydrogenation degrees of HSO. On the contrary, when the effects were 
examined with a view to the specific oils, however, it seemed as HSO were more harmful 
than HFO; all the tumor parameters seem to be increase by PHSO relative to PHFO, and 
statistical evidence was found for tumor number and load  in males. 
 
In the view to the specific oils, it actually seemed as any of the experimental oils, including 
those that were exemplifying oils consumed in Norway over different time periods, might 
contain substances that are risk factors in colorectal carcinogenesis; in any way in these 
animals. Even if it had been possible to draw this conclusion for the A/J mice, findings in 
experimental animals will not necessarily apply to man.  
 
If the oils in this experiment really may exemplify oils used in Norway, and if the results of 
this study might apply to humans; the results would have indicated that of the examined oils, 
HHFO might not be the most likely fat to play a role in the increasing CRC trend in Norway 
compared with its neighbouring countries. More likely candidates would be PHFO or FO (as 
cod liver oil), which besides HHFO were the only of the experimental oils with increased 
consumption relative to the other Nordic countries, and which were used to a great degree 
long enough and early enough to have affected the rising trend in Norway, which started at 
least as late as in the 1950s, when the registering of the CRC incidence started.  
 
4.3.9 FURTHER RESEARCH 
It seems important to look into the effects of those of the experimental oils that are still in use 
in human foods, such as SO, THSO, PHSO, PHFO, BO and cod liver oil, or that may be put 
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to use in the future, such as THFO. This might also give some answers with respect to the 
effects of the two suspected candidates in the Nordic region. 
 
There is some doubt about in what proportions PHFO and HHFO has been used in Norway in 
the earlier hard margarines. If possible, such information should be found.  
 
It might also be interesting to look closer at what fish species have been dominating in the 
hydrogenation of fish oil in Norway, since some species may have larger amounts of 
VLCPUFA, which may make a difference for the substances in the end products after 
hydrogenation. 
 
HHFO could be examined for increasing effects on CRC relative to a more neutral normal 
mouse diet. 
 
Studying effects of whale oil, which was also used to a great degree in Norway from 1912 and 
for approximately 50 years might also give some answers regarding the CRC trend.  
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Abstract  
The colorectal cancer (CRC) incidence in Norway has increased considerably during the last 
fifty years. The main aim of this study was to examine whether hydrogenated fish oil can 
induce or increase CRC in AOM treated A/J mice. The effects of three diets containing 
hydrogenated fish oil (HFO) (19 w/w %); partially hydrogenated (PHFO), highly 
hydrogenated (HHFO), or totally hydrogenated (THFO), mixed with corn oil (1 w/w %) in 
AIN-76M, was studied. Fish oil (FO), butter oil (BO), soybean oil (SO), and soybean oil 
similarly hydrogenated as the fish oil; PHSO, HHSO and THSO were controls. Tumors 
identified by surface examination of unsectioned methylene blue stained colon preparations 
transilluminated in the inverse light microscope, revealed no statistically significant evidence 
of HFO increasing induction and/or growth of CRC compared with FO, or with increasing 
degrees of HFO or HSO, or in comparison with corresponding hydrogenation degrees of 
HSO. On the contrary, PHSO clearly increased growth in females and tumor load in males, 
compared with PHFO. In females; THFO increased growth compared with PHFO, and PHSO 
tumor number compared with HHSO. In males; THFO increased number compared with 
PHFO and HHFO, and load compared with HHFO. Compared with SO; THFO protected 
females regarding incidence, PHFO regarding growth which FO did not, and PHFO and 
HHFO regarding load. Compared with BO; HHFO protected males regarding load which FO 
did not. Patterns in the material showed that all the oils, dependent of gender, showed signs of 
being related to induction and/or growth of CRC in these animals. 
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Introduction  
Findings indicate that increased ingestion of fats enhances colonic tumor promotion 1-4. 
Consumption of fat rose in the industrial world from early in the twentieth century, especially 
due to the new fat source margarine5. Partially hydrogenated vegetable and fish oils have been 
increasingly used, especially in margarine 6-14. Norway has experienced an increasing 
colorectal cancer (CRC) incidence trend over time compared with its neighbouring countries. 
The reason for this increasing trend is obscure 15. Norway is, however, diverging in at least 
the following factors; we have been consuming hydrogenated fish oils (HFO) in margarine 
and cod liver oil as a vitamin D source to a greater extent than most other countries during the 
last century 16-18. Negative effects on risk factors for circulation diseases from intake of HFO 
have been shown in humans and rodents 19,20. It seems important to study the consequences of 
HFO in the diet on CRC. This experiment was performed at the Norwegian Institute of Public 
Health preliminary to a larger project. 
 
Since it would be unethical to expose humans to amounts of edible oils considered to be 
potentially harmful, the influence of HFO was tested on A/J mice treated with the colon 
carcinogen azoxymethane (AOM) 21. These mice are wild type animals highly susceptible to 
inducement of multiple intestinal tumors 22, primarily in the distal colon 23, representative of 
human adenomas or carcinomas in situ 24. For these reasons they can be used as a murine 
model of human sporadic CRC as a sensitive test system for dietary factors.  
 
The first aim was to examine whether partially hydrogenated fish oil (PHFO), highly 
hydrogenated fish oil (HHFO), or totally hydrogenated fish oil (THFO) in the diet can 
increase induction and/or growth of CRC in AOM treated A/J mice. Native fish oil (FO), 
butter oil exclusive water and salt (BO), refined soybean oil (SO), partially hydrogenated
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soybean oil (PHSO), highly hydrogenated soybean oil (HHSO), or totally hydrogenated 
soybean oil (THSO) were used as controls. The objective was to relate the biological effects 
of HFO to the degree of hydrogenation. The second aim was to reveal patterns of effects on 
CRC on induction and/or growth of CRC in the material, also taking into account results 
which were not statistically significant. The data material did not fill the criteria for the use of 
tests that take into consideration confounding effects of both gender and body weight 25. The 
effects of the experimental oils were analysed separately for female and male animals in four 
series which had been decided in advance, and final weight (FW) is treated in the text, tables, 
and figures of all series in connection with the tumor parameters. 
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Materials and methods 
Animals, chemicals, and experimental oils. Female and male A/J mice bred in house from 
mice originally purchased from Jackson Laboratory, Bar Harbour, ME, USA were housed in 
polysterol cages in a room with 12 hr light/dark cycle and controlled humidity and 
temperature. AOM from Sigma Chemicals Company, St. Louis, MO, USA was dissolved in 
0.9% NaCl. The animals were given water and diet ad libitum. Fish oils and soybean oils 
were delivered by Denofa, Gamle Fredrikstad, Norway, and butter oil was delivered by Tine 
Fellesmeieriet BA, 0902 Oslo, Norway. The animals were randomly assigned to nine 
isocaloric diets, in which fat contributing 38.5 % of total energy, i.e. 19 w/w % experimental 
oil and 1 w/w % corn oil, were mixed in the standard feed AIN-76M composed by the 
American Institute of Nutrition, bought from Special Diets Services, P.O. Box 705, Witham, 
Essex CM8 3AD, UK. Diets containing three different hydrogenation degrees of fish oil; 
PHFO, HHFO or THFO, were compared with six different diets containing native FO, BO 
without salt and water, refined SO, or soybean oil similarly hydrogenated as the fish oil; 
PHSO, HHSO and THSO. The melting point of the partially hydrogenated oils was 31-33, of 
the highly hydrogenated oils 40-42, and of the totally hydrogenated oils 55-60. The 
experimental oils were taken directly from the ordinary production line and correspond to the 
raw materials used in commercial margarines and butter, except for THFO which was 
produced in the laboratory especially for this experiment. 
 
Experimental design. 104 female and 95 male A/J mice were injected subcutaneously with 
AOM (10 mg/kg body weight) once weekly for 2 weeks. The animals received the diets from 
d 4, were weighed once a week, and killed after 15 weeks. Colons were dissected, and their 
unsectioned whole mount preparations examined in order to identify, characterize and score
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tumors, and to study differences between genders and between diets for each gender 
separately in tumor incidence (number of animals with tumor/number of animals in the group)
and number (total number of tumors per animal in the group) as indices for induction of CRC, 
size (area of aberrant tissue per tumor per animal with tumor in the group) as index for growth 
of CRC, and load (total tumor area per animal in the group) which takes into consideration 
both induction and growth of CRC. For the differences between diets, four series of analyses 
were set up to search for answers to questions that were decided in advance.  
 
Scoring of tumors. The colons were dissected, rinsed in cold PBS, slit open longitudinally 
and fixed flat between wet (PBS) filter papers for 24 h in 10% neutral buffered formalin prior 
to 4 s staining with 0.2% methylene blue from George T. Gurr Ltd., UK dissolved in the same 
formalin solution. The examination of tumors was carried out blindly by the same investigator 
by transillumination of colons in an inverse light microscope at a magnification of x20, and 2 
types of tumors identified. Type 1 tumors were characterized by their bright blue staining, 
high protruding into the colonic lumen, circular appearance, and irregular and distorted crypts. 
Type 2 tumors were characterized by their bright blue or turquoise staining, irregular and 
distorted crypts, and slightly elevated and prominent appearance, but flat at the boundary line 
to the surrounding mucosa, which some times seemed normal and flat, and some times normal 
but discoloured and giving the impression of being elevated. Since the type 2 tumors were not 
observed as highly elevated structures, their bright blue or turquoise appearance and irregular 
and distorted crypts seen with transillumination were used as criteria for their identification.
Tumor number and size were recorded. Tumor size was scored by an eyepiece graticule as 
longitudinal diameter, and mm2 areas calculated. 
 111
Effects of hydrogenated fish oil in experimental colorectal carcinogenesis in A/J mice    Article   7 
 
Statistical analysis. Fisher’s Exact or Pearson Chi-Square tests were used to calculate 
relations between tumor incidence and type of oil in the diet, and Relative Risk with 95% 
Confidence Interval as a measure of effect with variance when comparing groups. Kruskal-
Wallis Test and Oneway Anova (seldom) were used to calculate relations between tumor 
number, size, or load and type of oil in the diet, Mann Whitney Test and T-Test (seldom) to 
compare groups, and median difference was used as effect measure. For each series of 
analyses, P-values were manually adjusted à la Bonferroni for differences between groups, 
but not for differences between genders. The significance level was set at p ≤ 0.05. 
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Results 
Weight development is illustrated by curves for female and male animals separately for each 
treatment group (Figures 3 and 4). Besides some minor temporary disturbances, animal body 
weights seemed to develop normally, and the animals were not visibly ill. The weight level 
seemed more or less differently influenced by the various experimental oils from early in life.  
 
Final body weights (FW) could be ranked almost equally for females and males by the diets 
as follows (deviation for males in parentheses): SO > BO > FO > PHSO > PHFO (THFO) > 
THFO (PHFO) > HHSO > THSO > HHFO (range estimated median = ♀ 24.9-17.8 g and ♂ 
29.9-20.3 g). Differences in FW between treatment groups are dealt with in connection with 
the tumor parameters. FW was increased in males compared with females without regard to 
type of oil in the diet, and the gender differences were ranked by the diets as follows; FO > 
BO = SO > THFO > HHSO > PHFO > THSO > PHSO > HHFO (range estimated median 
difference (md) = 5.9-2.5 g, and P-values differed between <0.0005 and 0.004).  
 
Effects of experimental oils on final body weight and on induction and growth of CRC. 
Differences in induction (tumor incidence and number) and growth (tumor size) of CRC, 
tumor load, and FW, between genders and between treatment groups within each gender were 
examined. An overview of the results is given in Figures 1 and 2.  
 
Results corresponding to p-values within the interval 0.2 ≥ p > 0.05 are referred to as 
tendencies and described by the words “tend” or “weak”, while results corresponding to p-
values > 0.2 are described by the word “seem”, consistently in the Results Chapter. 
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Gender differences. Effects of the experimental oils are illustrated along with FW by separate 
curves for each gender in Figures 5-8. In this paragraph, statistically significant results are 
marked (s) and tendencies (t). Induction of CRC was, tended to be, or seemed to be 
substantially increased in males compared with females by THFO (s), THSO (t), FO (t), BO 
(t), and PHSO and seemingly less by HHSO, HHFO and PHFO, while SO was the only oil 
seemingly increasing tumor incidence in females compared with males, also substantially. 
Growth of CRC was increased by SO (s) and THFO (s) and seemed to be increase by FO and 
THSO, substantially, and HHSO and HHFO seemingly less, in females compared with males, 
while it seemed to be substantially increased by PHFO and less by BO in males compared 
with females, and the result for PHSO seemed unclear. Tumor load tended to be substantially 
increased in males compared with females by THFO (t) and BO (t), less by FO (s), and 
seemingly even lesser by THSO and PHFO, while it seemed to be increased substantially in 
females compared with males by PHSO and SO, and to be equal in both genders by HHSO 
and HHFO. 
 
Differences between treatment groups 
Statistically significant results are indicated by underlined effect values in parenthesis.
 
1. Will HFO in the diet increase induction and/or growth of CRC in AOM treated A/J mice 
in comparison with unhydrogenated FO, thus losing the protecting properties of native 
FO? No statistically significant differences were found between HFO and FO regarding 
induction and/or growth of CRC irrespective of gender (Table 1, Figures 9 and 10). 
 
In females, all the HFO seemed to increase induction of CRC by tumor incidence, and PHFO 
by tumor number, and in males, THFO seemed to increase induction by tumor incidence and
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tended to increase it by tumor number, compared with FO. HHFO, on the contrary, seemed to 
reduce tumor incidence and number in males compared with unhydrogenated FO. Tumor 
incidence tended to be related (P = 0.104), and tumor number was related (P = 0.023), to type 
of fish oil in the diet for males, but no relations were found for females. 
 
In males, PHFO seemed to increase growth of CRC, while THFO and HHFO, on the contrary, 
seemed to reduce tumor size compared with FO, but tumor size was not related to type of fish 
oil in the diet. In females, all the HFO seemed to reduce tumor size compared with FO, and 
tumor size was weakly related to type of fish oil in the diet (P = 0.082).  
 
In females, PHFO seemed to increase tumor load compared with FO, but tumor load was not 
related to type of fish oil in the diet. In males, THFO seemed to increase tumor load, while 
PHFO and HHFO, on the contrary, seemed to reduce it, compared with FO. Tumor load was 
related to type of fish oil in the diet for males (P = 0.017).  
 
All the HFO reduced FW compared with FO irrespective of gender, and FW was clearly 
related to type of fish oil in the diet for both females and males (P = 0.003 and < 0.0005, 
respectively).  
 
2. Will FO, when it is hydrogenated, lose its protective properties for AOM treated A/J mice 
in comparison with SO or BO? Possible protecting properties of FO in the diet had been 
looked for in comparison with SO or BO in advance (figures not shown). Because the tumor 
parameters seemed more increased in females by SO and in males by BO, the protective
properties of fish oil after hydrogenation were analysed in comparison with SO for females 
and BO for males (Table 2, Figures 11 and 12). 
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Females. FO tended to protect females more than males regarding induction of CRC, and 
compared with SO, FO protected females, while protection was not clear for males (not 
shown). When FO was hydrogenated, compared with SO; THFO still had (RR SO-THFO = 
2.70), HHFO tended to have, and PHFO seemed to have protecting properties for females 
regarding tumor incidence, although seemingly less than FO had, and all the HFO still seemed 
to have protecting properties regarding tumor number, HHFO and THFO equal to FO, but 
PHFO seemingly less than FO had. Tumor incidence was related to type of oil in the diet for 
females (P = 0.029), but tumor number was not. 
 
FO seemed to protect males more than females against growth of CRC, and seemed to protect 
females, but not males, compared with SO (not shown). When FO was hydrogenated, 
compared with SO; PHFO protected females regarding growth (md = -3.9 mm2), seemingly 
gaining protecting properties relative to FO, and HHFO and THFO seemed to do the same. 
Tumor size was related to type of oil in the diet for females (P = 0.036). 
 
FO protected females more than males regarding tumor load, and protected females, and 
seemed to also protect males, compared with SO (not shown). When FO was hydrogenated, 
compared with SO; PHFO (md = -6.0 mm2) and HHFO (md = -6.2 mm2) still had, and THFO 
seemed to have, protecting properties for females regarding tumor load, although PHFO 
seemingly less than FO had. Tumor load was related to type of oil in the diet for females (P = 
0.041). 
 
FO tended to reduce FW in females compared with SO (not shown). When FO was 
hydrogenated, all the HFO reduced FW in females compared with SO and seemingly more
than FO did. FW was clearly related to type of oil in the diet (P < 0.0005). 
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Males. FO seemed to protect both genders regarding induction of CRC, males only by tumor 
incidence, compared with BO (not shown). When FO was hydrogenated, compared with BO; 
THFO seemed to increase tumor number in males, tending to increase it relative to FO, and 
also seemed to increase tumor incidence, thus to have lost the seemingly protecting properties, 
while on the contrary, HHFO tended to protect regarding tumor incidence and seemed to 
protect regarding tumor number, thus to have gained protective properties relative to FO. 
Tumor incidence and number were both related to type of oil in the diet for males (P = 0.045, 
and P = 0.019, respectively). 
 
FO did not seem to protect either gender regarding growth of CRC compared with BO, but 
rather to increase it (not shown). When FO was hydrogenated, compared with BO; PHFO 
seemed to increase growth even more than FO seemed to do, while on the contrary, HHFO 
and THFO seemed to protect males against growth, seemingly gaining protecting properties 
which FO lacked. Tumor size was not related to type of oil in the diet for males. 
 
FO seemed to protect both genders regarding tumor load compared with BO (not shown). 
When FO was hydrogenated, compared with BO; THFO seemed to increase tumor load in 
males and to have lost the seemingly protecting properties, while on the contrary, PHFO 
tended to protect, and HHFO (md = -4.0 mm2) protected males, and seemed to have gained 
protecting properties relative to FO, regarding tumor load. Tumor load was strongly related to 
type of oil in the diet for males (P = 0.003). 
 
FO seemed to reduce FW in males compared with BO (not shown). When FO was
hydrogenated, all the HFO reduced FW in males compared with BO, and more than FO did, 
and FW was strongly related to type of oil in the diet (P < 0.0005). 
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3. Will induction and/or growth of CRC in AOM treated A/J mice increase with increasing 
hydrogenation degree of fish or soybean oil in the diet? (Table 3, Figures 13 and 14). HFO. 
In females, PHFO seemed to increase induction of CRC by tumor incidence and number 
compared with HHFO or THFO, but neither tumor incidence nor number was related to 
degree of HFO in the diet. In males, THFO seemed to increase induction by tumor incidence 
and increased it by tumor number (md = 1) compared with PHFO, tended to increase tumor 
incidence and increased tumor number (md = 2) compared with HHFO, and both tumor 
incidence and number were related to degree of HFO in the diet (P = 0.051 and 0.011, 
respectively).  
 
In females, THFO seemed to increase growth of CRC by tumor size compared with HHFO 
and increased it compared with PHFO (md = 2.6 mm2), the difference between HHFO and 
PHFO not being statistically significant, and tumor size was related to degree of HFO in the 
diet (P = 0.031). In males, PHFO seemed to increase tumor size compared with THFO or
HHFO, but tumor size was not related to degree of HFO in the diet. In females, PHFO seemed 
to increase tumor load compared with HHFO or THFO, but tumor load was not related to 
degree of HFO in the diet. In males, THFO tended to increase tumor load compared with 
PHFO and increased it compared with HHFO (md = 4.5 mm2), the difference between PHFO 
and HHFO not being statistically significant, and tumor load was clearly related to degree of 
HFO in the diet (P = 0.005). 
 
Weak evidence was found that FW did neither increase nor decrease with increasing degree of 
HFO irrespective of gender, since HHFO tended to reduce FW compared with both PHFO 
and THFO, the differences between PHFO and THFO being far from statistically significant.
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FW was weakly related to degree of HFO in the diet for females (P = 0.061) and related for 
males (P = 0.044). 
 
HSO. In females, PHSO seemed to increase induction of CRC by tumor incidence compared 
with THSO or HHSO, to increase tumor number compared with THSO, and increased tumor 
number compared with HHSO (md = 2), and tumor number was related to degree of HSO in 
the diet (P = 0.039), but tumor incidence was not.  In males, THSO tended to increase tumor 
incidence compared with HHSO, PHSO seemed to do the same, and both THSO and PHSO 
tended to increase tumor number compared with HHSO. Tumor incidence was weakly 
related, and tumor number related, to degree of HSO in the diet for males (P = 0.094 and 
0.033, respectively). 
 
In females, HHSO seemed to increase growth of CRC compared with PHSO or THSO, and in 
males, PHSO and HHSO seemed to increase it compared with THSO. But tumor size was not 
related to degree of HSO in the diet for either gender. 
 
In females, PHSO seemed to increase tumor load compared with THSO and tended to 
increase it compared with HHSO. In males, PHSO seemed to increase tumor load compared 
with both THSO and HHSO, and THSO tended to increase it compared with HHSO. Tumor 
load was weakly related to degree of HSO for both females (P = 0.094) and males (P = 
0.085). 
 
HHSO and THSO (ns for males) reduced FW compared with PHSO, and THSO seemed to 
give lowest FW, in both genders. Thus, FW seemed to decrease with increasing degree of 
HSO irrespective of gender, and therefore to be related to the hydrogenation process as such.
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But there was no evidence for this, since the differences in FW between THSO and HHSO 
were far from statistically significant. FW was related to degree of HSO in the diet for both 
females (P = 0.004) and males (P = 0.021). 
 
4. Will HFO in the diet increase induction and/or growth of CRC in AOM treated A/J mice 
in comparison with HSO when compared by corresponding hydrogenation degrees? (Table 
4, Figures 15 and 16). HHFO seemed to increase induction of CRC by tumor incidence 
slightly compared with HHSO in both genders. On the contrary; PHSO seemed to increase 
induction by both tumor incidence and number in females, and seemed to increase tumor 
incidence and tended to increase tumor number in males, compared with PHFO, and THSO 
seemed to increase induction by both tumor incidence and number in females, but not in 
males, compared with THFO. 
 
The HFO seemed not to increase growth of CRC compared with corresponding hydrogenation 
degrees of HSO. On the contrary, in females, PHSO clearly increased tumor size compared 
with PHFO (md = 2.6 mm2), and also HHSO seemed to increase tumor size compared with 
HHFO, while THFO and THSO seemed to increase growth equally. Tumor size was weakly 
related to hydrogenated oils in the diet for females. In males, PHSO seemed to increase tumor 
size compared with PHFO, HHSO compared with HHFO, and THSO compared with THFO. 
 
THFO seemed to increase tumor load in males compared with THSO. On the contrary, PHSO 
seemed to increase tumor load in females and increased it in males (md = 3.9 mm2) compared 
with PHFO, and THSO seemed to increase it in females compared with THFO. HHFO and 
HHSO seemed to give equal tumor load in both genders. 
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THFO increased FW in males and seemed to increase it also in females compared with 
THSO. On the contrary, PHSO seemed to increase FW compared with PHFO and HHSO 
compared with HHFO in both genders. FW was related to type of hydrogenated oil in the diet 
irrespective of gender (P = 0.007 for both). 
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Discussion  
The CRC incidence rate in Norway has doubled the last fifty years and has the last decade 
been the highest in the Nordic countries 26. On this background, the main aim of this study 
was to examine the effects of PHFO, HHFO, and THFO in the diet on induction (tumor 
incidence and number) and growth (tumor size) of CRC, and on tumor load (induction and/or 
growth of CRC) by transillumination of unsectioned colon preparations from AOM treated 
A/J mice, with FO, BO, SO, PHSO, HHSO, and THSO as controls. Several degrees of 
hydrogenated fish oil have not been tested before in the A/J mouse model. An experiment 
with Min mice, a model for Familial Adenomatous Polyposis (FAP), dealing with similar 
hydrogenation degrees of fish oil, was performed simultaneously here at the Norwegian 
Institute of Public Health 27. No additional literature was found with regard to effects of the 
experimental oils on the tumor parameters studied. The second aim was to reveal patterns of 
effects in the material, even if the results were not statistically significant. The discussion 
therefore includes also the results that were not statistically significant.  
 
Weight development and final weight. Besides some temporary disturbances in the weekly 
animal weights, the weight development seemed normal and even. There were no signs of 
major illness. This seemed to indicate that the experimental oils might contribute to the more 
or less different body weight levels found in the treatment groups during the experimental 
period more than the colorectal cancer illness they induced did. The oils could be ranked 
almost equally for females and males with respect to the FW they gave. This seemed to 
indicate that all of the oils each might have a similar effect on body weight in both genders, 
perhaps except PHFO and THFO. Males had increased FW compared with females 
regardless of type of oil in the diet. Body weight is known to be controlled by sex hormones, 
and it is normal for males to have higher body weight than females. Body weight is also 
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known to be a confounding factor in carcinogenesis. When some oil in comparison with some 
other oil in this experiment increases induction and/or growth of CRC while it decreases FW, 
additional risk factors to body weight should be present.  
 
Gender differences. Induction of CRC seemed to be increased in males compared with 
females, most substantially by THFO, THSO, FO, BO and PHSO, while SO was the only oil 
increasing tumor incidence in females compared with males. Growth of CRC seemed to be 
increased in females compared with males by most of the oils, except by PHFO, PHSO and 
BO, while tumor load seemed to be increased in females compared with males only by PHSO 
and SO. The results seemed to indicate that the effects of the experimental oils might be 
differently influenced by sex hormones depending on oil and hydrogenation degree, and might 
be different in induction and growth of CRC. 
 
1. Change in effects when FO was hydrogenated. Induction of CRC and tumor load. 
Compared with unhydrogenated FO; even though all the HFO reduced FW in the animals, 
mostly supported in a similar experiment with Min mice 27; in females, all the HFO seemed to 
increase induction of CRC considerably, PHFO most (seemingly also in Min mice), and 
PHFO seemed to increase tumor load, while in males, THFO seemed to increase induction 
(seemingly also in Min mice by tumor incidence) and tumor load considerably, while PHFO 
seemed to reduce tumor load. PHFO seemed to increase tumor incidence and load slightly in 
males compared with females (seemingly also in Min mice), while THFO increased induction 
(seemingly also in Min mice), and tended to increase tumor load considerably in males 
compared with females. This seemed to indicate that additional risk factors to body weight 
are present, and that protecting substances in FO against induction of CRC may have been 
destroyed and perhaps substituted by harmful fatty acids during the hydrogenation.
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The PHFO contained a high amount of trans fatty acids (TFA) (55-60%), a putative risk 
factor for CRC, at least in humans 28. The estrogen level has been shown to play a role in
colorectal carcinogenesis in women 29. If this also applies to these experimental animals, the 
seemingly lower tumor incidence by PHFO in females compared with males might partly be 
accounted for by the higher estrogen level in females. But the contribution of TFA to total 
energy intake would probably have been much higher for these female animals 
(approximately 20%) than for the mentioned women, and therefore might partly explain the 
harmfulness of PHFO for these animals.  
 
Earlier evidence seems consistent with no relationship between palmitic or stearic acids and 
CRC in humans 30; if these results should apply to these experimental animals, it seems as the 
high content of very long chain fatty acids (VLCSFA) in THFO, even though they are poorly 
absorbed in male rodents 31, might be a significant risk factor for CRC for these male animals.  
No literature was found on effects of VLCSFA on induction and/or growth of CRC. These 
results seemed to indicate that in induction of CRC, PHFO might contain substances more 
harmful to the female and THFO substances more harmful to the male animals than 
substances in the other HFO.  
 
HHFO seemed to be the most protecting fish oil against induction of CRC for males 
(seemingly also in Min mice by tumor number), and second to unhydrogenated FO also for 
females (seemingly the most protecting in Min mice). Still HHFO seemed to increase 
induction considerably in males compared with females (seemingly also in Min mice). 
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Growth of CRC. Compared with unhydrogenated FO; in females, all the HFO seemed to 
reduce growth of CRC considerably (not supported in Min mice), PHFO most, while in 
males, PHFO seemed to increase growth considerably and THFO to reduce it considerably 
(not supported in Min mice). Since all the HFO reduced FW in the animals compared with
FO, lower body weight might be involved in the reduction of growth, but if so, PHFO 
transcended this protection in the males. While THFO reduced growth considerably in males 
compared with females (seemingly also in Min mice), PHFO seemed to increase growth 
considerably in males compared with females (not supported in Min mice). These results 
seemed to indicate that in growth of CRC, PHFO might contain substances more harmful to 
the male and THFO substances more harmful to the female animals than substances in the 
other HFO, effects quite opposite to those observed in induction of CRC. 
 
What THFO did not have in common with FO (36% C14-20 including 0.2% C20, 4% C18, 
22% C16, and 8% C14) was the much higher content of VLCSFA and long chain saturated 
fatty acids (LCSFA) in THFO (97% C14-22 including 13% C22, 18% C20, 22% C18, 36% 
C16, and 8% C14). Lower absorption of THFO may be the reason for the lower body weight, 
and lead to lower bioavailability of VLCSFA, both of these might partly explain the reduced 
growth of CRC in the animals by THFO compared with FO. The absorption of VLCSFA has 
been shown to be as low as 61% in rats and 19-41% in hamsters 32,33, and of LCSFA 31-39 % 
in humans 34, because of melting points substantially above body temperatures and a strong 
tendency to form insoluble soap in the small intestine 35,36. The difference between THFO and 
FO might also partly have been due to hydrogenation of risk factors in FO such as 
cholesterols, tocopherols, carotenes, or deltanoids 37-40. 
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Even if THFO reduced growth compared with FO, both of these oils increased growth 
substantially compared with the other fish oils, especially in females. What THFO and FO 
had in common was a large content of saturated fatty acids (SFA). A 20% by weight FO diet 
has earlier been shown to increase both secondary tumor formation in colon cancer involving 
liver metastases in rats, and to develop 1000 fold more metastases than rats fed a low fat diet 
or a diet enriched with safflower oil 41. These results seemed to indicate that unhydrogenated 
FO might have a harmful effect on growth of CRC. 
 
HHFO seemed to be the most protecting fish oil also against growth of CRC for males (not 
supported in Min mice), and second to PHFO also for females (seemingly second to FO in 
Min mice). Still HHFO seemed to increase growth considerably in females compared with 
males (not supported in Min mice).  
 
The results seemed to indicate that HHFO might be the most protecting fish oil for males and 
the second most protecting for females in both induction and growth of CRC.  
 
There probably are several reasons for the seemingly protective capacity of HHFO in 
colorectal carcinogenesis in both genders compared with the other fish oils. HHFO tended to 
give lower FW than the other fish oils in both genders. This might possibly partly have been 
due to lower feed intake; the HHFO group seemed to have the lowest feed expenditure of all 
the treatment groups, and possibly due to low absorption of the fatty acids. In addition, HHFO 
contained > 10% less trans and unnatural fatty acids than PHFO, of which less possibly 
would be absorbed, and 46% less SFA than THFO of which possibly some more would be 
absorbed. HHFO has earlier shown protective potential against heart disease by reducing the 
plasma TG concentration in male rats compared with FO or PHFO 20. 
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2. Change in protective properties when FO was hydrogenated. FO tended to protect 
females more than males against induction of CRC, and compared with SO, FO clearly 
protected females considerably, while protection for males was not clear. For females; when 
FO was hydrogenated, all the HFO still seemed to have protecting properties against 
induction of CRC compared with SO, although seemingly less than before. All the HFO 
reduced FW in females also compared with SO. That PHFO seemed to have lost most 
protecting properties, may be a consequence of better bioavailability of the fatty acids from 
PHFO than from the other HFO. The absorption degree for PHFO has been shown to be as 
high as 95% in rats, which is closer to that of SO (99%) than to that of THFO (61%) 42.  
 
FO seemed to protect females considerably less than males against growth of CRC, and to 
protect females moderately, but not males, compared with SO. When FO was hydrogenated;
compared with SO, all the HFO seemed to have gained considerably larger protecting 
properties against growth in females at the same time as FW was reduced by all the HFO, 
compared with SO. This seemed to indicate that reduced body weight may play a larger 
protecting role in growth than in induction of CRC for the females. But the reduced body 
weight did not seem to explain all of the gain in protecting properties of HFO against growth 
for females, since PHFO seemed to have gained more, and THFO much less, protecting 
properties than the other HFO.  
 
The SO contained 61% PUFA, 23% MUFA, < 1% TFA, and 15% SFA, including a high 
amount of ω-6 fatty acids (55%) and a high ω-6/ω-3 ratio (9.4:1), both putative risk factors 
for CRC possibly in both humans and rodents. Studies in animal models and recent 
observations in humans have provided evidence that a high intake of ω-6 PUFA stimulates 
several stages in the development of colon cancer, also by influences on free estrogen levels
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and hormonal catabolism 43-47. Indeed, in females; SO seemed to increase the risk of CRC 1.6-
2.7 times, growth of CRC 1.4-8.9 times, and tumor load at least 38.6 times, relative to the 
HFO. The results seemed to indicate that SO might be extremely harmful in induction and 
growth of CRC in the female animals, and that the effects of substances in the SO may affect 
the figures describing protective properties of the HFO. 
 
For males: FO seemed to possibly protect both genders regarding induction of CRC compared 
with BO. When FO was hydrogenated; HHFO seemingly showed a considerable and PHFO a 
minimal gain in protecting properties against induction of CRC in males, while THFO on the 
contrary seemed to increase induction in males and lose the possible protecting properties. 
HHFO protected substantially regarding tumor load compared with BO. 
 
FO possibly seemed not to protect either gender against growth of CRC compared with BO, 
but rather to increase it. When FO was hydrogenated, compared with BO, HHFO and THFO 
seemed to protect males against growth of CRC, seemingly gaining protecting properties 
which FO seemed to lack, while PHFO on the contrary seemed to increase growth, even more 
than FO did.  
 
The seemingly protecting properties for males of HHFO and PHFO against induction, and of 
HHFO and THFO against growth of CRC, compared with BO may partly be explained by 
reduced body weights. All the HFO reduced FW in males compared with BO. For discussion 
of substances in, and absorption of, the HFO, see above.  
  
The BO contained 3% PUFA and 32% MUFA including a few percents of TFA, and 65% 
SFA of C16, 18 and 14 mostly. The content of medium chain fatty acids (MCFA) was 
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approximately 21%. Rises in the intake of the MCFA lauric and myristic acids among 
subjects at high risk for CRC and CRC patients have been reported 30. These fatty acids are 
able to induce COX-2 overexpression in human tissues 48, and COX-2 is upregulated from 2 
to 50 fold in 85-90% of CRC patients 49. If this should also apply to the animals in this study, 
effects of such fatty acids might partly explain the increased induction and growth of CRC by 
BO in comparison with some of the HFO in the male animals. Indeed, BO, which seemingly 
increased tumor load in males compared with females, seemed to increase it at least 7.4 times 
relative to PHFO and HHFO in males. BO seemed, however, not to give very large tumors. 
These results seemed to indicate that BO might be harmful in induction and/or growth of CRC 
in these animals, especially to the males, and that possible effects of substances in the BO 
might affect the figures describing protective properties of the HFO. 
 
The results also seemed to indicate that protecting properties might not only be lost, but also 
gained, by hydrogenation of FO 
 
3. Change in effects with increasing hydrogenation degree of HFO or HSO. All the HFO 
and HSO reduced FW in the animals compared with their respective unhydrogenated oils, and 
FW seemed to decrease with increasing hydrogenation degree of HSO, but not of HFO. The 
effects of HFO or HSO on induction and/or growth of CRC did not seem to increase with 
increasing hydrogenation degree in a consistent manner. The results seemed to indicate that 
the effects of HFO or HSO on induction and/or growth of CRC might not be caused by the 
hydrogenation process per se, but might rather be related to specific hydrogenation degrees 
of the oils. 
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4. HFO compared with HSO by corresponding hydrogenation degrees. HHFO seemed to 
increase tumor incidence slightly in both genders compared with HHSO, and THFO seemed 
to increase tumor load considerably in males compared with THSO. On the contrary, HSO 
seemed to be considerably more harmful than HFO in fourteen of the comparisons.
 
Irrespective of gender, the most substantial increases seemed to be by THSO compared with 
THFO in increased female incidence, by HHSO compared with HHFO in increased growth, 
and by PHSO compared with PHFO in increases in all the tumor parameters. The results 
seemed to indicate that all the hydrogenation degrees of soybean oil might contain substances 
more harmful regarding induction and/or growth of CRC in these animals than the 
substances in the corresponding hydrogenation degrees of fish oil. 
 
HFO and HSO judged by hydrogenation degree. Irrespective of gender, the PH degree of 
fish or soybean oil seemed to be the most harmful degree in increasing induction of CRC in 
these animals (except the TH degree in males). Partial hydrogenation of fish oil creates 
positional and geometrical isomers of very long chain polyunsaturated fatty acids 
(VLCPUFA) as well as VLCSFA not existing in partially hydrogenated vegetable oils 50. 
Still, of the two partially hydrogenated oils only PHSO led to seemingly extremely large 
tumor loads. These results seemed to indicate the presence of harmful substances in the PH 
oils, that PHFO still might contain protecting substances, and/or that PHSO might contain 
extremely harmful substances, for these animals in induction of CRC, irrespective of gender. 
PHSO seemed to increase induction by tumor incidence, but not growth, substantially and to 
almost double tumor load in females compared with males. This seemed to indicate that in 
induction of CRC, substances in PHSO might be more harmful to the female than to the male 
animals.
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For males, the TH degree of fish or soybean oil seemed to be at least equally harmful to 
PHSO in induction of CRC, but only THFO and PHSO led to equally substantially large 
tumor load in males. This seemed to indicate the presence of harmful substances for males in 
THFO compared with THSO. One reason might be that total hydrogenation of fish oil creates
VLCSFA which do not exist in hydrogenated vegetable oils 47, such as C20-22 fatty acids. 
THFO also led to considerably higher FW than THSO. THFO seemed substantially more 
harmful for males than for females regarding induction of CRC and tumor load, but 
substantially more harmful for females than for males regarding growth of CRC. The results 
seemed to indicate that in induction of CRC, substances in THFO might be more harmful to 
the male than to the female animals, and in growth of CRC more harmful to the female than 
to the male animals. These indications also seemed to pertain to THSO, albeit to a lesser 
degree, and THFO seemingly increased tumor load substantially compared with THSO, but 
only in males. The difference in tumor load did not seem real, however, and might possibly be 
a result of the large variance in tumor load in the THSO group related to tumor size. 
 
Compared with the other hydrogenation degrees; irrespective of gender, the HH degree of 
both fish and soybean oil seemed to give body weights among the lowest, and seemed to 
protect regarding induction and growth (second to PHFO in females) of CRC and tumor load 
(together with THFO in females), except HHSO which seemed to give the most extreme 
increases in growth of CRC (together with PHSO in males). Including fatty acids changed by 
the hydrogenation, the HHSO contained 70% MUFA and 30% SFA, and the HHFO contained 
50% UFA (mostly PUFA) and 50% SFA. There was a predominance of changed C18:1 fatty 
acids in the HHSO, and a predominance of changed C20-22 PUFA and SFA in the HHFO. 
These results might indicate that the HH degree of the hydrogenated fish and soybean oils
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might be less harmful to these animals in induction and/or growth of CRC than the PH or TH 
degrees, except HHSO in growth.  
 
In spite of the protection of both genders, The HH degree of both oils seemed to increase 
tumor incidence in males compared with females and to increase growth in females compared 
with males, but the gender differences still seemed to be among the lowest in this experiment. 
The results seemed to indicate that in induction of CRC, substances in the HH degree of fish 
and soybean oils might be more harmful to the male than to the female animals, and in 
growth of CRC more harmful to the female than to the male animals. 
 
Patterns of effects in the material. It looked like the effects of the HFO rather than being 
caused by the hydrogenation process per se might be related to gender, hydrogenation degree, 
and phase of colorectal carcinogenesis. This seemed to apply also to the control oils. Since 
these results were not built on statistically significant evidence, no such conclusions can be 
made. The indications put forward in italics during the discussion are only intended to be a 
background for generating new hypotheses.  
 
For induction of CRC, most results in series 1 were, however, consistent with the results of an 
experiment in Min mice, which were not either statistically significant, but for growth of CRC 
they were not consistent. The reason for this might be that in Min mice, most tumors appear 
in the small intestine 27, and few colorectal tumors were present as samples for the analysis of 
tumor size. 
 
This study was characterized by large variances, weak tests, and occasionally samples less 
than ten that may have weakened the usefulness of specific tests 51.  
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Conclusion  
Certain effect patterns in this material seemed to indicate that the effects of the experimental 
oils on colorectal carcinogenesis in the AOM treated A/J mice, in addition to being influenced 
by gender and body weight, might be different in the induction and growth phase of CRC, and 
dependent on type of oil in the diet and hydrogenation degree, the latter might differ between 
HFO and HSO. These indications were not based on statistically significant results only, so 
they must be taken for what they are worth. Some evidence was however found. 
 
No statistically significant evidence was found of increasing CRC by HFO relative to 
unhydrogenated FO, with loss of protecting properties, nor of increasing effects with 
increasing hydrogenation degree; which would have indicated that the effects of HFO were 
due to a change in fish oil by the hydrogenation process per se.  
 
That the HH degree of HSO reduced induction of CRC relative to the TH degree, indicated 
that the effects of HSO were dependent on specific hydrogenation degrees, i.e., were related 
to specific substances in these oils. Even if the null hypotheses for HFO could not be rejected, 
the possibility that also the effects of HFO might be dependent on specific hydrogenation 
degrees could not be ruled out. 
 
No statistically significant evidence was either found of increased effects of HFO relative to 
corresponding hydrogenation degrees of HSO. On the contrary, when the effects were 
examined with a view to the specific oils, however, it seemed as HSO were more harmful 
than HFO; all the tumor parameters seem to be increase by PHSO relative to PHFO, and 
statistical evidence was found for tumor number and load  in males. 
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In the view to the specific oils, it actually seemed as any of the experimental oils, including 
those that were exemplifying oils consumed in Norway over different time periods, might 
contain substances that are risk factors in colorectal carcinogenesis; in any way in these 
animals. Even if it had been possible to draw this conclusion for the A/J mice, no conclusions 
can be drawn from mouse to man. Findings in experimental animals will not necessarily apply 
to man. The mouse is, however, the model organism which is closest to humans 52. 
 
If the oils in this experiment really may exemplify oils used in Norway, and if the results of 
this study might apply to humans; the results would have indicated that of the examined oils, 
HHFO might not be the most likely fat to play a role in the increasing CRC trend in Norway 
compared with its neighbouring countries. More likely candidates would be PHFO or FO (as 
cod liver oil), which besides HHFO were the only of the experimental oils with increased 
consumption relative to the other Nordic countries, and which were used to a great degree 
long enough and early enough to have affected the rising trend in Norway, which started at 
least as late as in the 1950s, when the registering of the CRC incidence started.  
 
Further research. It seems important to look into the effects of those of the experimental oils 
that are still in use in human foods, such as SO, THSO, PHSO, PHFO, BO and cod liver oil, 
or that may be put to use in the future, such as THFO. This might also give some answers 
with respect to the effects of the two suspected candidates in the Nordic region. 
 
It might also be interesting to look closer at what fish species have been dominating in the 
hydrogenation of fish oil in Norway, since some species may have larger amounts of 
VLCPUFA, which may make a difference for the substances in the end products after 
hydrogenation.
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Studying effects of whale oil, which was also used to a great degree in Norway from 1912 and 
for approximately 50 years might also give some answers regarding the CRC trend.  
 
HHFO could be examined for increasing effects on CRC relative to a more neutral normal 
mouse diet. 
 
 
 
This article was a part of a thesis in clinical nutrition for the degree of Candidata Scientiarum. 
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Table 1 Effects of HFO versus FO on final weight and colorectal tumor parameters in AOM treated A/J mice.  
Diet   Sex N Na  FW, g Incidenceb  Numberc    Sized, mm2  Loade, mm2
 
FO ♀ 11   2 20.85 (15.24, 28.08)*** 2/11 (0.182)♦ 0.0 (0.0, 1.0)♦  3.70 (0.33, 7.07) 0.00 (0.00, 7.07)* 
 ♂   9   9 26.72 (23.92, 33.00)††† 6/9   (0.667)♦ 1.0 (0.0, 4.0)♦♦  1.33 (0.13, 11.04) 0.79 (0.00, 14.77)*  
 
PHFO ♀   7   6 19.01 (18.25, 20.63)* 4/7   (0.571) 1.0 (0.0, 3.0)  0.50 (0.16, 2.83) 0.16 (0.00, 2.83) 
 ♂ 16 13 22.41 (20.06, 26.91)†    10/16 (0.625) 1.0 (0.0, 2.0)  2.01 (0.20, 11.04) 0.54 (0.00, 13.58) 
 
HHFO ♀   9   7 17.82 (14.97, 21.59)* 3/9   (0.333) 0.0 (0.0, 3.0)  1.04 (0.39, 4.91) 0.00 (0.00, 8.87) 
 ♂ 12 10 20.27 (17.43, 23.83)† 5/12 (0.417) 0.0 (0.0, 4.0)  0.81 (0.16, 3.63) 0.00 (0.00, 6.77) 
 
THFO ♀ 12 15 18.93 (16.30, 22.98)* 4/12 (0.333)* 0.0 (0.0, 7.0)*  3.14 (0.44, 12.56)* 0.00 (0.00, 27.98)♦ 
 ♂ 11 28 23.11 (20.32, 25.76)†    10/11 (0.909)* 2.0 (0.0, 7.0)*♦  0.91 (0.16, 9.62)* 4.45 (0.00, 13.16)♦ 
Final weight, number, size, and load are given by median (minimum, maximum). N, Number of animals; FW, 
final weight; FO, native fish oil; HFO, hydrogenated fish oils; AOM, azoxymethane; PHFO, partially 
hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil. aNumber of 
tumors for analysis of their size. bTumor incidence, number of animals with tumor/number of animals in the 
group. cTumor number, total number of tumors per animal in the group. dTumor size, area of aberrant tissue per 
tumor per animal with tumor in the group. eTumor load, total tumor area per animal in the group. ♦0.20 ≥ P > 
0.05, *P ≤ 0.05, † P ≤ 0.005. ﻿﻿﻿ 
 
 
Table 2 Effects of HFO versus SO for females, and versus BO for males on final weight and colorectal tumor 
parameters in AOM treated A/J mice.  
Diet N Na   FW, g Incidenceb   Numberc Sized, mm2 Loade, mm2
 
♀ 
SO 10 16 24.95 (20.51, 32.35)††† 9/10 (0.900)*♦ 1.5 (0.0, 3.0) 4.44 (0.24, 10.75)*   6.18 (0.00, 3.00)** 
PHFO   7   6 19.01 (18.25, 20.63)† 4/7   (0.571) 1.0 (0.0, 3.0) 0.50 (0.16, 2.83)*   0.16 (0.00, 2.83)* 
HHFO   9   7 17.82 (14.97, 21.59)† 3/9   (0.333)♦ 0.0 (0.0, 3.0) 1.04 (0.39, 4.91)   0.00 (0.00, 8.87)* 
THFO 12 15 18.93 (16.30, 22.98)† 4/12 (0.333)* 0.0 (0.0, 7.0) 3.14 (0.44, 12.56)   0.00 (0.00, 27.98) 
 
♂ 
BO 13 26 27.53 (21.92, 33.11)†††   11/13 (0.846)♦ 1.0 (0.0, 10.0) 1.08 (0.16, 5.94)   3.97 (0.00, 10.84)♦* 
PHFO 16 13 22.41 (20.06, 26.91)†   10/16 (0.625) 1.0 (0.0, 2.0) 2.01 (0.20, 11.04)   0.54 (0.00, 13.58)♦ 
HHFO 12 10 20.27 (17.43, 23.83)† 5/12 (0.417)♦ 0.0 (0.0, 4.0) 0.81 (0.16, 3.63)   0.00 (0.00, 6.77)* 
THFO 11 28 23.11 (20.32, 25.76)†   10/11 (0.909) 2.0 (0.0, 7.0) 0.91 (0.16, 9.62)   4.45 (0.00, 13.16) 
Final weight, number, size and load are given by median (minimum, maximum). N, Number of animals; FW, 
final weight; SO, refined soybean oil; BO, butter oil without water and salt. HFO, hydrogenated fish oils; AOM, 
azoxymethane; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally 
hydrogenated fish oil; aNumber of tumors for analysis of their size. bTumor incidence, number of animals with 
tumor/number of animals in group. cTumor number, total number of tumors per animal in the group. dTumor 
size, area of aberrant tissue per tumor per animal with tumor in the group. eTumor load, total tumor area per 
animal in the group. ♦0.20 ≥ P > 0.05, *P ≤ 0.05, † P ≤ 0.005. 
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Table 3 Effects of HFO or HSO on final weight and colorectal tumor parameters in AOM treated A/J mice 
compared by increasing hydrogenation degree. 
Diet N Na  FW, g Incidenceb   Numberc   Sized, mm2    Loade, mm2
 
♀ 
PHFO   7   6 19.01 (18.25, 20.63)♦ 4/7   (0.571) 1.0 (0.0, 3.0) 0.50 (0.16, 2.83)*   0.16 (0.00, 2.83) 
HHFO   9   7 17.82 (14.97, 21.59)♦♦ 3/9   (0.333) 0.0 (0.0, 3.0) 1.04 (0.39, 4.91)   0.00 (0.00, 8.87) 
THFO 12 15 18.93 (16.30, 22.98)♦ 4/12 (0.333) 0.0 (0.0, 7.0) 3.14 (0.44, 12.56)*   0.00 (0.00, 27.98) 
 
PHSO 13 28 20.51 (17.56, 23.12)** 8/13 (0.615) 2.0 (0.0, 7.0)* 3.14 (0.44, 9.62)   8.29 (0.00, 21.85)♦ 
HHSO 16   5 18.08 (15.21, 20.86)* 5/16 (0.313) 0.0 (0.0, 1.0)* 3.97 (0.20, 18.47)   0.00 (0.00, 18.47)♦ 
THSO 12 11 17.96 (16.62, 19.98)*♦ 6/12 (0.500) 0.5 (0.0, 3.0) 3.14 (0.20, 12.56)   0.32 (0.00, 15.01) 
 
♂ 
PHFO 16 13 22.41 (20.06, 26.91)♦    10/16 (0.625) 1.0 (0.0, 2.0)* 2.01 (0.20, 11.04)   0.54 (0.00, 13.58)♦ 
HHFO 12 10 20.27 (17.43, 23.83)♦♦ 5/12 (0.417)♦ 0.0 (0.0, 4.0)* 0.81 (0.16, 3.63)   0.00 (0.00, 6.77)* 
THFO 11 28 23.11 (20.32, 25.76)♦*    10/11 (0.909)♦ 2.0 (0.0, 7.0)** 0.91 (0.16, 9.62)   4.45 (0.00, 13.16)♦* 
 
PHSO   8 16 23.26 (20.67, 26.72)* 7/8   (0.875) 2.0 (0.0, 4.0)♦ 3.14 (0.24, 9.62)   4.46 (0.00, 23.19) 
HHSO   5   2 21.97 (19.74, 24.20)* 2/5   (0.400)♦ 0.0 (0.0, 1.0)♦♦ 3.13 (0.33, 5.94)   0.00 (0.00, 5.94)♦ 
THSO 11 21 20.96 (18.78, 23.91)*♦    10/11 (0.909)♦ 2.0 (0.0, 6.0)♦ 1.13 (0.16, 15.90)   0.80 (0.00, 29.30)♦ 
Final weight, number, size and load are given by median (minimum, maximum). HFO, hydrogenated fish oils; 
HSO, hydrogenated soybean oils; AOM, azoxymethane; N, number of animals; FW, final weight; PHFO, 
partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil; 
PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally 
hydrogenated soybean oil. aNumber of tumors for analysis of their size. bTumor incidence, number of animals 
with tumor/number of animals in the group. cTumor number, total number of tumors per animal in the group. 
dTumor size, area of aberrant tissue per tumor per animal with tumor in the group. eTumor load, total tumor area 
per animal in the group. ♦0.20 ≥ P > 0.05, *P ≤ 0.05, † P ≤ 0.005. 
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Table 4 Effects of HFO versus HSO on final weight and colorectal tumor parameters in AOM treated A/J mice 
by corresponding hydrogenation degrees. 
Diet N Na  FW, g Incidenceb   Numberc   Sized, mm2 Loade, mm2
 
♀ 
PHFO   7   6 19.01 (18.25, 20.63) 4/7   (0.571) 1.0 (0.0, 3.0) 0.50 (0.16, 2.83)†   0.16 (0.00, 2.83) 
PHSO 13 28 20.51 (17.56, 23.12) 8/13 (0.615) 2.0 (0.0, 7.0) 3.14 (0.44, 9.62)†   8.29 (0.00, 21.85) 
 
HHFO   9   7 17.82 (14.97, 21.59) 3/9   (0.333) 0.0 (0.0, 3.0) 1.04 (0.39, 4.91)   0.00 (0.00, 8.87) 
HHSO 16   5 18.08 (15.21, 20.86) 5/16 (0.313) 0.0 (0.0, 1.0) 3.97 (0.20, 18.47)   0.00 (0.00, 18.47) 
 
THFO 12 15 18.93 (16.30, 22.98) 4/12 (0.333) 0.0 (0.0, 7.0) 3.14 (0.44, 12.56)   0.00 (0.00, 27.98) 
THSO 12 11 17.96 (16.62, 19.98) 6/12 (0.500) 0.5 (0.0, 3.0) 3.14 (0.20, 12.56)   0.32 (0.00, 15.01) 
 
♂ 
PHFO 16 13 22.41 (20.06, 26.91)    10/16 (0.625) 1.0 (0.0, 2.0)♦ 2.01 (0.20, 11.04)   0.54 (0.00, 13.58)* 
PHSO   8 16 23.26 (20.67, 26.72) 7/8   (0.875) 2.0 (0.0, 4.0)♦ 3.14 (0.24, 9.62)   4.46 (0.00, 23.19)* 
 
HHFO 12 10 20.27 (17.43, 23.83) 5/12 (0.417) 0.0 (0.0, 4.0) 0.81 (0.16, 3.63)   0.00 (0.00, 6.77) 
HHSO   5   2 21.97 (19.74, 24.20) 2/5   (0.400) 0.0 (0.0, 1.0) 3.13 (0.33, 5.94)   0.00 (0.00, 5.94) 
 
THFO 11 28 23.11 (20.32, 25.76)*    10/11 (0.909) 2.0 (0.0, 7.0) 0.91 (0.16, 9.62)   4.45 (0.00, 13.16) 
THSO 11 21 20.96 (18.78, 23.91)*    10/11 (0.909) 2.0 (0.0, 6.0) 1.13 (0.16, 15.90)   0.80 (0.00, 29.30) 
Final weight, number, size and load are given by median (minimum, maximum). HFO, hydrogenated fish oils; 
HSO, hydrogenated soybean oils; AOM, azoxymethane; N, number of animals; FW, final weight; PHFO, 
partially hydrogenated fish oil; PHSO, partially hydrogenated soybean oil; HHFO, highly hydrogenated fish oil; 
HHSO, highly hydrogenated soybean oil; THFO, totally hydrogenated fish oil; THSO, totally hydrogenated 
soybean oil. aNumber of tumors for analysis of their size. bTumor incidence, number of animals with 
tumor/number of animals in the group. cTumor number, total number of tumors per animal in the group. dTumor 
size, area of aberrant tissue per tumor per animal with tumor in the group. eTumor load, total tumor area per 
animal in the group. ♦0.20 ≥ P > 0.05, *P ≤ 0.05, † P ≤ 0.005. 
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Figures 1 and 2. A survey of tumor incidence, number, size, and load along with final weight by all the 
experimental oils, separate curves for female and male AOM treated A/J mice. BO, butter oil; FO, fish oil; 
PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish 
oil; SO, soybean oil; PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; 
THSO, totally hydrogenated soybean oil. 
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Figures 3 and 4. Weight development wk 3-15 in AOM treated A/J mice fed butter oil (BO), fish oil (FO), 
partially hydrogenated fish oil (PHFO), highly hydrogenated fish oil (HHFO), totally hydrogenated fish oil 
(THFO), soybean oil (SO), partially hydrogenated soybean oil (PHSO), highly hydrogenated soybean oil 
(HHSO), and totally hydrogenated soybean oil (THSO), separate curves for female and male animals. 
 146
Effects of hydrogenated fish oil in experimental colorectal carcinogenesis in A/J mice  Article   42 
Figures 
 
 
Genders - median tumor 
incidence A/J mice
0
0,2
0,4
0,6
0,8
1
BO F
O
PH
FO
H
H
FO
TH
FO SO
PH
SO
H
H
SO
TH
SO
Treatment
In
ci
de
nc
e
17
19
21
23
25
27
29
31
Fi
na
l w
ei
gh
t, 
g
Incidence females Incidence males
FW females FW males
 
Genders - median tumor 
number A/J mice
0
0,5
1
1,5
2
2,5
BO F
O
PH
FO
H
H
FO
TH
FO SO
PH
SO
H
H
SO
TH
SO
Treatment
N
um
be
r
17
19
21
23
25
27
29
31
Fi
na
l w
ei
gh
t, 
g
Number females Number males
FW females FW males
 
Figures 5 and 6. Separate curves for tumor incidence and number along with final weight (FW) for female and 
male AOM treated A/J mice. BO, butter oil; FO, fish oil; PHFO, partially hydrogenated fish oil; HHFO, highly 
hydrogenated fish oil; THFO, totally hydrogenated fish oil; SO, soybean oil; PHSO, partially hydrogenated 
soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally hydrogenated soybean oil. 
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Figures 7 and 8. Separate curves for tumor size and load along with final weight (FW) for female and male AOM 
treated A/J mice. BO, butter oil; FO, fish oil; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated 
fish oil; THFO, totally hydrogenated fish oil; SO, soybean oil; PHSO, partially hydrogenated soybean oil; 
HHSO, highly hydrogenated soybean oil; THSO, totally hydrogenated soybean oil. 
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Figures 9 and 10. Series 1 Change in effects when FO was hydrogenated. Tumor incidence, number, size, and 
load along with final weight, separate curves for female and male AOM treated A/J mice. FO, fish oil; PHFO, 
partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil. 
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Figures 11 and 12. Series 2 Change in protective properties when FO was hydrogenated. Tumor incidence, 
number, size, and load along with final weight, separate curves for female and male AOM treated A/J mice. 
PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish 
oil; SO, soybean oil; BO, butter oil. 
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Figures 13 and 14. Series 3 Effects of increasing hydrogenation degree of fish or soybean oil. Tumor incidence, 
number, size, and load along with final weight, separate curves for female and male AOM treated A/J mice. 
PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish 
oil; PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally 
hydrogenated soybean oil. 
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Figures 15 and 16. Series 4 Effects of corresponding hydrogenation degrees of fish and soybean oil. Tumor 
incidence, number, size, and load along with final weight, separate curves for female and male AOM treated A/J 
mice. PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated 
fish oil; PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally 
hydrogenated soybean oil. 
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DIFFERENCES IN EFFECTS BETWEEN GENDERS 
 
Induction of CRC, shown by tumor incidence and number 
 
Table 1 Risk estimates with confidence intervals and p-values for gender differences in AOM treated A/J mice fed butter oil, 
fish oils, and soybean oils.  
 
Gender differencesa   Animals TUMOR INCIDENCE Risk estimate 
Animals with and without tumors   N   ♂ - ♀ Df P-valueb RR ♂/♀ (95 % CI)  
 
Association   199     95 - 104 1 0.001† 1.528 (1.196, 1.952)* 
Differences within groups 
BO 27 13 - 14 (1)  0.103♦ 1.692 (0.954, 3.001) 
FO 20   9 - 11 (1)  0.065♦ 3.667 (0.964, 13.947) 
PHFO 23 16 -   7 (1)  1.000 1.094 (0.519, 2.305) 
HHFO 21 12 -   9 (1)  1.000 1.250 (0.399, 3.912) 
THFO 23 11 - 12 (1)  0.009* 2.727 (1.199, 6.203)* 
SO 20 10 - 10 (1)  0.303 0.667 (0.386, 1.152) 
PHSO 21   8 - 13 (1)  0.336 1.422 (0.860, 2.352) 
HHSO 21   5 - 16 (1)  1.000 1.280 (0.350, 4.680) 
THSO 23 11 - 12 (1)  0.069♦ 1.818 (1.002, 3.299)* 
aPearson Chi-Square Test was used and Fisher’s Exact Test when Df figure in parenthesis. bP-values have not been adjusted à 
la Bonferroni. *P ≤ 0.05 or 95 % CI not including 1. † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; RR, relative risk; 
CI, confidence interval; BO, butter oil without water and salt; FO, native fish oil; PHFO, partially hydrogenated fish oil; 
HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil; SO, refined soybean oil; PHSO, partially 
hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally hydrogenated soybean oil. 
 
 
Table 2 Estimated median gender differences for tumor number and final weight in AOM treated A/J mice fed butter oil, fish 
oils, and soybean oils, with p-values.  
 
Gender differencesa   Animals TUMOR NUMBER  Final weight 
Animals with and without tumors   N     ♂ - ♀ P-valueb md . md, g ♂/♀ P-value 
 
Association   199     95 - 104   0.003† . 3.7 1.2 < 0.0005†c 
Differences within groups ♂-♀ . 
BO 27   13 - 14 0.147♦ 0.5 . 5.0 1.2 < 0.0005† 
FO 20     9 - 11 0.053♦ 1.0 . 5.9 1.3     0.001† 
PHFO 23   16 -   7 0.915 0.0 . 3.4 1.2 < 0.0005† 
HHFO 21   12 -   9 0.877 0.0 . 2.5 1.1     0.003† 
THFO 23   11 - 12 0.041* 2.0 . 4.2 1.2 < 0.0005† 
SO 20   10 - 10 0.845 0.0 . 5.0 1.2     0.004† 
PHSO 21     8 - 13 0.814 0.0 . 2.8 1.1     0.001† 
HHSO 21     5 - 16 1.000 0.0 . 3.9 1.2     0.002† 
THSO 23   11 - 12 0.092﻿﻿♦ 1.5 . 3.0 1.2 < 0.0005† 
aMann-Whitney Test with Exact Sig. (2-sided) was used. bP-values have not been adjusted à la Bonferroni. cAsymp. Sig. (2-
sided). *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. md, estimated median difference; BO, butter oil without water and salt; FO, 
native fish oil; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish 
oil; SO, refined soybean oil; PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, 
totally hydrogenated soybean oil. 
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Growth of CRC, shown by tumor size 
 
Table 3 Estimated median gender differences for tumor size and final weight in AOM treated A/J mice fed butter oil, fish oils, 
and soybean oils, with p-values.  
 
Gender differencesa    Tumors TUMOR SIZE . Final weight 
Animals with tumors   N   ♂ - ♀ P-valueb md, mm2 . md, g ♂/♀   P-Value 
 
Association   249   145 - 104 0.001†c  . 3.7 1.2 < 0.0005†c
Differences within groups ♂ - ♀ . 
BO 40 26 - 14 0.817  0.1 . 5.0 1.2 < 0.0005† 
FO 11   9 -   2 0.909 -2.4 . 5.9 1.3     0.001† 
PHFO 19 13 -   6 0.253  1.5 . 3.4 1.2 < 0.0005† 
HHFO 17 10 -   7 0.239 -0.2 . 2.5 1.1     0.003† 
THFO 43 28 - 15 0.026* -2.2 . 4.2 1.2 < 0.0005† 
SO 36 20 - 16 0.050* -3.2 . 5.0 1.2     0.004† 
PHSO 44 16 - 28 0.517  0.0 . 2.8 1.1     0.001† 
HHSO   7   2 -   5 0.857 -0.8 . 3.9 1.2     0.002† 
THSO 32 21 - 11 0.218 -2.8 . 3.0 1.2 < 0.0005† 
aMann-Whitney Test with Exact Sig. (2-sided) was used. bP-values have not been adjusted à la Bonferroni. cAsymp. Sig. (2-
sided). *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. md, estimated median difference; BO, butter oil without water and salt; FO, 
native fish oil; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish 
oil; SO, refined soybean oil; PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, 
totally hydrogenated soybean oil. 
 
 
Tumor load, shows induction and/or growth of CRC 
 
Table 4 Estimated median gender differences for tumor load and final weight in AOM treated A/J mice fed butter oil, fish oils, 
and soybean oils, with p-values.  
 
Gender differencesa  Animals TUMOR LOAD . Final weight 
animals with and without tumors   N   ♂ - ♀ P-valueb md, mm2 . md, g ♂/♀ P-value 
 
Association   199 95 - 104 0.033* . 3.7 1.2 < 0.0005†c
Differences within groups ♂ - ♀ .    
BO 27 13 - 14 0.086♦  3.8 . 5.0 1.2 < 0.0005† 
FO 20   9 - 11 0.035*  0.8 . 5.9 1.3     0.001† 
PHFO 23 16 -   7 0.531  0.4 . 3.4 1.2 < 0.0005† 
HHFO 21 12 -   9 1.000  0.0 . 2.5 1.1     0.003† 
THFO 23 11 - 12 0.081♦  4.4 . 4.2 1.2 < 0.0005† 
SO 20 10 - 10 0.251 -2.4 . 5.0 1.2     0.004† 
PHSO 21   8 - 13 0.874 -3.8 . 2.8 1.1     0.001† 
HHSO 21   5 - 16 0.893  0.0 . 3.9 1.2     0.002† 
THSO 23 11 - 12 0.309  0.5 . 3.0 1.2 < 0.0005† 
aMann-Whitney Test with Exact Sig. (2-sided) was used. bP-values have not been adjusted à la Bonferroni. cAsymp. Sig. (2-
sided). *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. md, estimated median difference; BO, butter oil without water and salt; FO, 
native fish oil; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish 
oil; SO, refined soybean oil; PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, 
totally hydrogenated soybean oil. 
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DIFFERENCES IN EFFECTS BETWEEN TREATMENT GROUPS FOR FEMALE 
AND MALE ANIMALS SEPARATELY 
 
Table 5 Series 1. Risk estimates with confidence intervals and p-values for AOM treated A/J mice. Hydrogenated fish oils 
compared with unhydrogenated fish oil. 
 
Series 1a Animals TUMOR INCIDENCE Risk Estimate 
Animals with and without tumors N   n - n Df P-value P x 3b RR (95 % CI)  
 
Associations 
The fish oils ♀ 39   (3) 0.419 
 ♂ 48 (3) 0.104♦  
 
Differences between groups 
♀ PHFO - FO 18   7 - 11 (1) 0.141 0.423 3.143 (0.769, 12.850) 
 HHFO - FO 20   9 - 11 (1) 0.617 1.000 1.833 (0.386, 8.701) 
 THFO - FO 23 12 - 11 (1) 0.640 1.000 1.833 (0.414, 8.112) 
♂ PHFO - FO 25 16 -   9 (1) 1.000 1.000 0.938 (0.516, 1.705) 
 HHFO - FO 21 12 -   9 (1) 0.387 1.000 0.625 (0.277, 1.410) 
 THFO - FO 20 11 -   9 (1) 0.285 0.855 1.364 (0.828, 2.245) 
aFisher’s Exact Test was used. bP-value adjusted à la Bonferroni. *P ≤ 0.05 or 95 % CI not including 1. † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ 
P > 0.05. Df, degrees of freedom; RR, relative risk; CI, confidence interval; FO, native fish oil; PHFO, partially hydrogenated 
fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil. 
 
 
 
Table 6 Series 1. Estimated median differences for tumor number and final weight in AOM treated A/J mice, with p-values. 
Hydrogenated fish oils compared with unhydrogenated fish oil.  
 
Series 1a Animals TUMOR NUMBER . Final weight 
Animals with and without tumors N    n - n Df P-value P x 3b   md . P-value P x 3 
 . 
Associations . 
The fish oils ♀ 39   3 0.455 .     0.003c† 
 ♂ 48  3 0.023* . < 0.0005c† 
 . 
Differences between groups . md, g 
♀ PHFO - FO 18   7 - 11 0.107 0.321   1.0 . -1.8      0.045* 
 HHFO - FO 20   9 - 11 0.408 1.000   0.0 . -3.0     0.012* 
 THFO - FO 23 12 - 11 0.245 0.735   0.0 . -1.9     0.039* 
♂ PHFO - FO 25 16 -   9 1.000 1.000   0.0 . -4.3 < 0.0015† 
 HHFO - FO 21 12 -   9 0.581 1.000  -1.0 . -6.5 < 0.0015† 
 THFO - FO 20 11 -   9 0.033 0.099♦   1.0 . -3.6 < 0.0015† 
aKruskal-Wallis Test with Exact Sig. and Mann-Whitney Test with Exact Sig. (2-sided) were used. bP-value adjusted à la 
Bonferroni. cAsymp. Sig. *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; md, estimated median difference; 
FO, native fish oil; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated 
fish oil. 
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Table 7 Series 1. Estimated median differences for tumor size and final weight in AOM treated A/J mice, with p-values. 
Hydrogenated fish oils compared with unhydrogenated fish oil.  
 
Series 1a  Tumors TUMOR SIZE . Final weight 
Animals with tumors  N   n - n Df P-value P x 3b   md, mm2 . P-value P x 3 
 . 
Associations . 
The fish oils ♀ 30   3 0.082♦c .     0.003c 
 ♂ 60  3 0.456c . < 0.0005c† 
 . 
Differences between groups . md, g 
♀ PHFO - FO  8   6 -   2  0.643 1.000  -3.2 . -1.8     0.045* 
 HHFO - FO  9   7 -   2  1.000 1.000  -2.7 . -3.0     0.012* 
 THFO - FO  17 15 -   2  0.706 1.000  -0.6 . -1.9     0.039* 
♂ PHFO - FO 22 13 -   9 0.935 1.000   0.7 . -4.3 < 0.0015† 
 HHFO - FO 19 10 -   9 0.305 0.915  -0.5 . -6.5 < 0.0015† 
 THFO - FO 37 28 -   9 0.595 1.000  -0.4 . -3.6 < 0.0015† 
aKruskal-Wallis Test with Exact Sig. and Mann-Whitney Test with Exact Sig. (2-sided) were used. bP-value adjusted à la 
Bonferroni. cAsymp. Sig. *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; md, estimated median difference; 
FO, native fish oil; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated 
fish oil. 
 
 
 
Table 8 Series 1. Estimated median differences for tumor load and final weight in AOM treated A/J mice, with p-values. 
Hydrogenated fish oils compared with unhydrogenated fish oil.  
 
Series 1a Animals TUMOR LOAD . Final weight 
Animals with and without tumors N    n - n Df P-value P x 3b   md, mm2 . P-value P x 3 
 . 
Associations . 
The fish oils ♀ 39   3  0.598 .     0.003c 
 ♂ 48  3 0.017c* . < 0.0005c† 
 . 
Differences between groups . md, g 
♀ PHFO - FO 18   7 - 11 0.143 0.429   0.2 . -1.8    0.045* 
 HHFO - FO 20   9 - 11 0.438 1.000   0.0 . -3.0    0.012* 
 THFO - FO 23 12 - 11 0.385 1.000   0.0 . -1.9    0.039* 
♂ PHFO - FO 25 16 -   9 0.887 1.000  -0.2 . -4.3 < 0.0015† 
 HHFO - FO 21 12 -   9 0.200 0.600  -0.8 . -6.5 < 0.0015† 
 THFO - FO 20 11 -   9 0.181 0.543   3.7 . -3.6 < 0.0015† 
aKruskal-Wallis Test with Exact Sig. and Mann-Whitney Test with Exact Sig. (2-sided) were used. bP-value adjusted à la 
Bonferroni. cAsymp. Sig. *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; md, estimated median difference; 
FO, native fish oil; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated 
fish oil. 
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Table 9 Series 2. Risk estimates with confidence intervals and p-values for AOM treated A/J mice fed hydrogenated fish oils 
or soybean oil (females) or butter oil (males). 
 
Series 2a Animals TUMOR INCIDENCE Risk Estimate 
Animals with and without tumors N    n - n Df P-value P x 3b RR (95 % CI) 
 
Associations  
HFO and SO ♀ 38 (3) 0.029* 
HFO and BO ♂ 52 (3) 0.045* 
 
Differences between groups 
♀ SO - PHFO 17 10 -   7 (1) 0.250 0.750 1.575 (0.803, 3.090) 
 SO - HHFO 19 10 -   9 (1) 0.020 0.060♦ 2.700 (1.048, 6.959)* 
 SO - THFO 22 10 - 12 (1) 0.011 0.033* 2.700 (1.182, 6.170)* 
♂ PHFO - BO 29 16 - 13 (1) 0.238 0.714 0.739 (0.473, 1.152) 
 HHFO - BO 25 12 - 13 (1) 0.041 0.123♦ 0.492 (0.242, 1.000) 
 THFO - BO 24 11 - 13 (1) 1.000 1.000 1.074 (0.798, 1.447) 
aFisher’s Exact Test was used. bP-value adjusted à la Bonferroni. *P ≤ 0.05 or 95 % CI not including 1. † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ 
P > 0.05. Df, degrees of freedom; RR, relative risk; CI, confidence interval; HFO, hydrogenated fish oils; PHFO, partially 
hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil; BO, butter oil without water 
and salt; SO, refined soybean oil;  
 
 
 
Table 10 Series 2. Estimated median differences for tumor number and final weight in AOM treated A/J mice fed 
hydrogenated fish oils or soybean oil (females) or butter oil (males), with p-values. 
 
Series 2a Animals TUMOR NUMBER . Final weight 
Animals with and without tumors N    n - n Df P-value P x 3b     md . P-value P x 3 
 . 
Associations . 
HFO and SO ♀ 38  3 0.206 . < 0.0005c† 
HFO and BO ♂ 52  3 0.019c* . < 0.0005c†  
 . 
Differences between groups . md, g 
♀ SO - PHFO 17 10 -   7 0.128 0.384    0.5 .  6.0 < 0.0015† 
 SO - HHFO 19 10 -   9 0.078 0.234    1.5 .  7.2 < 0.0015† 
 SO - THFO 22 10 - 12 0.115 0.345    1.5 .  6.1 < 0.0015† 
♂ PHFO - BO 29 16 - 13 0.103 0.309    0.0 . -5.1 < 0.0015† 
 HHFO - BO 25 12 - 13 0.084 0.252   -1.0 . -7.2 < 0.0015† 
 THFO - BO 24 11 - 13 0.252 0.756    1.0 . -4.4 0.003† 
aKruskal-Wallis Test with Exact Sig. and Mann-Whitney Test with Exact Sig. (2-sided) were used. bP-value adjusted à la 
Bonferroni. cAsymp. Sig. *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; md, estimated median difference; 
HFO, hydrogenated fish oils; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally 
hydrogenated fish oil; BO, butter oil without water and salt; SO, refined soybean oil. 
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Table 11 Series 2. Estimated median differences for tumor size and final weight in AOM treated A/J mice fed hydrogenated 
fish oils or soybean oil (females) or butter oil (males), with p-values. 
 
Series 2a Tumors TUMOR SIZE . Final weight 
Animals with tumors N    n - n Df P-value P x 3b   md, mm2 . P-value P x 3 
 . 
Associations . 
HFO and SO ♀ 44   3 0.036*c . < 0.0005c† 
HFO and BO ♂ 77  3 0.471c . < 0.0005c† 
 . 
Differences between groups . md, g 
♀ SO - PHFO 22 16 -   6  0.016 0.048*    3.9 .  6.0 < 0.0015† 
 SO - HHFO 23 16 -   7  0.138 0.414    3.4 .  7.2 < 0.0015† 
 SO - THFO 31 16 - 15  0.747 1.000    1.3 .  6.1 < 0.0015† 
♂ PHFO - BO 39 13 - 26  0.924 1.000    0.9 . -5.1 < 0.0015† 
 HHFO - BO 36 10 - 26  0.197 0.591   -0.3 . -7.2 < 0.0015† 
 THFO - BO 54 28 - 26  0.754 1.000   -0.2 . -4.4 0.003† 
aKruskal-Wallis Test with Exact Sig. and Mann-Whitney Test with Exact Sig. (2-sided) were used. bP-value adjusted à la 
Bonferroni. cAsymp. Sig. *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; md, estimated median difference; 
HFO, hydrogenated fish oils; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally 
hydrogenated fish oil; BO, butter oil without water and salt; SO, refined soybean oil. 
 
 
 
Table 12 Series 2. Estimated median differences for tumor load and final weight in AOM treated A/J mice fed hydrogenated 
fish oils or soybean oil (females) or butter oil (males), with p-values. 
 
Series 2a Animals TUMOR LOAD . Final weight 
Animals with and without tumors N    n - n Df P-value P x 3b   md, mm2 . P-value P x 3 
 . 
Associations . 
HFO and SO ♀ 38  3 0.041*c . < 0.0005c† 
HFO and BO ♂ 52  3 0.003c† . < 0.0005c† 
 . 
Differences between groups . md, g 
♀ SO - PHFO 17 10 -   7 0.010 0.030*   6.0 .  6.0 < 0.0015† 
 SO - HHFO 19 10 -   9 0.015 0.045*   6.2 .  7.2 < 0.0015† 
 SO - THFO 22 10 - 12 0.073 0.219   6.2 .  6.1 < 0.0015† 
♂ PHFO - BO 29 16 - 13 0.035 0.105♦  -3.4 . -5.1 < 0.0015† 
 HHFO - BO 25 12 - 13 0.006 0.018*  -4.0 . -7.2 < 0.0015† 
 THFO - BO 24 11 - 13 0.399 1.000   0.5 . -4.4 0.003† 
aKruskal-Wallis Test with Exact Sig. and Mann-Whitney Test with Exact Sig. (2-sided) were used. bP-value adjusted à la 
Bonferroni. cAsymp. Sig. *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; md, estimated median difference; 
HFO, hydrogenated fish oils; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally 
hydrogenated fish oil; BO, butter oil without water and salt; SO, refined soybean oil. 
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Table 13 Series 3a. Risk estimates with confidence intervals and p-values for AOM treated A/J mice fed increasing 
hydrogenation degrees of fish oil.  
 
Series 3aa Animals TUMOR INCIDENCE Risk Estimate 
Animals with and without tumors N   n - n Df P-value P x 3b RR (95 % CI)  
 
Associations ♀ 28  (2) 0.616 
 ♂ 39    (2) 0.051(*)
Differences between groups 
♀ THFO - PHFO 19 12 -   7 (1) 0.377 1.000 0.583 (0.209, 1.627) 
 HHFO - PHFO 16   9 -   7 (1) 0.615 1.000 0.583 (0.189, 1.796) 
 THFO - HHFO 21 12 -   9 (1) 1.000 1.000 1.000 (0.295, 3.395) 
♂ THFO - PHFO 27 11 - 16 (1) 0.183 0.549 1.455 (0.953, 2.221) 
 HHFO - PHFO 28 12 - 16  1 0.274 0.822 0.667 (0.309, 1.439) 
 THFO - HHFO 23 11 - 12 (1) 0.027 0.081♦ 2.182 (1.089, 4.372)* 
aPearson Chi-Square Test was used and Fisher’s Exact Test when Df figure in parenthesis. bP-value adjusted à la Bonferroni. 
*P ≤ 0.05 or 95 % CI not including 1. † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; RR, relative risk; CI, 
confidence interval; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated 
fish oil.  
 
 
 
Table 14 Series 3a. Estimated median differences for tumor number and final weight in AOM treated A/J mice fed increasing 
hydrogenation degrees of fish oil, with p-values. 
 
Series 3aa Animals TUMOR NUMBER . Final weight 
Animals with and without tumors N   n - n Df P-value P x 3b   md . P-value P x 3 
 . 
Associations ♀ 28   2 0.851 . 0.061c♦ 
 ♂ 39   2 0.011* . 0.044c* 
Differences between groups . md, g 
♀ HHFO - PHFO 16   9 -   7 0.629 1.000  -1.0 . -1.2 0.165♦ 
 THFO - PHFO 19 12 -   7 0.735 1.000  -1.0 . -0.1 1.000 
 THFO - HHFO 21 12 -   9 0.857 1.000   0.0 .  1.1 0.123♦ 
♂ HHFO - PHFO 28 12 - 16 0.600 1.000  -1.0 . -2.1 0.078♦ 
 THFO - PHFO 27 11 - 16   0.010 0.030*   1.0 .  0.7 1.000 
 THFO - HHFO 23 11 - 12 0.015 0.045*   2.0 .  2.8 0.111♦ 
aKruskal-Wallis Test with Exact Sig. and Mann-Whitney Test with Exact Sig. (2-sided) were used. bP-value adjusted à la 
Bonferroni. cAsymp. Sig. *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; md, estimated median difference; 
PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil. 
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Table 15 Series 3b. Risk estimates with confidence intervals and p-values for AOM treated A/J mice fed increasing 
hydrogenation degrees of soybean oil. 
 
Series 3ba Animals TUMOR INCIDENCE Risk Estimate 
Animals with and without tumors N   n - n Df P-value P x 3b RR (95 % CI)  
 
Associations ♀ 41    2 0.254 
 ♂ 24 (2) 0.094♦ 
Differences between groups 
♀ THSO - PHSO 25 12 - 13  1 0.561 1.000 0.813 (0.399, 1.653) 
 HHSO - PHSO 29 16 - 13  1 0.103 0.309 0.508 (0.218, 1.181) 
 THSO - HHSO 28 12 - 16 (1) 0.441 1.000 1.600 (0.637, 4.019) 
♂ THSO - PHSO 19 11 -   8 (1) 1.000c 1.000 1.039 (0.753, 1.433) 
 HHSO - PHSO 13   5 -   8 (1) 0.217 0.651 0.457 (0.151, 1.380) 
 THSO - HHSO 16 11 -   5 (1) 0.063 0.189♦ 2.273 (0.764, 6.757) 
aPearson Chi-Square Test was used and Fisher’s Exact Test when Df figure in parenthesis. bP-value adjusted à la Bonferroni. 
cThe minimum expected count is 0.84. *P ≤ 0.05 or 95 % CI not including 1. † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of 
freedom; RR, relative risk; CI, confidence interval; PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated 
soybean oil; THSO, totally hydrogenated soybean oil. 
 
 
 
Table 16 Series 3b. Estimated median differences for tumor number and final weight in AOM treated A/J mice fed 
increasing hydrogenation degrees of soybean oils, with p-values. 
 
Series 3ba Animals TUMOR NUMBER . Final weight 
Animals with and without tumors N   n - n Df P-value P x 3b    md . P-value P x 3 
 . 
Associations ♀ 41    2  0.039* . 0.004c† 
 ♂ 24  2 0.033* . 0.021c* 
Differences between groups . md, g 
♀ HHSO - PHSO 29 16 - 13 0.016 0.048*   -2.0 . -2.4 0.012* 
 THSO - PHSO 25 12 - 13 0.223 0.669   -1.5 . -2.5 0.009* 
 THSO - HHSO 28 12 - 16 0.152 0.456   -0.5 . -0.1 1.000 
♂ HHSO - PHSO 13   5 -   8 0.037 0.111♦   -2.0 . -1.3 0.666 
 THSO - PHSO 19 11 -   8 0.661 1.000    0.0 . -2.3 0.015* 
 THSO - HHSO 16 11 -   5 0.026 0.078♦    2.0 . -1.0 0.960 
aKruskal-Wallis Test with Exact Sig. and Mann-Whitney Test with Exact Sig. (2-sided) were used. bP-value adjusted à la 
Bonferroni. cAsymp. Sig. *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; md, estimated median difference; 
PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally hydrogenated soybean 
oil.
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Table 17 Series 3a. Estimated median differences for tumor size and final weight in AOM treated A/J mice fed increasing 
hydrogenation degrees of fish oil, with p-values. 
 
Series 3aa Tumors TUMOR SIZE . Final weight 
Animals with tumors N    n - n Df P-value P x 3b    md, mm2 . P-value P x 3 
 . 
Associations ♀ 28   2 0.031c* . 0.061c♦ 
 ♂ 51   2 0.282c . 0.044c* 
Differences between groups . md, g 
♀ HHFO - PHFO 13   7 -   6 0.168 0.504    0.5 . -1.2 0.165♦ 
 THFO - PHFO 21 15 -   6 0.010 0.030*    2.6 . -0.1 1.000 
 THFO - HHFO 22 15 -   7 0.216 0.648    2.1 .  1.1 0.123♦ 
♂ HHFO - PHFO 23 10 - 13 0.118 0.354   -1.2 . -2.1 0.078♦ 
 THFO - PHFO 41 28 - 13 0.917 1.000   -1.1 .  0.7 1.000 
 THFO - HHFO 38 28 - 10 0.173 0.519    0.1 .  2.8 0.111♦ 
aKruskal-Wallis Test with Exact Sig. and Mann-Whitney Test with Exact Sig. (2-sided) were used. bP-value adjusted à la 
Bonferroni. cAsymp. Sig. *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; md, estimated median difference; 
PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil. 
 
 
 
Table 18 Series 3b. Estimated median differences for tumor size and final weight in AOM treated A/J mice fed increasing 
hydrogenation degrees of soybean oil, with p-values. 
 
Series 3ba Tumors TUMOR SIZE . Final weight 
Animals with tumors N    n - n Df P-value P x 3b    md, mm2 . P-value P x 3 
 . 
Associations ♀ 44   2 0.812c . 0.004c† 
 ♂ 39    2 0.304c . 0.021c* 
Differences between groups . md, g 
♀ HHSO - PHSO 33   5 - 28 0.634 1.000    0.8 . -2.4 0.012* 
 THSO - PHSO 39 11 - 28 0.740 1.000    0.0 . -2.5 0.009* 
 THSO - HHSO 16 11 -   5 0.597 1.000   -0.8 . -0.1 1.000 
♂ HHSO - PHSO 18   2 - 16 0.824 1.000    0.0 . -1.3 0.666 
 THSO - PHSO 37 21 - 16 0.124 0.372   -2.0 . -2.3 0.015* 
 THSO - HHSO 23 21 -   2 0.775 1.000   -2.0 . -1.0 0.960 
aKruskal-Wallis Test with Exact Sig. and Mann-Whitney Test with Exact Sig. (2-sided) were used. bP-value adjusted à la 
Bonferroni. cAsymp. Sig. *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; md, estimated median difference; 
PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally hydrogenated soybean 
oil.
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Table 19 Series 3a. Estimated median differences for tumor load and final weight in AOM treated A/J mice fed increasing 
degrees of hydrogenated fish oil, with p-values. 
 
Series 3aa Animals TUMOR LOAD . Final weight 
Animals with and without tumors N    n - n Df P-value P x 3b    md, mm2 . P-value P x 3 
 . 
Association ♀ 28  2 0.911 . 0.061c♦ 
 ♂ 39  2 0.005c† . 0.044c* 
Differences between groups . md, g 
♀ HHFO - PHFO 16   9 -   7 0.721 1.000   -0.2 . -1.2 0.165♦ 
 THFO - PHFO 19 12 -   7 0.882 1.000   -0.2 . -0.1 1.000 
 THFO - HHFO 21 12 -   9 0.724 1.000    0.0 .  1.1 0.123♦ 
♂ HHFO - PHFO 28 12 - 16 0.198 0.594   -0.5 . -2.1 0.078♦ 
 THFO - PHFO 27 11 - 16 0.017 0.051♦    3.9 .  0.7 1.000 
 THFO - HHFO 23 11 - 12 0.002 0.006*    4.4 .  2.8 0.111♦ 
aKruskal-Wallis Test with Exact Sig. and Mann-Whitney Test with Exact Sig. (2-sided) were used. bP-value adjusted à la 
Bonferroni. cAsymp. Sig. *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; md, estimated median difference; 
PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil. 
 
 
 
Table 20 Series 3b. Estimated median differences for tumor load and final weight in AOM treated A/J mice fed increasing 
degrees of hydrogenated soybean oil, with p-values. 
 
Series 3ba Animals TUMOR LOAD .   Final weight 
Animals with and without tumors N    n - n Df P-value P x 3b    md, mm2 . P-value P x 3 
 . 
Associations ♀ 41  2 0.094♦ . 0.004 c† 
 ♂ 24   2 0.085c♦ . 0.021c* 
Differences between groups . md, g 
♀ HHSO - PHSO 29 16 - 13 0.041 0.123♦   -8.3 . -2.4 0.012* 
 THSO - PHSO 25 12 - 13 0.189 0.567   -8.0 . -2.5 0.009* 
 THSO - HHSO 28 12 - 16 0.337 1.000    0.3 . -0.1 1.000 
♂ HHSO - PHSO 13   5 -   8 0.070 0.210   -4.5 . -1.3 0.666 
 THSO - PHSO 19 11 -   8 0.406 1.000   -3.7 . -2.3 0.015* 
 THSO - HHSO 16 11 -   5 0.052 0.156♦    0.8 . -1.0 0.960 
aKruskal-Wallis Test with Exact Sig. and Mann-Whitney Test with Exact Sig. (2-sided) were used. bP-value adjusted à la 
Bonferroni. cAsymp. Sig. *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; md, estimated median difference; 
PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally hydrogenated soybean 
oil.
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Table 21 Series 4. Risk estimates with confidence intervals and p-values for AOM treated A/J mice fed corresponding 
hydrogenation degrees of fish and soybean oil. 
 
Series 4a Animals TUMOR INCIDENCE Risk Estimate 
Animals with and without tumors N   n - n Df P-value P x 3b RR (95 % CI)  
 
Associations ♀ 69   (5) 0.526 
 ♂ 63    (5) 0.024* 
Differences between groups 
♀ PHSO - PHFO 20 13 -   7 (1) 1.000 1.000 1.077 (0.498, 2.331) 
 HHSO - HHFO 25 16 -   9 (1) 1.000 1.000 0.938 (0.289, 3.037) 
 THSO - THFO 24 12 - 12  1 0.408 1.000 1.500 (0.563, 3.997) 
♂ PHSO - PHFO 24   8 - 16 (1) 0.352 1.000 1.400 (0.883, 2.220) 
 HHSO - HHFO 17   5 - 12 (1) 1.000 1.000 0.960 (0.271, 3.402) 
 THSO - THFO 22 11 - 11 (1) 1.000 1.000 1.000 (0.768, 1.302) 
aPearson Chi-Square Test was used and Fisher’s Exact Test when Df figure in parenthesis. bP-value adjusted à la Bonferroni. 
*P ≤ 0.05 or 95 % CI not including 1. † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; RR, relative risk; CI, 
confidence interval; PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated 
fish oil; PHSO, partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally hydrogenated 
soybean oil. 
 
 
 
Table 22 Series 4. Estimated median differences for tumor number and final weight in AOM treated A/J mice fed 
corresponding hydrogenation degrees of fish and soybean oil, with p-values. 
 
Series 4a Animals TUMOR NUMBER  . Final weight 
Animals with and without tumors N   n - n Df P-value P x 3b   md . P-value P x 3 
 . 
Associations ♀ 69   5 0.256 . 0.007c* 
 ♂ 63    5 0.005† . 0.007c* 
Differences between groups . md, g 
♀ PHSO - PHFO 20 13 -   7  0.330 0.990   1.0 .  1.5 0.489 
 HHSO - HHFO 25 16 -   9  0.688 1.000   0.0 .  0.3 1.000 
 THSO - THFO 24 12 - 12   0.771 1.000   0.5 . -1.0 0.384 
♂ PHSO - PHFO 24   8 - 16 0.028 0.084♦   1.0 .  0.9 0.792 
 HHSO - HHFO 17   5 - 12 0.748 1.000   0.0 .  1.7 0.984 
 THSO - THFO 22 11 - 11 0.498 1.000   0.0 . -2.2 0.048* 
aKruskal-Wallis Test with Exact Sig. and Mann-Whitney Test with Exact Sig. (2-sided) were used. bP-value adjusted à la 
Bonferroni. cAsymp. Sig. *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; md, estimated median difference; 
PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil; PHSO, 
partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally hydrogenated soybean oil. 
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Table 23 Series 4. Estimated median differences for tumor size and final weight in AOM treated A/J mice fed corresponding 
hydrogenation degrees of fish and soybean oil, with p-values. 
 
Series 4a Tumors TUMOR SIZE . Final weight 
Animals with tumors N    n - n Df P-value P x 3b    md, mm2 . P-value P x 3 
 . 
Associations ♀ 72    5 0.065 c♦ . 0.007c* 
 ♂ 90     5 0.265c . 0.007c* 
Differences between groups . md, g 
♀ PHSO - PHFO 34 28 -   6 0.001 0.003†    2.6 .  1.5 0.489 
 HHSO - HHFO 12   5 -   7  0.321 0.963    2.9 .  0.3 1.000 
 THSO - THFO 26 11 - 15  0.655 1.000    0.0 . -1.0 0.384 
♂ PHSO - PHFO 29 16 - 13 0.187 0.561    1.1 .  0.9 0.792 
 HHSO – HHFO 12   2 - 10 0.485 1.000    2.3 .  1.7 0.984 
 THSO - THFO 49 21 - 28 0.760 1.000    0.2 . -2.2 0.048* 
aKruskal-Wallis Test with Exact Sig. and Mann-Whitney Test with Exact Sig. (2-sided) were used. bP-value adjusted à la 
Bonferroni. cAsymp. Sig. *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; md, estimated median difference; 
PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil; PHSO, 
partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally hydrogenated soybean oil. 
 
 
 
Table 24 Series 4. Estimated median differences for tumor load and final weight in AOM treated A/J mice fed corresponding 
hydrogenation degrees of fish and soybean oils, with p-values. 
 
Series 4a Animals TUMOR LOAD . Final weight 
Animals with and without tumors N    n - n Df P-value P x 3b    md, mm2 . P-value P x 3 
 . 
Associations ♀  69    5 0.314 . 0.007c* 
 ♂ 63     5 0.004c† . 0.007c* 
Differences between groups . md, g 
♀ PHSO - PHFO 20 13 -   7 0.148 0.444    8.1 .  1.5 0.489 
 HHSO - HHFO 25 16 -   9 0.897 1.000    0.0 .  0.3 1.000 
 THSO - THFO 24 12 - 12 0.690 1.000    0.3 . -1.0 0.384 
♂ PHSO - PHFO 24   8 - 16 0.014 0.042*    3.9 .  0.9 0.792 
 HHSO - HHFO 17   5 - 12 1.000 1.000    0.0 .  1.7 0.984 
 THSO - THFO 22 11 - 11 0.468 1.000   -3.6 . -2.2 0.048* 
aKruskal-Wallis Test with Exact Sig. and Mann-Whitney Test with Exact Sig. (2-sided) were used. bP-value adjusted à la 
Bonferroni. cAsymp. Sig. *P ≤ 0.05, † P ≤ 0.005, ﻿﻿﻿♦0.20 ≥ P > 0.05. Df, degrees of freedom; md, estimated median difference; 
PHFO, partially hydrogenated fish oil; HHFO, highly hydrogenated fish oil; THFO, totally hydrogenated fish oil; PHSO, 
partially hydrogenated soybean oil; HHSO, highly hydrogenated soybean oil; THSO, totally hydrogenated soybean oil. 
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